tsawon lokacin da kake da wadannan alamun?
kuma duk wani ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman ma a shekarunka
musamman idan kana da zazzabi
kuma cholesterol da jini kuma dole ne a duba
kuma kuna da zazzabi a yanzu?
kuna jin ciwon kirji a yanzu?
kana da wahalar numfashi?
Za ku iya gaya mani idan kuna da wasu alamun?
Kuma yawan zazzabi da kuka yi?
kuma ina tari ma
kuma ina da ɗan sanyi kuma ina tari
kuma ina da ciwon kirji sosai yau
Shin wannan lokacin yana da kyau don kamuwa da cutar hay?
kuma ina da wannan ciwon a kirji
kuma ina ganin ina da zazzabi kadan
Za ka iya gaya mini inda kake jin ciwon kirji?
kuma suna da zazzabi kadan suma
da kuma tarihin ciwon sukari
kuma kun san ina jin kamar kirji na zai fashe
kuma kun san mutane suna tari a kaina a koda yaushe
kuma kana da ciwo a kirji
kuma ka ce kana jin matsin lamba a kirjinka
Shin akwai wani cikin iyalinku da yake da ciwon zuciya ko ciwon zuciya ko ciwon zuciya ko kuma mai yawan jini?
kuna da wasu alamomi ko matsaloli ban da ciwon tsoka?
akwai wasu marasa lafiya a gidanku da ke da alamun cutar?
kuna da wasu alamun cutar?
Shin kana da numfashi?
har yanzu kuna da ciwon kirji?
saboda lokacin mura ne
amma kuma bai kamata mu yi watsi da yiwuwar ciwon kirji da ke tattare da matsalar zuciya ba
amma wannan ciwon kirji yafi matsala yanzu
amma ina da wahalar numfashi
amma na san mutane da dama suna tari a kaina
amma dole ne mu kula da duk wani ciwo a kirji da kulawa sosai
Amma kuna numfashi daidai a yanzu, ko ba haka ba?
domin na manta gaba daya saboda wannan ciwon a kirji
kana jin kamar an matsa maka kirji
har yanzu kana da numfashi kaɗan?
suna gunaguni cewa suna rashin lafiya ko kuma suna da irin wannan alamun?
kuna da wata cuta ta kullum kamar hawan jini ko wani abu makamancin haka?
kuna da wasu cututtuka, ko kuma ciwon sukari?
kuna da numfashi a baya ga wannan ciwon kirji?
Shin kana da hawan jini?
kana da numfashi a baya ga wannan?
Shin kun san irin alamun da ta ke da su?
Kuna ganin hoton?
ku sha ruwa mai yawa yau
duk da haka ina yin gwajin ciwon suga
duk da haka tana da alamun da suka yi kama da nawa
Yaya yawan zafin jikinka yake?
Yaya karfin jini naka yake?
idan har yanzu kana da zazzabi mai tsanani
idan kana da zazzabi ɗari biyu ko sama da haka
idan ka ga alamun cututtukanka ko matsalolin da kake da su sun cancanci ƙarin bincike
ina da zazzabi jiya
ni ma na samu zazzabi kadan
ina da zazzabi jiya
na ji ciwo mai tsanani a nan cikin kirji
Ina da wasu matsalolin numfashi ni ma
Zan aiko muku da hoto
naji ciwon kirji yau
ina da ciwon kai da zazzabi kadan yau
ina ganin mura ce
ina ganin karamin mura ne
Kamar wani mutum mai nauyi ne yake zaune a kan kirjinka?
ya fara da ciwon kai tare da zazzabi kusan lokaci guda
yana ciwo a tsakiya na kirji
ciwo ne mai raɗaɗi a kirji
yana cikin kirjina
yana tsakiyar kirjina
yana tsakiyar kirji
ina da ciwo a kirji
wannan ciwon kirji yana damuna sosai
ina son ki bayyana min wannan ciwon a kirji
kamar hawan jini ko ciwon sukari
kamar tsiri a tsakiyar kirji
yanzu don zazzabi zaka iya shan paracetamol
Mary, yaushe ne daga yanzu da kake da alamun cutar?
yanzu ka ce kana da ciwo a kirji
wani lokacin na kanji ciwo a kirji
OK kuna da wasu alamun bayyanar cututtuka ko kawai wannan ciwon kirji
Ko kuma wani yana zaune a kan kirjinka?
kusan iri daya ne da zazzabi da tari, ciwon kai da ciwon tsoka
a tsakiyar kirji
nuna min a wannan hoton inda kake ciwo
tun lokacin da kake da zazzabi
Don haka kuna ganin wasu daga cikin wadannan alamun zasu iya danganta da ciki?
Shin yaranku suna da wasu daga cikin wadannan alamun?
Ka faɗa min ciwon ƙirjinka
zazzabi yana ƙaruwa da dare
zazzabin da na yi a cikin kwanaki biyu da suka gabata
zazzabi ya fara ƙaruwa a daren jiya
Wannan shi ne Dr. Porter daga cibiyar tantancewa a cikin gaggawa
To, za ka iya gaya mini game da ciwon kirjinka?
Ina jin zafi a gaban jikina, a cikin kirji
da kyau, ina da ciwo mai tsanani a kirji
To, idan na samu wannan ciwon a kirji
wane irin ciwo kake da shi a kirjinka?
yaushe wannan ciwon kirji ya fara?
ina ciwon kirjinki?
ina kake jin wannan ciwon kirji a kirji
kana jin kamar an matsa maka a kirji
ka sani ina da ciwon sukari da sauransu
kin ce kina da wannan ciwon a kirji
Saurin karuwa a yawan kamuwa da cutar coronavirus (COVID-19) a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ingila, tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan masu kamuwa da cutar coronavirus (COVID-19) ya nuna irin wannan ci gaba a ƙasashen Tarayyar Turai/Yankin Tattalin Arzikin Turai da Ingila, wanda ke tabbatar da cewa ko da yake a matakai daban-daban, annobar COVID-19 tana ci gaba da sauri a duk ƙasashe.
Bisa ga abin da Italiya ta fuskanta, ƙasashe, asibitoci da sassan kula da marasa lafiya na musamman suna bukatar su shirya don ƙaruwar yawan marasa lafiya da ke da cutar COVID-19 da ke buƙatar kulawa, musamman masu kula da marasa lafiya.
A ranar 31 ga Disamba, 2019, an samu rahoton wani mutum da ya kamu da cutar sankarar bargo da ba a san dalilinsa ba a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta kasar Sin ta bayyana cewa sabon kwayar cutar coronavirus ne wanda yanzu ake kira coronavirus 2 mai cutar cututtukan numfashi mai tsanani (SARS-CoV-2).
Tun daga lokacin, cutar da ke haifar da kamuwa da SARS-CoV-2 an kira ta cutar coronavirus (COVID-19).
A yau, kusan kashi 80 cikin ɗari na mutanen da ke da COVID-19 suna da rashin lafiya mai sauƙi, wato, kamuwa da cutar numfashi tare da ciwon huhu ko babu ciwon huhu, kuma yawancinsu suna warkewa.
A cikin kusan kashi 14 cikin ɗari na masu cutar, COVID-19 yana haifar da mummunan rauni wanda ke buƙatar asibiti, yayin da sauran kashi 6 cikin ɗari na masu cutar ke samun mummunan yanayin cutar wanda ke buƙatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kusan kashi 4 cikin ɗari.
A cikin wannan binciken, mun kimanta yawan kamuwa da COVID-19 a kowace ƙasa a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai (EU/EEA) da kuma Ingila (UK), kuma mun kwatanta shi da na lardin Hubei, China.
Mun kuma kwatanta adadin masu kamuwa da COVID-19 a yanzu a cikin EU/EEA da UK da na Italiya na lokacin daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Masu kamuwa da COVID-19 a ƙasashen EU/EEA da Ingila
Bayan China, COVID-19 ta ci gaba da yaduwa, kuma halin da annobar COVID-19 ke ciki a sauran duniya yanzu yana kama da na ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cikin fitowar 5 ga Maris na Eurovigilance 2020, Spiteri et al. sun ba da rahoton farkon tabbatar da cutar COVID-19 a Turai bisa ga ma'anar WHO.
A cikin EU/EEA, Faransa ta bayar da rahoton mutane uku da suka kamu da cutar a ranar 24 ga Janairu, 2020 a cikin mutanen da suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano wasu mutane da cutar COVID-19 a kowace ƙasa 30 na EU/EEA da kuma Ingila (UK) inda, daga 31 ga Disamba, 2019, an samu mutum 39,768 da suka kamu da cutar da kuma mutum 1,727 da suka mutu, daga cikinsu akwai mutum 17,750 da suka kamu da cutar da kuma mutum 1,441 da suka mutu a Italiya kadai.
Samun jimlar adadin mutane da ke fama da cutar COVID-19
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana sabunta adadin masu kamuwa da COVID-19 da aka ruwaito a kowace ƙasa a duniya, wanda aka samo daga kafofin hukuma kamar ma'aikatun kiwon lafiya, hukumomin kiwon lafiya na ƙasa da na yanki da WHO, kowace rana da ƙarfe 8:00.
An yi amfani da wannan bayanan don tantance cigaban COVID-19 a cikin EU/EEA da Ingila, da kuma kwatanta shi da kwarewar Italiya.
Don tantance yawan masu kamuwa da cutar COVID-19, mun lissafa jimlar yawan masu kamuwa da cutar COVID-19 a cikin kwanaki 14 ta hanyar yin la'akari da yanayin COVID-19 a cikin kowace ƙasa ta EU/EEA da Ingila, daga ranar 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma kwatanta jimillar adadin masu cutar da aka ruwaito a kowace ƙasa a ranar 15 ga Maris, 2020 da ƙarfe 8:00 na safe da bayanan Italiya na lokacin daga 31 ga Janairu zuwa 15 ga Maris, 2020.
Canjin COVID-19 a cikin EU/EEA da UK
Yawan adadin mutane da suka kamu da cutar COVID-19 a cikin kwanaki 14 a cikin ƙasashen EU/EEA da Ingila ya yi daidai da na lardin Hubei na China (Hoto na 1).
A cikin EU/EEA da Birtaniya, yawan kamuwa da COVID-19 ya fara ƙaruwa a kusan 21 ga Fabrairu kafin ya ƙaru sosai a kusan 28 ga Fabrairu, 2020 (ƙarin bayani).
Wannan ci gaban ya fi yawa ne saboda saurin karuwar adadin masu kamuwa da cutar a Italiya, amma duk sauran ƙasashen EU/EEA da Ingila sun nuna irin wannan karuwar a cikin yawan kamuwa da COVID-19 (ƙarin bayanai).
Hoto na 2 ya nuna jimillar adadin masu kamuwa da COVID-19 a cikin EU/EEA da Ingila idan aka kwatanta da bayanan Italiya na lokacin daga 31 ga Janairu zuwa 15 ga Maris, 2020.
An lura cewa a ranar 15 ga Maris da ƙarfe 8:00, wasu ƙasashe 15 na EU/EEA da Ingila sun riga sun ba da rahoton jimlar adadin masu cutar kamar Italiya makonni 3 da suka gabata ko ƙasa da haka.
Sakamakon bincikenmu ya nuna cewa adadin masu kamuwa da COVID-19 yana ƙaruwa cikin sauri a cikin EU/EEA da Ingila.
Canjin yanayin cutar COVID-19 ya nuna cewa annobar tana ci gaba da sauri a duk ƙasashe.
Kuma wannan duk da cewa ƙasashe suna cikin matakai daban-daban kuma akwai bambance-bambance a cikin amsoshin sabis na kiwon lafiyar jama'a na ƙasa, bambance-bambance masu yuwuwa a cikin ma'anar shari'a da bambance-bambance a cikin hanyoyin zaɓar marasa lafiya da za a gwada don tabbatar da COVID-19, gami da gwajin kamawa.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta shafa na Italiya sun ba da rahoton cewa kusan kashi 10 cikin ɗari na marasa lafiyar COVID-19 suna bukatar kulawa mai tsanani, kuma kafofin watsa labarai sun ba da rahoton cewa asibitoci da sassan kula da gaggawa a waɗannan yankuna sun riga sun cika ƙarfin su.
Bayanai game da karɓar marasa lafiya na COVID-19 a asibitoci da/ko dakunan kulawa na musamman a halin yanzu suna samuwa a cikin EU/EEA don kashi 6 cikin ɗari da kashi 1 cikin ɗari na masu cutar, bi da bi (ba a gabatar da bayanai ba).
Duk da haka, akwai buƙatar tattara bayanai a kai a kai don haɓaka bayanan sa ido na yanzu waɗanda ke mai da hankali kan yawan adadin rahotanni da mutuwar.
Wani bincike da aka yi a 201011 ya nuna bambanci mai yawa a cikin adadin gadaje da ke akwai a sassan kulawa na tsakiya da na musamman a Turai, daga gadaje 29.2 ga mutane 100,000 a Jamus zuwa gadaje 4.2 a Portugal.
Hakan yana nufin cewa ƙasashen suna da ƙarin ko ƙasa da Italiya (12.5 gadaje na kulawa mai tsanani da matsakaici ga kowane mutum 100,000 a 201011).
Ana ba da yanayin samfurin da ya shafi cikawar kulawa, tare da kimantawa ga kowace ƙasa ta EU/EEA da Ingila na yawan masu cutar COVID-19 da aka kwantar a asibiti da ke da haɗarin kashi 90% na wucewar ƙarfin gado a cikin ICU, a cikin sabuntawa na shida na kimanta haɗarin haɗarin CEPCM na COVID-19.
Tun da yake har yanzu an tattara cututtuka a wasu yankuna na EU/EEA da UK, kuma asibitoci da cibiyoyin kulawa da gaggawa galibi suna ɗaukar ƙayyadadden yanki, ya kamata a fi dacewa a tattara bayanan shari'o'i da gadaje a matakin 2 na Ƙididdigar Ƙungiyoyin Ƙasa (NUTS 2).
Kwarewar Italiya da kuma ci gaban da ake samu a wasu ƙasashe ya nuna cewa annobar COVID-19 tana ci gaba cikin sauri a cikin EU/EEA da kuma Ingila.
Saboda haka, ƙasashe, asibitoci da sassan kula da marasa lafiya masu tsanani dole ne su shirya don yanayin ci gaba da yaduwar SARS-CoV-2 a cikin al'umma da kuma ƙaruwar yawan marasa lafiya da ke da COVID-19 da ke buƙatar kulawa, musamman masu kula da marasa lafiya masu tsanani, kamar a yankunan da cutar ta shafa a Italiya.
Kamar yadda aka nuna a cikin binciken haɗarin CEPCM na kwanan nan, hanzari, aiki da kuma cikakkiyar hanya yana da mahimmanci don jinkirta yaduwar SARS-COV-2, daga hanyar hanawa zuwa ragewa, saboda saurin karuwa da farkon adadin masu cutar na iya ba masu yanke shawara da asibitoci isasshen lokaci don fahimta, karɓa da daidaita amsar su daidai, idan ba a aiwatar da komai ba a gaba.
Binciken haɗarin da aka yi cikin sauri ya kuma nuna matakan kiwon lafiyar jama'a don rage tasirin annobar.
Akwai ɗan gajeren lokaci da kowace ƙasa za ta iya ƙara ƙarfin ƙoƙarin ta na hana yaduwar SARS-CoV-2 da rage matsin lamba a kan ma'aikatun kiwon lafiya.
Idan ba haka ba, tsarin kiwon lafiya na sauran ƙasashen EU/EEA na iya fuskantar ƙaruwar marasa lafiya da ke buƙatar kulawa mai tsanani a cikin kwanaki ko makonni masu zuwa.
Cutar coronavirus ta 2019 (COVID-19), wadda cutar SARS-CoV-2 ke haifarwa, ta kashe mutane sama da 3,000 kuma ta harba mutane sama da 80,000 a China da sauran wurare a duniya, wanda hakan ya haifar da bala'in jin kai.
Kamar takwaransa, SARS-CoV, wanda ya haifar da dubban masu cutar SARS a 2003, SARS-CoV-2 na iya yaduwa ta hanyar bera kuma yana haifar da irin wannan alamun ta hanyar irin wannan tsari.
Koyaya, COVID-19 ba ta da tsanani da mutuwa kamar SARS, amma tana da saurin yaduwa, kuma tana shafar tsofaffi fiye da matasa kuma maza fiye da mata.
A sakamakon haka, mutane da yawa sun soma yin bincike a kan wannan cuta mai tasowa.
Za mu tattauna abubuwa na asali game da cututtuka, cututtuka, cututtuka, ganewar asali, magani, tsinkaya da kuma rigakafin cututtuka.
Ko da yake akwai tambayoyi da yawa da ba a amsa ba, muna fatan wannan binciken zai taimaka wajen fahimtar wannan muguwar cuta da kuma kawar da ita.
Bikin bazara a ranar 25 ga Janairu, 2020 ya yi tasiri sosai a kan Sinawa, waɗanda aka tilasta su kasance a kulle a cikin makon zinariya da kuma wasu makonni masu tsawo saboda yaduwar sabon cutar kwayar cuta.
Kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) da ta haifar da barkewar cutar SARS a shekara ta 2003; saboda haka, Hukumar Lafiya ta Duniya (WHO) ta kira ta SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma cutar da ke tattare da ita ana kiranta cutar coronavirus 19 (COVID-19).
Cutar ta fara ne a Wuhan kuma ta bazu cikin sauri a duk faɗin China kafin ta bazu zuwa kusan ƙasashe 50 a duniya.
Har zuwa 2 ga Maris, 2020, cutar ta haifar da mutane fiye da 80,000 da suka kamu da COVID-19, tare da marasa lafiya sama da 40,000 da aka kwantar a asibiti da kuma mutuwar sama da 3,000.
WHO ta ce COVID-19 ita ce  magabcin jama'a na 1 , mai yuwuwar zama mafi haɗari fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga bincike sama da 200 kan COVID-19, gami da fannonin ilimin ƙwayoyin cuta, cututtukan cututtuka, cututtukan cututtuka, ganewar asali da magani, tun lokacin da aka fara bayar da rahoto a ranar 7 ga Janairu, 2020 game da jerin ƙwayoyin cuta, waɗanda aka ware daga marasa lafiya da yawa.
Wannan bita ya yi ƙoƙari ya tattara ci gaban bincike a kan wannan sabon batu mai tasowa.
Da zaran mun iya, za mu gwada COVID-19 da SARS da kuma wata cuta mai kama da coronavirus, wato Middle East Respiratory Syndrome (MERS, wadda ta ɓarke a shekara ta 2012).
Za mu kuma duba abin da muka koya a kan yadda za a hana cutar da kuma yadda za a yi hasashen cutar, kuma za mu tattauna wasu batutuwa da ba a warware ba amma da ake bukatar gaggawa.
An saba ɗaukar coronavirus a matsayin ƙwayoyin cuta marasa mutuwa ga ɗan adam, galibi suna haifar da kusan kashi 15 cikin ɗari na mura 4.
Koyaya, a cikin wannan ƙarni, mun sami cututtukan coronavirus guda biyu masu cutarwa ga ɗan adam, wato SARS-CoV da MERS-CoV, waɗanda suka haifar da barkewar cutar da ta fara a China a 2003 da Saudi Arabiya a 2012, bi da bi, kafin ya bazu cikin sauri zuwa wasu ƙasashe da yawa tare da yawan kamuwa da cuta da mutuwa.
Saboda haka, cutar COVID-19 ta yanzu ita ce annobar korona ta uku da ta bulla a tarihin kwanan nan.
Kamar yadda aka nuna a Fig. Fig.1,1, an fara bayar da rahoton cutar sankarar bargo a Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta Kasa ta China.
Bayan kwana bakwai, an gano yadda cutar ta korona ta fito.
A ranar 15 ga Janairun 2020, an samu mutum na farko da ya mutu a Wuhan.
A halin yanzu, annobar ta yadu cikin sauri zuwa garuruwa, larduna da ƙasashe makwabta.
A ranar 20 ga watan Janairu, an ba da rahoton cewa wasu ma'aikatan kiwon lafiya sun kamu da cutar, wanda ke nuna cewa ana iya samun kamuwa da cutar daga mutum zuwa mutum.
A ranar 23 ga Janairu, an keɓe birnin Wuhan kuma an dakatar da duk hanyoyin sufuri.
A ranar 24 ga Janairu, binciken asibiti na farko game da cutar ya nuna cewa daga cikin mutane 41 da aka tabbatar da cutar, marasa lafiya 21 ne kawai suka taɓa cin kasuwa na abincin teku a Wuhan, wanda ake ganin asalin cutar daga dabba ne da ba a sani ba.
A ranar 30 ga watan Janairu, Hukumar Lafiya ta Duniya ta bayyana cutar a matsayin gaggawa ta kiwon lafiya a duniya.
A lokacin da aka rubuta wannan rahoton, cutar ta riga ta yadu zuwa dukan ƙasar Sin da kuma kusan ƙasashe 50 a duniya (Fig. (Fig.2).2).
Yayin da yanayin ke ci gaba cikin sauri, har yanzu ba a san iyakar cutar da kuma tsananin cutar ba.
A ranar 11 ga Fabrairu, 2020, binciken da aka yi a cibiyoyi da yawa da aka yi a kan marasa lafiya 8,866, ciki har da mutane 4,021 da aka tabbatar da cutar COVID-19, ya ba da cikakken bayanin annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 ya kamu da mutane a kowane zamani, amma mafi yawa a tsakanin shekaru 30 zuwa 65.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun haura shekaru 50, kaɗan ne kawai suka kasa shekara 20, kuma 14 ne kawai suka kasa shekara 10.
SARS-CoV-2 ya fi kamuwa da maza (0.31/100,000) fiye da mata (0.27/100,000).
COVID-19 ta bazu a cikin gidaje, musamman a lardin Hubei da kuma yankunan da ke kewaye da shi.
Matsakaicin lokacin da ya wuce tsakanin bayyanar cututtuka da ganewar asali na COVID-19 ya kasance kwanaki 5 (2-9).
Matsakaicin lokacin incubation ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin da ya wuce tsakanin bayyanar cututtuka da mutuwa ya kasance kwanaki 9.5 (4.8-13).
Yawan haifuwa na asali (R0) ya kasance 3.77 (95% CI: 3.51-4.05) kuma daidaitaccen R0 ya kasance 2.23-4.82.
Yawan mutanen da suka kamu da cutar ya karu sosai har zuwa 23 ga Janairu, 2020, wanda ya yi daidai da yawan ƙaura da aka yi kafin bikin bazara a China.
Mutuwar marasa lafiya da aka gano a matsayin tabbataccen lamari ya kasance 1.44% (CI 95%: 1.10-1.86%) da daidaitaccen mutuwar dukkan marasa lafiya ya kasance 3.06% (CI 95%: 2.02-4.59%).
Abubuwa uku da ke haifar da kamuwa da COVID-19 sune jinsi (maza), tsufa (≥ 60), da kuma ciwon huhu mai tsanani.
Kwayoyin cutar korona suna cikin ƙananan ƙwayoyin cuta masu girma da ke ɗauke da RNA guda.
Ana iya rarraba su zuwa jinsuna huɗu, wato, alpha, beta, gamma, da delta, waɗanda aka sani da cutar coronavirus da ke kamuwa da mutane a cikin jinsunan alpha da beta.
Glycoprotein Spike (S) na ambulaf ya ɗaure da enzyme mai canza angiotensin 2 (ACE2) da dipeptidyl peptidase-4 (DPP4) na masu karɓar kwayoyin halitta don SARS-CoV da MERS-CoV, bi da bi, sannan haɗuwa da membrane yana faruwa.
Ana sakin kwayar RNA ta kwayar cutar zuwa cikin kwayar halitta; bayan kwayar cutar ta kwayar halitta ta sakewa, kwayar RNA ta kwayar halitta tare da glycoproteins da nucleocapsid sun hada da kwayar halitta da ke dauke da virions, wanda ke haɗuwa da membrane plasma don sakin kwayar cutar.
An gabatar da jerin kwayoyin halittar SARS-CoV-2 na farko a ranar 10 ga Janairu, 2020.
An tabbatar da cewa SARS-CoV-2 wani sabon nau'in betacoronavirus ne, tare da fiye da kashi 99.98 cikin ɗari na asalin kwayoyin halitta tsakanin samfuran 10 da aka tattara daga wurin da cutar ta samo asali, kasuwar abincin teku ta Huanan a Wuhan.
SARS-CoV-2 ya fi kusa da SARS-CoV fiye da MERS-CoV.
Ta amfani da na'urar duban dan adam ta lantarki, an gano wasu ƙwayoyin SARS-CoV-2 a cikin ƙananan sassan jikin mutum na numfashi.
An gano cewa mutum ACE2 mai karɓar SARS-CoV-2 da SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana ɗaure da ACE2 na ɗan adam da ƙarancin ƙarfi fiye da na SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙarancin kamuwa da cuta fiye da SARS-CoV.
SARS-CoV-2 na iya samar da sabon ɗan gajeren furotin da aka tsara ta hanyar lorf3b da kuma furotin mai ɓoyewa wanda aka tsara ta hanyar lorf8.
Lorf3b na SARS-CoV-2 na iya taka rawa wajen cutar kwayar cuta da hana lIFNβ bayyanawa; duk da haka, lorf8 ba shi da sanannun yankuna ko alamu na aiki.
A ranar 18 ga Fabrairu, 2020, Zhou, et al. sun nuna tsarin cryo-ME na cikakken ɗan adam ACE2 a ƙuduri na 2.9 Å a cikin hadaddun tare da mai jigilar amino acid B0AT1.
Sun gano cewa hadaddun, wanda ke da fasalin buɗewa da rufewa, an haɗa shi a matsayin dimer kuma hadaddun ACE2-B0AT1 na iya ɗaure sunadarai biyu na S, wanda ke ba da alamomi don ganewa da kamuwa da cutar coronavirus.
B0AT1 na iya zama maƙasudin magani don tantance magunguna don kawar da kamuwa da SARS-CoV-2.
Mai watsa shiri na asali da mai watsa shiri na tsakiya
An gano cewa SARS-CoV da MERS-CoV sun samo asali ne daga bera kuma an watsa su ga mutane ta hanyar civets da camelliids, bi da bi.
Bayan kwatanta kwayoyin halittar SARS-CoV-2 da sauran cututtukan coronavirus, an gabatar da bera a matsayin mai karɓar SARS-CoV-2 na asali, saboda sabon kwayar cutar ta kasance daidai da kashi 96 cikin ɗari tare da nau'ikan SARS-CoVs guda biyu daga bera da ake kira bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, ba a san ko wane mai watsa shiri ne ya ba da damar cutar ta ƙetare shingen jinsuna don ya kamu da mutane ba, kuma ba a san hanyar watsawa ba tukuna.
Ji, et al., sun yi hasashen cewa cutar ta iya yaduwa daga bera zuwa mutum ta hanyar macizai, wanda ke nuna sake haɗuwa a cikin furotin S.
Wani bincike da masu bincike a Guangzhou, China suka yi ya nuna cewa pangolin - dabba mai dogon baki da ke cin tururuwa, wanda ake amfani da shi a maganin gargajiya na kasar Sin - na iya zama mai karɓar bakuncin SARS-CoV-2 idan aka yi la'akari da daidaiton kwayoyin halitta kashi 99 cikin ɗari tsakanin coronavirus da aka gano a pangolin da SARS-CoV-2.
Duk da haka, bambanci na 1% tsakanin kwayoyin halitta biyu yana da bambanci mai mahimmanci; saboda haka dole ne a jira sakamakon ƙarshe don tabbatar da hujja (Fig. (Fig.33).
Har yanzu ba a san yawancin abubuwan da ke tattare da SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin gwaje-gwaje na tsawon awanni 48 a cikin bushewa da har zuwa kwanaki 5 a zafin jiki na 20 °C da zafi na 40 zuwa 50%.
SARS-CoV-2 na iya samun irin wannan halaye.
Ya bayyana cewa SARS-CoV-2 yana da ƙarancin ƙarancin haske da zafin jiki na 56 °C na minti 30; ether, 75% ethanol, chlorine-based disinfectants, peracetic acid, chloroform da sauran masu narkewa mai ƙanshi, amma ba chlorhexidine ba, na iya kashe kwayar cutar yadda ya kamata.
Yawan jama'ar duniya gabaɗaya ba su da rigakafi ga SARS-CoV-2 kuma saboda haka suna da saukin kamuwa da sabon kwayar cutar.
A halin yanzu, ba a ba da rahoton cikakken bincike game da amsar rigakafi ga SARS-CoV-2.
Saboda haka, za mu iya komawa ne kawai ga binciken da aka yi a baya game da wasu cututtukan coronavirus, musamman SARS-CoV da MERS-CoV (Fig. (Fig.4).4).
A yadda aka saba, idan kwayar cuta ta kamu da mai gidan, tsarin garkuwar jikin mutum na asali ya fara gane ta ta hanyar masu karɓar ƙwayoyin halitta (PRRs), musamman masu karɓar nau'in C na lectin, masu karɓar nau'in Toll (TLRs), masu karɓar nau'in NOD (NLRs) da masu karɓar nau'in RIG-I (RLRs).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar abubuwan kumburi, tsufa na ƙwayoyin dendritic da samar da nau'in interferons na I (IFN) wanda ke iyakance yaduwar kwayar cutar da kuma hanzarta phagocytosis na kwayar cutar.
Duk da haka, furotin N na SARS-CoV na iya ba da damar kwayar cutar ta tsere daga amsawar rigakafi.
Ba da daɗewa ba, tsarin garkuwar jiki zai soma yaƙi da ƙwayar.
Kwayoyin T, musamman CD4+ da CD8+ T cells suna da muhimmanci wajen kāre jiki.
Kwayoyin T CD4+ suna motsa ƙwayoyin B waɗanda ke samar da ƙwayoyin rigakafi na musamman ga ƙwayar cuta, kuma ƙwayoyin T CD8+ suna kashe ƙwayoyin cutar kai tsaye.
Kwayoyin T suna taimaka wa ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Koyaya, coronavirus na iya hana ayyukan ƙwayoyin T ta hanyar haifar da apoptosis.
Ƙarfin jiki na jiki, tare da ƙarin abubuwa kamar C3a da C5a da kuma ƙwayoyin cuta, yana da muhimmanci wajen yaƙi da kamuwa da ƙwayoyin cuta.
Alal misali, ƙwayoyin cuta da aka ware daga mai haƙuri da ya warke sun kawar da MERS-CoV.
A wani ɓangare kuma, idan jikinmu ya yi tsayayya da cutar, za mu iya samun ƙwayoyin cuta da yawa, kuma hakan zai iya sa huhu da sauran gabobin jikinmu su lalace sosai.
Cutar SARS-CoV-2, wanda ke faruwa a gida, tana iya shafar tsofaffi da ke fama da cututtuka da yawa da kuma mata masu ciki.
An yarda cewa mutanen da ke fama da ƙwayoyin cuta da yawa ko kuma waɗanda ke da ƙarancin aikin rigakafi suna cikin haɗarin kamuwa da cutar fiye da sauran mutane.
An kiyasta matsakaicin lokacin kamuwa da SARS-CoV-2 ya kasance daga kwana 1 zuwa 14, amma yawanci daga kwana 3 zuwa 7 bisa ga binciken da aka yi kan mutane 425 da aka fara gano a Wuhan.
Duk da haka, binciken da aka yi kan mutane 1099 ya nuna cewa tsawon lokacin kamuwa da cutar ya kai kwanaki 3 a matsakaita, daga kwanaki 0 zuwa 24.
Wani sabon bincike, kamar yadda aka bayyana a sama, ya kammala da tsawon lokacin incubation na kwanaki 4.8 (3.0-7.2) bisa ga yawan mutane 8,866.
Yana da matukar muhimmanci hukumomin kiwon lafiya su daidaita tsawon lokacin keɓewa bisa ga lokacin ɓoyewa daidai gwargwado, don hana mutane masu kamuwa da cutar amma ba su da alamun cutar daga watsa kwayar cutar.
A yawancin lokaci, ana keɓe mutanen da suka kamu da cutar ko kuma waɗanda suka kamu da ita na kwanaki 14.
Shin ya kamata a tsawaita keɓewar zuwa kwanaki 24?
Sau da yawa zazzabi ne farkon kuma babban alamar COVID-19, kuma yana iya kasancewa ko ba ya tare da wasu alamomi kamar tari mai bushewa, numfashi, ciwon tsoka, zafin jiki, ciwon kai, ciwon makogwaro, hanci, ciwon kirji, zawo, tashin zuciya da amai.
Wasu marasa lafiya sun sami dyspnea da/ko hypoxemia mako guda bayan cutar ta fara.
A cikin marasa lafiya masu tsanani, sun soma ciwon numfashi, ciwon ƙwayar cuta, ƙwayar cuta da kuma ciwon jini.
Masu fama da zazzabi da/ko alamun numfashi da masu fama da zazzabi mai tsanani, koda babu wani abu mara kyau a cikin radiography na kirji, ya kamata a gwada su don cutar don saurin ganewa.
Wani bincike da aka yi a ƙarshen Disamba 2019 ya nuna cewa kashi 98 cikin ɗari na marasa lafiya suna da zazzabi, kashi 76 cikin ɗari na tari mai bushe, kashi 55 cikin ɗari na numfashi, da kashi 3 cikin ɗari na zawo; kashi 8 cikin ɗari na marasa lafiya sun bukaci taimakon numfashi.
An samu irin wannan binciken a cikin binciken biyu da aka yi kwanan nan da aka yi a kan iyali da kuma wani ciwo da ya faru bayan kamuwa da cutar daga mutum marar alamun cutar.
Hakazalika, binciken yawan jama'a da aka yi a shekara ta 2012 ya nuna cewa manyan alamun cututtukan marasa lafiya da ke da MERS-CoV sune zazzabi (98%) da tari mai bushe (47%) da kuma numfashi mai wuya (55%).
Koyaya, kashi 80 cikin ɗari sun buƙaci taimakon numfashi, wanda ya fi na marasa lafiya da COVID-19, wanda ya dace da yawan mutuwar MERS idan aka kwatanta da COVID-19.
An kuma lura da gudawa (26%) da ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A game da SARS, an gano cewa manyan alamun cutar zazzabi ne (99%-100%), tari mai bushe (29%-75%), numfashi (40%-42%), zawo (20%-25%) da ciwon makogwaro (13%-25%) kuma ana buƙatar taimakon numfashi ga kusan kashi 14-20% na marasa lafiya.
A ranar 14 ga Fabrairu, yawan mutanen da COVID-19 ya kashe ya kai kashi 2 cikin ɗari, inda aka samu mutane 66,576 da suka kamu da cutar a duniya.
Idan aka gwada, mutuwar SARS a watan Nuwamba 2002 ya kai kashi 10 cikin ɗari a cikin mutane 8,096 da aka tabbatar da cutar.
A cikin MERS, a cewar wani binciken yawan jama'a da aka yi a watan Yunin 2012, mutuwar ta kai kashi 37 cikin ɗari a cikin mutane 2,494 da aka tabbatar da cutar.
Wani bincike da aka yi a baya ya nuna cewa R0 na SARS-CoV-2 ya kai 6.47 tare da 95% dogara (CI) na 5.71-7.23, yayin da R0 na SARS-CoV ya kai 2 zuwa 4.
An kwatanta alamun cututtuka, mutuwar da R0 na SARS-CoV-2, MERS-CoV da SARS-CoV a cikin Tebur Tebur1.1.
Bayanai da ke sama sun nuna cewa SARS-CoV-2 yana da ƙarfin yaduwa fiye da MERS-CoV da SARS-CoV, amma ba ya kashe mutane sosai.
Saboda haka, yana da wuya a sarrafa barkewar SARS-CoV-2 fiye da barkewar MERS-CoV da SARS-CoV.
Sau da yawa ana samun cutar a cikin iyali ko kuma a wurin taro ko kuma a cikin mota, kamar a jirgin ruwa.
Sau da yawa marasa lafiya sun yi tafiya ko zama a Wuhan ko wasu yankuna da cutar ta shafa, ko kuma sun kasance tare da mutane masu cutar ko marasa lafiya a cikin makonni biyu kafin bayyanar cututtuka.
Koyaya, an nuna cewa mutane na iya ɗaukar kwayar cutar ba tare da nuna alamomi ba sama da makonni biyu kuma marasa lafiya da suka warke na iya sake ɗaukar kwayar cutar, wanda ke nuna buƙatar ƙara tsawon lokacin keɓewa.
Marasa lafiya suna da ƙarancin ƙwayoyin farin jini (musamman ƙwayoyin lymphocytes) a farkon matakan.
Alal misali, an gano cutar lymphopenia da ke da adadin farin jini 4 × 109/L da kuma adadin lymphocytes 1 × 109/L, da kuma yawan aspartate aminotransferase da kuma cutar cutar jini a cikin marasa lafiya 1,099 da ke da COVID-19.
Wasu marasa lafiya suna da ƙwayoyin enzymes na hanta, ƙwayoyin enzymes na muscle da myoglobin a cikin jini, kuma mafi yawan suna da ƙwayoyin C-reactive da ƙwayoyin red cell.
A cikin mutane da suka fi ciwo, yawan sinadarin D-dimer da ke cikin jini yana ƙaruwa kuma ƙwayoyin jini suna raguwa.
Ana ganin rashin daidaito a cikin hotunan kirji a yawancin marasa lafiya da ke da COVID-19, wanda ke nuna inuwa mara daidaituwa ta ɓangarorin biyu ko kuma rashin haske a cikin gilashin da aka cire a cikin huhu.
Sau da yawa marasa lafiya suna kamuwa da ciwon huhu, ciwon huhu mai tsanani da kuma ciwon numfashi mai tsanani (ADRS).
A wani lokaci, ciwon ƙanƙara yana sa jiki ya ƙone sosai kuma ya riƙa ɗumbin ruwa a jikin mutum.
Rashin aiki na nau'in ƙwayoyin huhu na I da na II yana haifar da raguwar matakin surfactant da ƙaruwa a cikin ƙarfin jiki, don haka rage ƙarfin huhu don kumbura da haɓaka haɗarin rushewar huhu.
Saboda haka, idan aka yi wa mutum gwajin kirji, yakan yi daidai da yanayin da ya fi muni.
A ranar 18 ga Fabrairu, 2020, gwajin farko na cutar COVID-19 ya nuna ƙwayoyin cuta na huhu, samar da ƙwayoyin hyaline, shiga cikin ƙwayoyin lymphocyte na ciki da kuma ƙwayoyin syncytial multinuclear a cikin huhu na wani mai haƙuri da ya mutu daga cutar, wanda ya dace da cutar kwayar cuta da SDRA kuma yayi kama da na marasa lafiya da SARS da MERS.
An yi amfani da gano SARS-CoV-2 RNA ta hanyar maganin polymerase chain reaction bayan sake rubutun (RT-PCR) a matsayin babban ma'auni don gano COVID-19.
Duk da haka, saboda yawan ƙarancin ƙarancin ƙwayoyin cuta, wanda zai iya sa cutar ta yi saurin yaduwa, an fara amfani da bayyanar cututtuka don ganewar asali (wanda a lokacin ya dogara da RT-PCR kawai) a China a ranar 13 ga Fabrairu, 2020.
An lura da irin wannan yanayin don ganewar asali na SARS.
Saboda haka, haɗuwa da tarihin lafiyar mutum, bayyanar cututtuka, gwaje-gwaje na dakin gwaje-gwaje, da kuma gwajin radiology yana da muhimmanci kuma yana da muhimmanci wajen gano cutar.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana wata hanyar amfani da fasaha ta SHERLOCK da ke da tushen CRISPR don gano SARS-CoV-2, wanda ke ba da damar gano ɓangarorin RNA na SARS-CoV-2 tsakanin 20 × 10-18 mol/L da 200 × 10-18 mol/L (10-100 kwafi a kowane microlit na samfurin) ta amfani da madaurin amsawa a cikin ƙasa da awa ɗaya, ba tare da buƙatar kayan aiki masu ƙwarewa ba.
Ana sa ran wannan sabuwar hanyar za ta inganta ƙwarewa da amfani sosai idan ta kasance mai amfani a kan samfuran asibiti.
Saboda rashin gogewa game da sabon coronavirus, likitoci na iya ba da tallafi ne kawai ga marasa lafiya da ke fama da COVID-19, yayin da suke gwada magungunan da aka riga aka yi amfani da su ko kuma aka ba da shawarar don magance wasu coronavirus, kamar SARS-CoV da MERS-CoV, da sauran cututtukan ƙwayoyin cuta (Table (Table2).2).
Irin wannan magani ya haɗa da maganin riga-kafi da na gaba da magungunan hana yaduwar cuta, magungunan hana kamuwa da cuta, magungunan steroid, jini na marasa lafiya da suka warke, maganin kasar Sin da kuma taimakon tunani.
Har jini na marasa lafiya da suka warke ma an ba da shi don magani.
Kamfanonin ƙwayoyi suna aiki don samar da rigakafi da alluran rigakafi don cutar.
SARS-CoV-2 ya fi kai hari ga huhu da farko kuma mai yiwuwa ma, a cikin ƙananan, wasu gabobin da ke nuna ACE2, kamar tsarin hanji da kodan.
Duk da haka, rashin aiki da kuma rashin numfashi ne ainihin abin da ke jawo mutuwa ga marasa lafiya.
Don haka, taimakon numfashi yana da muhimmanci wajen rage alamun cutar da ceton rayuka, wanda ya haɗa da maganin oxygen na gaba ɗaya, maganin oxygen mai saurin gudu, numfashi mara saurin shiga ciki da kuma numfashi mai saurin shiga ciki, dangane da tsananin cutar.
Marasa lafiya da ke fama da mummunan alamun numfashi ya kamata su sami iskar oxygen ta hanyar membrane (EMO), wata hanyar canzawar zuciya da huhu da ake amfani da ita don magance ciwon zuciya ko rashin ƙarfi na numfashi.
Bugu da ƙari, kiyaye daidaiton wutan lantarki, hanawa da magance cututtukan na biyu da bugun jini, da kare ayyukan gabobin rayuwa ma suna da mahimmanci ga marasa lafiya da ke da SARS-CoV-2.
An tabbatar da cewa yawan amsawar tsarin garkuwar jiki yana haifar da harin cytokine a cikin marasa lafiya da ke fama da SARS da MERS.
Cytokine shock wani nau'i ne na amsawar kumburi na tsarin da aka nuna ta hanyar sakin jerin cytokines, gami da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Waɗannan kwayoyin suna sa ƙwayoyin jikinmu su saki ƙwayoyin ƙwayoyin cuta da yawa, waɗanda suke haddasa cutar ADRS da kuma rashin aiki.
Maganin rigakafi yana da mahimmanci wajen magance tashin hankali na cytokine, musamman ga manyan lokuta.
An yi amfani da corticosteroids da tocilizumab, kwayar cutar rigakafin IL6 mai ƙarancin ƙwayar cuta don magance tashin hankali na cytokine.
Sauran maganin rigakafi na cytokine sun haɗa da daidaitawar amsawar rigakafi ta T-cell, toshe IFN-γ, IL-1, da TNF cytokines, hana JAK, blinatumomab, mai hana siginar cytokine 4, da masu hana HDAC.
Ana amfani da kwayoyin steroid a matsayin masu hana rigakafi a cikin maganin SARS don rage tsananin cutar kumburi.
Koyaya, shan magungunan steroid masu yawa ba su da tasiri mai amfani akan mummunan lalacewar huhu a cikin marasa lafiya da ke fama da SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako, ciki har da cutar ƙwayoyin cuta, wanda hakan ke shafar yanayin cutar sosai.
Duk da haka, an ba da shawarar yin amfani da gajeren lokaci na ƙananan allurai na corticosteroids a hankali ga marasa lafiya da ke da mummunan COVID-19.
A lokacin da aka rubuta wannan rahoton, babu wani magani mai tasiri wanda aka tabbatar.
Koyaya, shan remdesivir a cikin jijiya, wanda yake kama da nucleoside, ya tabbatar da inganci a cikin wani mai cutar COVID-19 na Amurka.
Remdesivir wani sabon magani ne na rigakafin ƙwayoyin cuta wanda Gilead ta fara samarwa don maganin cututtukan da ƙwayoyin cuta na Ebola da Marburg ke haifarwa.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin RNA guda ɗaya, ciki har da MERS da SARS.
Bisa ga waɗannan binciken, Gilead ta tura mahaɗin zuwa China don ba da damar gwaji da yawa akan mutane da ke da cutar SARS-CoV-2, kuma ana sa ran sakamakon sosai.
Bugu da ƙari, baricitinib, interferon-α, lopinavir/ritonavir da ribavirin an gabatar da su azaman yiwuwar jiyya ga marasa lafiya da ke fama da cututtukan numfashi.
Za a iya samun zawo, tashin zuciya, amai, lalacewar hanta da sauran cututtuka sakamakon maganin haɗin lopinavir/ ritonavir.
Ya kamata a kula da hulɗar waɗannan magungunan tare da wasu magungunan da ake amfani da su a cikin marasa lafiya.
Jinin marasa lafiya da suka warke da kuma samar da rigakafi
Tattara jini daga marasa lafiya da suka warke daga wata cuta mai yaduwa don magance wasu marasa lafiya da ke fama da cutar ko kuma don kare lafiyayyun mutane daga wannan cuta al'ada ce ta dā.
A wasu lokatai, marasa lafiya da suka warke suna da yawan ƙwayoyin cuta da ke hana su kamuwa da cutar.
Kwayoyin rigakafi suna da ƙwayar cuta da ƙwayoyin B ke samarwa don su yaƙi ƙwayoyin cuta da kuma wasu abubuwa da baƙi.
An cire jini daga jinin wasu marasa lafiya da suka warke daga COVID-19 kuma an yi musu allurar jini a cikin marasa lafiya 10 da ke fama da cutar.
Alamun su sun inganta cikin awanni 24, tare da rage kumburi, rage yawan kwayar cutar da kuma karuwar iskar oxygen a cikin jini.
Duk da haka, ana bukatar tabbatarwa da kuma bayani kafin a iya ba da shawarar wannan hanyar don amfani da yawa har sai an samar da magani na musamman.
Bugu da ƙari, saboda tasirin magani, wasu rashin lafiyar da ke tattare da plasma ya kamata a bincika su sosai.
Alal misali, ƙwayoyin rigakafi suna iya sa jikin mutum ya riƙa yin tsayayya da cututtuka kuma hakan yana iya sa mutum ya kamu da cutar da ake kira cytokine-release syndrome.
Yawan ƙwayoyin cuta a cikin jini yawanci ƙasa ne, kuma ana buƙatar jini don kula da marasa lafiya masu tsanani.
Yana da wuya a samar da takamaiman rigakafi da sauri don magance annobar duniya.
Saboda haka, yana da mahimmanci kuma mafi inganci don ware ƙwayoyin B daga marasa lafiya da suka warke da kuma gano lambobin kwayoyin da ke ƙunshe da ƙwayoyin cuta masu dacewa ko neman ƙwayoyin cuta masu tasiri ga manyan sunadarai na kwayar cutar.
Hakan zai sa a samu ƙarin ƙwayoyin cuta da sauri.
An yi amfani da maganin gargajiya na gargajiya na gargajiya na shekaru dubbai a ƙasar Sin don a warkar da cututtuka dabam dabam.
Amma, sakamakon yana dogara ne da yadda aka haɗa abubuwa da yawa a cikin wani tsari da ke dabam dabam bisa ga yadda aka yi bincike a kan ra'ayin TCM.
Yawancin abubuwa masu amfani da ƙwayoyin halitta ba su da yawa ko kuma ba a san su ba domin yana da wuya a gano su kuma a tabbatar da su ko kuma a san yadda za su yi aiki tare.
A halin yanzu, saboda rashin ingantaccen magani na musamman don COVID-19, TCM shine ɗayan manyan hanyoyin magani na madadin marasa lafiya tare da alamun rashin lafiya mai sauƙi zuwa matsakaici ko kuma masu murmurewa daga mummunan cutar.
Alal misali, an gano cewa Shu Feng Jie Du da Lian Hua Qing Wen sun yi tasiri wajen maganin COVID-19.
An samu mafi yawan adadin masu warkewa daga COVID-19 a lardunan China da suka yi amfani da TCM a kan kashi 87 cikin ɗari na marasa lafiyarsu, musamman lardunan Gansu (63.7 cikin ɗari), Ningxia (50 cikin ɗari) da Hunan (50 cikin ɗari), yayin da lardin Hubei, wanda ya yi amfani da kashi 30 cikin ɗari na marasa lafiyar COVID-19 ne kawai, ya sami mafi ƙarancin adadin masu warkewa (13 cikin ɗari).
Amma wannan kwatancen na kusanci ne domin akwai wasu abubuwa da yawa da za a yi la'akari da su a lokacin da ake tantancewa, kamar yawan marasa lafiya da kuma tsananin cutar.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun wallafa wani bincike da ya kwatanta magani da ke amfani da maganin Yammacin Turai (WMD) da kuma magani da ke haɗa WMD da TCM.
An gano cewa lokacin dawowa zuwa yanayin zafin jiki na al'ada, lokacin bayyanar cututtuka, da tsawon lokacin asibiti sun fi guntu a cikin ƙungiyar MO + MTC fiye da ƙungiyar MO kawai.
Abin da ya fi ban sha'awa shi ne, yawan ciwon da ke sa cututtuka su yi muni (daga mai sauƙi zuwa mai tsanani) ya yi ƙasa sosai a rukunin MO+MTC fiye da rukunin MO kaɗai (7.4% da 46.2%); haka nan kuma, mutuwar ta yi ƙasa a rukunin MO+MTC fiye da rukunin MO kaɗai (8.8% da 39%).
Duk da haka, har yanzu ana bukatar a tabbatar da inganci da amincin TCM ta hanyar gwaji da aka gudanar a wurare da yawa.
Hakanan zai zama da ban sha'awa don bayyana tsarin aikin da kuma bayyana ingantattun abubuwan haɗin maganin TCM ko haɗuwa da su, idan zai yiwu.
Mutanen da aka gano a matsayin masu yiwuwar ko tabbataccen cutar COVID-19 galibi suna da damuwa game da wannan cuta mai saurin yaduwa da kisa, kuma waɗanda aka keɓe suna jin haushi, kaɗaici da fushi.
Ƙari ga haka, alamun kamuwa da cuta kamar zazzabi, rashin ƙarfi, da tari da kuma sakamakon rashin barci da ake samu daga shan magunguna kamar rashin barci da ake samu ta shan magungunan corticosteroids suna iya sa mutum ya ƙara damuwa da kuma baƙin ciki.
A farkon barkewar cutar SARS, an samu rahotanni da yawa na cututtukan ƙwaƙwalwa, ciki har da ci gaba da baƙin ciki, damuwa, firgita, tashin hankali, alamun psychotic, rikicewa mai tsanani har ma da tunanin kashe kansa.
Binciken da ake bukata na tuntuɓar mutane da kuma keɓewa, a matsayin ɓangare na maganin kiwon lafiyar jama'a ga annobar COVID-19, na iya ƙara damuwa da kuma sa marasa lafiya su ji laifi game da tasirin kamuwa da cutar, keɓewa, da kuma ɓata sunan danginsu da abokansu.
Don haka, dole ne a ba da kulawar lafiyar kwakwalwa ga marasa lafiya da ke fama da COVID-19, mutanen da aka gano a matsayin masu yiwuwar kamuwa da cutar, mutanen da ke hulɗa da waɗannan mutanen, da duk wani mutum da ke cikin wahala.
Wannan tallafi na tunani ya kamata ya haɗa da samar da ƙungiyoyi masu ƙwarewa da yawa, sadarwa mai kyau tare da sabuntawa na yau da kullun da kuma takamaiman bayani game da barkewar SARS-CoV-2 da tsare-tsaren magani, da kuma amfani da aikace-aikacen ƙwararru da kayan lantarki don kauce wa kusanci.
Alluran rigakafi masu tasiri suna da mahimmanci don katse sarkar watsawa daga wuraren ajiyar dabbobi da mutane masu kamuwa da cutar zuwa masu karɓar marasa lafiya, kuma galibi suna haɓaka maganin rigakafin cutar a cikin kula da cututtukan da ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari don samar da alluran rigakafi na S-protein, don samar da ƙwayoyin cuta masu ƙarfi na dogon lokaci da / ko haifar da rigakafin kariya daga SARS-CoV.
An gwada alluran rigakafin da aka rage su a cikin samfurin dabbobi don SARS.
Koyaya, ingancin in vivo na waɗannan alluran rigakafin a cikin tsofaffi da samfuran da ke fuskantar mummunan kisa da kariya daga kamuwa da cutar kwayar cutar dabbobi har yanzu ba a tantance su ba, saboda ba a fara binciken asibiti ba.
Wataƙila hakan ya faru ne domin SARS ya ƙare shekaru 17 da suka shige kuma ba a samu wani sabon kamuwa da cutar ba.
A gefe guda, ana ci gaba da samun wasu cututtuka da ɓarkewar MERS a Gabas ta Tsakiya da wasu yankuna saboda ci gaba da tushen cututtukan dabbobi a yankunan da ke fama da cutar.
An samar da dabarun rigakafi daban-daban don MERS ta amfani da kwayar cutar da ba ta aiki, plasmids na DNA, masu ɗaukar hoto, nanoparticles, ƙwayoyin cuta masu alaƙa da kwayar cuta da ƙwayoyin ƙwayoyin cuta masu haɗuwa, kuma an kimanta wasu a cikin samfuran dabbobi.
Samar da rigakafi mai lafiya da tasiri ga SARS-CoV-2 ga mutanen da ba su da rigakafi shine gaggawa da mahimmin burin don sarrafa annobar da ke gudana.
Koyaya, wannan babban ƙalubale ne saboda tsayi mai yawa (a matsakaita watanni 18) da ake buƙata don haɓaka allurar rigakafi da canjin canjin coronavirus.
A matsayin sabon cuta, COVID-19 tana fara aikinsa na asibiti ta dubban marasa lafiya.
A yawancin lokaci, marasa lafiya suna warkewa a hankali ba tare da wata matsala ba.
Koyaya, kamar SARS da MERS, COVID-19 kuma yana da alaƙa da yawan rashin lafiya da mutuwa ga mafi munin yanayin.
Saboda haka, kafa tsarin tsinkaya yana da muhimmanci don hukumomin kiwon lafiya su ba da fifiko ga ayyukan su, musamman a yankunan da ba su da isasshen albarkatu.
Bisa ga binciken asibiti da aka yi zuwa yanzu, abubuwan da za su iya shafar ko kuma haɗuwa da cutar COVID-19 sune waɗannan (Table (Table33)):
Shekaru: Shekaru sune babban abin da ke haifar da cutar SARS, kuma hakan yana faruwa da COVID-19.
COVID-19 ya fi shafar mutane masu shekaru 30 zuwa 65, tare da kashi 47.7 cikin ɗari da suka haura shekaru 50 bisa ga binciken da aka yi a kan mutane 8,866, kamar yadda aka bayyana a sama.
Marasa lafiya da ke buƙatar kulawa mai tsanani sun fi fuskantar cututtuka da rikitarwa, kuma sun fi tsufa sosai (tsakanin shekaru 66 da 51, wanda ke nuna cewa shekaru ne ke haifar da cutar COVID-19.
Jima'i: SARS-CoV-2 ya kamu da maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka bayyana a baya.
Cutar da ke tattare da ita da kuma matsaloli: marasa lafiya da ke da COVID-19 da ke bukatar kulawa mai tsanani suna iya samun ciwon zuciya da kuma bugun jini.
Abubuwan da ke faruwa na zuciya sune babban dalilin mutuwar marasa lafiya da SARS.
An gano cewa SARS-CoV-2 na iya ɗaure kansa ga cholangiocytes masu kyau na ACE2, wanda zai iya haifar da rashin aiki na hanta a cikin marasa lafiya da ke da COVID-19.
Ya kamata a lura cewa shekaru da kuma kasancewar matsalolin kiwon lafiya suna da alaƙa sosai kuma suna iya tsoma baki tare.
Sakamakon gwaje-gwaje na yau da kullun: matakin C-reactive protein (CRP) a cikin jini yana nuna tsananin kumburi ko lalacewar nama; an gabatar da shi azaman mai yiwuwa mai hasashen cutar, amsa magani da warkarwa.
An kuma ba da shawarar alaƙar da ke tsakanin yawan CRP da tsananin cutar da kuma tsinkayar COVID-19.
Bugu da ƙari, yawan lactate dehydrogenase (LDH), daspartate aminotransferase (AST), dalanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen tsara hasashen.
Ana fitar da waɗannan ƙwayoyin a cikin gabobin jiki da yawa, musamman a zuciya da hanta, kuma ana fitar da su idan akwai lahani a nama.
Saboda haka, a al'ada, waɗannan alamun suna nuna ciwon zuciya ko kuma hanta.
Manyan alamun cututtuka: sakamakon hotunan kirji da ci gaban alamun cututtuka a lokaci ya kamata a bincika tare da sauran abubuwa don ƙayyade tsinkaye da rikitarwa na COVID-19.
Amfani da steroid: kamar yadda aka bayyana a sama, steroids sune masu hana rigakafi waɗanda aka saba amfani dasu azaman ƙarin magani don cututtukan cututtuka don rage tsananin lalacewar kumburi.
Tun da yake ana amfani da magungunan ƙwayar cuta mai yawa don cututtukan SARS masu tsanani, yawancin waɗanda suka tsira sun sami cututtukan ƙwayoyin cuta wanda ke haifar da nakasa na dindindin da rashin ingancin rayuwa.
Don haka, idan ya cancanta, ya kamata a iyakance shan kwayoyin cutar steroids ga marasa lafiya da ke da COVID-19 zuwa ƙananan allurai da gajeren lokaci.
Damuwa ta hankali: Kamar yadda aka bayyana a baya, annobar COVID-19 ta haifar da mutane da yawa da ke fama da damuwa ta musamman, sau da yawa marasa lafiya suna fuskantar keɓewa na dogon lokaci, rashin tabbas mai tsanani da mutuwar dangi ko wasu marasa lafiya.
Yana da muhimmanci a ba da taimako na dogon lokaci da kuma taimako na tunani don a taimaka wa waɗannan mutane su shawo kan wannan matsi kuma su koma rayuwa ta al'ada.
Bisa ga binciken yawan jama'a da aka yi har zuwa yanzu, COVID-19 tana da alamun cututtuka daban-daban da SARS.
Baya ga kwayar cutar ta SARS-CoV-2 ta ninka a cikin ƙananan hanyoyin numfashi, SARS-CoV-2 tana kuma ninkawa cikin inganci a cikin hanyoyin numfashi na sama kuma ba ta haifar da alamomi ko kaɗan a farkon lokacin kamuwa da cutar, kamar coronavirus da ke haifar da mura.
Saboda haka, mutane da suka kamu da cutar kwanan nan ko kuma waɗanda ke cikin lokacin kamuwa da cutar za su iya samar da ƙwayoyin cuta da yawa a cikin ayyukansu na yau da kullun, wanda ke kawo babbar matsala ga kula da annobar.
Koyaya, an ɗauka cewa SARS-CoV ana watsa shi ne daga marasa lafiya masu fama da rashin lafiya, tare da ƙarancin yiwuwar watsawa a farkon matakin.
Saboda haka, annobar COVID-19 ta yanzu ta fi SARS tsanani da kuma wahalar sarrafawa.
Ana yin ƙoƙari sosai a China a yanzu, ciki har da rufe Wuhan da biranen da ke kusa da shi da kuma keɓe kusan dukan mazauna ƙasar don hana yaduwar SARS-CoV-2.
Ko da yake waɗannan matakan sun yi tasiri sosai ga tattalin arziki da sauran sassan ƙasar, yawan sabbin masu kamuwa da cutar na raguwa, wanda ke nuna cewa annobar ta ragu.
Kimanin al'amuran da suka fi dacewa sun nuna cewa annobar za ta ƙare a watan Maris kuma za ta rage tsawon watanni uku zuwa huɗu.
Amma, ba dukan masana ba ne suke da wannan ra'ayin.
Paul Hunter, da sauransu sun yi imanin cewa COVID-19, wanda ya fi SARS kamuwa da cuta, ba zai ƙare a shekara ta 2020 ba.
Ira Longini, et al., sun tsara samfurin don hango ƙarshen annobar kuma sun kammala cewa SARS-CoV-2 na iya kamuwa da kashi biyu bisa uku na yawan mutanen duniya.
Wata ƙungiya a Kanada ta ba da rahoton cewa an gano SARS-CoV-2 a cikin ƙwayar hanci da makogwaro na marasa lafiya da suka warke makonni 2 bayan an sallame su daga asibiti, wanda ke nuna cewa sabon ƙwayar cutar na iya zama wani abu mai kama da mura.
Koyaya, an lura da alamun ƙarfafawa a China tare da raguwar sabbin shari'o'in a hankali, wanda ke nuna cewa dabarun da aka aiwatar sun yi aiki.
A farkon hasashen, cutar Ebola za ta kai mutum miliyan ɗaya da mutuwar mutane miliyan ɗaya da rabi.
Amma, ta wajen keɓe mutane sosai, an daina cutar.
Yana yiwuwa, kamar SARS-CoV, SARS-CoV-2 ya raunana a cikin kamuwa da cuta kuma daga ƙarshe ya mutu ko kuma ya canza zuwa kwayar cuta mai ƙarancin cuta da ke rayuwa tare da mutane.
An kwatanta annobar COVID-19 da SARS da MERS a ƙasa (Fig. (Fig.55).
SARS-CoV-2 yana yaduwa sosai ta tari ko hancin mutum, kuma mai yiwuwa ta hanyar tuntuɓar abubuwa masu cutar kai tsaye.
An kuma gano kwayar cutar a cikin bargo, wanda hakan ya nuna cewa ana iya yaduwa ta hanyar bargo da baki.
Wani bincike da aka yi kwanan nan a kan marasa lafiya 138 ya nuna cewa kashi 41 cikin ɗari na waɗanda suka kamu da cutar sun kamu da cutar a asibiti, kuma 17 daga cikinsu suna da cututtuka da suka riga sun kamu da su kuma 40 ma'aikatan kiwon lafiya ne.
Don haka, ya kamata a ɗauki matakan kariya don kare mutane, musamman ma ma'aikatan kiwon lafiya, ma'aikatan zamantakewa, dangi da abokan aikin marasa lafiya, har ma da duk wanda zai iya kasancewa a cikin hulɗa da marasa lafiya ko masu kamuwa da cuta.
Hanya ta farko da za a iya kare kansa don rage haɗarin kamuwa da cuta ita ce sanya abin rufe fuska; amfani da abin rufe fuska na tiyata da N95 (1860) yana taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata na hana zubar da ruwa ko kuma kwararar ruwa a kan wasu wurare da za su iya yaduwa ga wasu mutane.
Koyaya, kawai abin rufe fuska na N95 (1860) yana ba da kariya daga numfashi na virions daga 10 zuwa 80 nm, tare da kashi 5 cikin ɗari na virions kawai waɗanda zasu iya shiga gaba ɗaya; SARS-CoV-2 yayi kama da SARS-CoV a girma, tunda duka suna da kusan 85 nm.
Tun da yake ƙwayoyin suna iya wucewa ta cikin masks biyar na tiyata da aka tara a kan juna, yana da mahimmanci cewa ma'aikatan kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya su sa masks na N95 (1860s) maimakon masks na tiyata.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya dole ne su sa rigunan warewa da suka dace don rage haɗuwa da ƙwayoyin cuta.
Ƙari ga haka, ƙwayoyin cuta suna iya kamuwa da mutum ta idanunsa.
A ranar 22 ga Janairun 2020, an gano cewa wani likita yana da cutar SARS-CoV-2 duk da cewa yana sanye da abin rufe fuska na N95; ƙila cutar ta shiga jikinsa ta hanyar idanu saboda kumburi.
Saboda haka, ma'aikatan kiwon lafiya su sa abin rufe fuska ko tabarau na kariya idan suna hulɗa da marasa lafiya.
Ga mutanen da ke cikin yankunan da cutar ta shafa ko kuma za su iya kamuwa da ita, an ba da shawarar sosai su wanke hannayensu da sabulu mai kashe ƙwayoyin cuta sau da yawa fiye da yadda suke saba, su kasance a cikin gida kamar yadda zai yiwu, kuma su rage hulɗa da mutanen da cutar ta shafa.
Ana ba da shawarar a nisanta tsakanin mutum da mai ciwo da nisan mita ɗaya.
Waɗannan matakan hanyoyi ne masu tasiri don rage haɗarin kamuwa da cutar da hana yaduwar kwayar cutar.
Ko da yake SARS-CoV-2 sabuwar kwayar cuta ce ga mutane, yawan kamaninta da SARS-CoV, kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020, ya sa China ta kasance cikin gagarumin yanayi bayan barkewar cutar SARS a 2003.
Amma a ranar 19 ga Janairu, 2020, darektan Cibiyar Kula da Cututtuka da Rigakafin cutar Wuhan ya tabbatar wa jama'a cewa sabon kwayar cutar ba ta da saurin yaduwa, yana da iyakantaccen yaduwar mutum zuwa mutum, kuma ba zai yi wuya a hana da kuma hana cutar ba.
Wannan saƙon ya haifar da raguwa sosai, musamman a lokacin da ƙasar ta shirya don bikin bazara, kuma an rasa babbar dama don hana cutar a Wuhan.
Hukumar kula da cututtuka ta kasar Sin ta bukaci ta koyi darasi daga wannan kuma ta dauki matakin da ya dace.
Alal misali, waɗannan hukumomin suna bukatar su (1) yi hankali a sanarwar da suke yi wa jama'a, domin kowace kalma tana da muhimmanci kuma tana iya shafan halin mutane da kuma shawarwarinsu; (2) su kasance da hankali da kuma saurin amsawa ga bayanan da ba a saba gani ba daga asibitoci maimakon jiran rahotanni na likita ko hukumomi; (3) su kasance da ƙuntatawa don hana barkewar cutar a farkon lokacin da ta fara maimakon su yi ƙoƙarin kwantar wa jama'a rai; da kuma (4) su yi ƙarin ayyuka masu ma'ana da suka dace don wayar da kan jama'a game da cututtuka masu yaduwa, amma kuma su gwada da kuma inganta tsarin amsawar jama'a a kai a kai.
Cutar COVID-19 ta barke ne sakamakon sabon kwayar cutar SARS-CoV-2 da ta fara a ƙarshen Disamba 2019.
A cikin ƙasa da watanni biyu, a lokacin da na rubuta wannan rahoton, ya bazu zuwa dukan ƙasar Sin da kuma kusan ƙasashe 50 a duniya.
Tun da cutar ta yi kama da SARS-CoV kuma alamun COVID-19 sun yi kama da na SARS, cutar ta COVID-19 ta zama kamar riga-kafi.
Koyaya, akwai bambance-bambance masu mahimmanci tsakanin COVID-19 da SARS, waɗanda ya kamata a kula dasu don hana yaduwar cutar da kula da marasa lafiya.
COVID-19 ta fi shafar tsofaffi fiye da matasa kuma ta fi shafar maza fiye da mata; kuma tsananin cutar da kuma yawan mutuwar ta fi yawa a tsakanin tsofaffi.
SARS yana da yawan mace-mace fiye da COVID-19 (10.91% da 1.44%).
Ana iya yaduwar kwayar cutar COVID-19 ko da babu alamomi, yayin da SARS ya fi yaduwa daga marasa lafiya masu tsanani, saboda haka yana da wuya a hana yaduwar COVID-19.
Wannan ya bayyana wani ɓangare na dalilin da yasa SARS-CoV-2 ya yadu da sauri kuma ya fi SARS-CoV yawa.
Gwaje-gwaje na yau da kullun don gano SARS-CoV-2 RNA na iya zama mara kyau ga wasu marasa lafiya da ke da COVID-19.
A wani ɓangaren kuma, marasa lafiya da suka warke suna iya sake kamuwa da cutar.
Hakan yana sa mutane da yawa su soma yin rashin lafiya.
Duk da ci gaban bincike kan COVID-19, akwai wasu tambayoyi masu mahimmanci da ba a amsa ba, ciki har da:
Daga ina ne SARS-CoV-2 ya fito?
Ko da yake an gano kamanceceniya tsakanin kwayoyin halitta tsakanin SARS-CoV-2 da wasu cututtukan SARS guda biyu da suka samo asali daga bera, wannan bai isa ba don tabbatar da cewa SARS-CoV-2 ya samo asali ne daga ƙwari.
Wane irin halitta ne ya kawo cutar daga kwayar halitta ta farko, kamar su ƙuda zuwa ga mutane?
Idan ba a amsa tambayoyi 1 da 2 ba, ba za a iya dakatar da yaduwar cutar yadda ya kamata ba, kuma cutar za ta iya sake barkewa a kowane lokaci.
Tsarin kwayoyin halitta da nazarin sunadarai sun nuna cewa SARS-CoV-2 yana ɗaure da ACE2, amma ta yaya kwayar cutar ke shiga cikin ƙwayoyin numfashi kuma ta yaya take haifar da canje-canje na cututtuka?
Shin kwayar cutar tana ɗaure kansa ga ƙwayoyin da ke nuna ACE2 a wasu gabobin jiki?
Idan ba a sami amsoshi masu kyau ba, ba za a iya sanin cutar nan da nan ba.
Har yaushe cutar za ta ci gaba?
Ta yaya kwayar cutar ke canzawa a cikin kwayoyin halitta yayin yaduwar mutum zuwa mutum?
Shin zai zama annoba ta duniya, ko kuma zai ɓace kamar SARS, ko kuma zai sake bayyana a kai a kai kamar mura?
Yana da muhimmanci, ko da yake yana iya ɗaukan lokaci, a sami amsoshin waɗannan tambayoyin da kuma wasu da yawa.
Amma ko da yaya farashinsa, ba mu da wani zaɓi sai dai mu kawo ƙarshen annobar da wuri-wuri don mu ci gaba da rayuwa.
Yawanci, lokacin kamuwa da waɗannan ƙwayoyin cuta biyu bai kai mako ɗaya ba, sannan kuma kusan makonni biyu na rashin lafiya.
Wasu marasa lafiya da ke fama da rashin lafiya sun kamu da ciwon huhu mai tsanani.
An fara samun mutum na farko da ya kamu da cutar SARS a lardin Guangdong a ƙasar Sin a ƙarshen shekara ta 2002.
Ban da masu watsawa, an kiyasta cewa kowane hali na iya haifar da kusan wasu lokuta biyu tare da lokacin ɓoyewa tsakanin kwanaki 4 zuwa 7, tare da ƙaruwa na ƙwayoyin cuta a ranar 10 na cutar.
Marasa lafiya da ke dauke da SARS-CoVs suna fara nuna ciwon tsoka, ciwon kai, zazzabi, rashin lafiya da sanyi, sannan numfashi, tari da wahalar numfashi a matsayin alamun bayyanar cutar.
Lymphopenia, gwajin cutar hanta da aka yi da kuskure da kuma yawan kwayar halitta sune abubuwan da ake gani a cikin gwaje-gwajen gwaje-gwaje idan ana zargin SARS.
Hakanan ana ganin lalacewar alveolar da yawa, ƙaruwa da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Aƙalla kashi 20 zuwa 30 cikin ɗari na marasa lafiya suna bukatar jinya mai tsanani da kuma iska mai ƙarfi.
Baya ga ƙananan hanyoyin numfashi, gabobin da yawa ciki har da hanyoyin hanji, hanta da koda, suma suna iya kamuwa da cutar a cikin waɗannan mawuyacin yanayi, sau da yawa tare da harin cytokine, wanda zai iya zama mai mutuwa musamman ga marasa lafiya masu fama da cutar.
Tun daga lokacin, an yi ƙoƙari sosai wajen bincike game da HCoV.
An gano HCoV-NL63 a cikin jariri ɗan wata 7 a Netherlands a ƙarshen 2004.
Da farko, ana yawan samun cutar a cikin yara ƙanana da tsofaffi da kuma marasa lafiya da ke fama da cututtukan numfashi.
A cikin cutar da HCoV-NL63 ke haifarwa, cutar coryza, conjunctivitis, zazzabi da kuma bronchiolitis sun zama ruwan dare gama gari.
Wani bincike mai zaman kansa ya bayyana ware wannan kwayar cutar daga hancin ɗan wata takwas da ke fama da ciwon huhu a Netherlands.
Ko da yake an gano shi ne a ƙasar Netherlands, amma a zahiri yana ko'ina a duniya.
HCoV-NL63 yana da alaƙa da cutar laryngitis mai hanawa, wanda ake kira croup.
A wannan shekarar, an gano HCoV-HKU1 a cikin wani mutum mai shekara 71 da aka kwantar da shi a asibiti da ciwon huhu da kuma cutar sankarar bargo a Hong Kong.
Kamar HCoV-NL63, HCoV-229E da HCoV-OC43, HCoV-HKU1 yana duniya, yana haifar da cututtukan numfashi masu sauƙi.
A yawancin lokaci, idan waɗannan HCoVs sun sami ikon watsawa da kyau da kuma ci gaba da kasancewa a cikin mutane, su ma ba sa cutarwa ko kuma cutarwa.
Wani annobar ta biyu ta sake bulla a Koriya ta Kudu a shekara ta 2015, inda aka samu mutum 186.
Alamun asibiti na MERS sun yi kama da na SARS kuma ana nuna su da ciwon huhu mai tsanani.
A cikin waɗannan lokuta, cutar SARS-CoV-2 ta fi yawa daga cikin masu cutar MERS.
Fiye da kashi 30 cikin ɗari na marasa lafiya suna nuna alamun cututtukan ciki kamar zawo da amai.
A ranar 14 ga Fabrairu, 2020, an samu sama da mutane 2,500 da aka tabbatar da cutar a cikin dakin gwaje-gwaje tare da yawan mutuwar mutum 34.4%, wanda ya sa MERS-CoV ya zama ɗaya daga cikin ƙwayoyin cuta masu saurin kashe mutane.
Wasu marasa lafiya suna kuma shan zawo.
SARS-CoV-2 ba ta da cutarwa sosai, amma tana da saurin yaduwa fiye da SARS-CoV da MERS-CoV.
An ba da rahoton mutane marasa alamun cutar SARS-CoV-2 kuma suna iya taimakawa wajen saurin yaduwar ta a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran HCoVs shida, an gano wasu kamanceceniya da bambance-bambance masu ban sha'awa.
Da farko, lokacin kamuwa da cutar da kuma tsawon lokacin kamuwa da cutar HCoVs suna kama da juna.
A wannan yanayin, SARS-CoV-2 yana bin tsarin sauran HCoVs shida.
Na biyu, tsananin alamun COVID-19 ya kasance tsakanin SARS-CoV da HCoVs huɗu na al'umma (watau HCoV-229E, HCoV-OC43, HCoV-HKU1, da HCoV-NL63).
A gefe guda, an lura da ƙaramin ƙaramin rukuni na mummunan yanayin COVID-19 kamar yadda yake a cikin SARS-CoV, kodayake adadin ya ɗan ragu.
A ƙarshe, kamar sauran HCoVs, ana iya gano SARS-CoV-2 a cikin samfuran ƙwaro.
Koyaya, halayen SARS-CoV-2, gami da watsawa, cutarwa, da ci gaba da yaduwa bayan watsawa ga mutane zai tasiri ƙarshen ƙarshen annobar COVID-19 ta yanzu.
A cikin waɗannan lokuta, cutar HCoV ta farko da aka gano a cikin cutar ta kamu da cutar ta hanyar cutar da ake kira HCoVs.
A wasu kalmomi, duka biyun na iya zama waɗanda suka tsira daga annobar HCoV da ta gabata.
Don wannan ya faru, HCoVs dole ne su ninka a cikin ɗan adam a cikin isasshen adadin don ba da damar tara canjin canji wanda ke biyan abubuwan ƙuntatawa na mai masaukin.
A wannan yanayin, idan cutar SARS-CoV-2 ta ci gaba da yaduwa kuma yawan mutanen da ke fama da ita ya yi yawa, za a iya samun yiwuwar cutar ta zama cikakkiyar mutum.
Idan ya daidaita da kyau, zai yi wuya a hana yaduwar cutar daga mutum zuwa mutum ta hanyar keɓewa ko wasu matakan hana kamuwa da cuta.
A cikin shekaru da yawa, waɗannan CoVs huɗu da aka samu a cikin al'umma suna yawo a cikin jama'a, suna haifar da sanyi mai sauƙi a cikin mutanen da ba su da rigakafi.
Waɗannan ƙwayoyin cuta ba sa bukatar wani dabba.
A gefe guda, SARS-CoV da MERS-CoV, masu cutar sosai, ba su daidaita da kyau ga mutane ba kuma ba a ci gaba da yaduwar su daga mutum zuwa mutum.
Dole ne su ci gaba da yaduwa a cikin wuraren ajiyar dabbobi kuma su nemi damar isa ga masu yuwuwar zama mutane, mai yiwuwa ta hanyar ɗayan ko fiye da masu watsawa da masu haɓaka.
SARS-CoV-2 yana da halaye masu kama da SARS-CoV/MERS-CoV da HCoVs huɗu da aka samo daga al'umma.
Duk da haka, yana da cutarwa fiye da HCoVs da aka samo daga al'umma kuma ba shi da cutarwa fiye da SARS-Cov ko MERS-CoV.
Har ila, ba a san ko zai iya zama da ɗan adam ba kuma ya riƙa tafiya a tsakanin mutane ba tare da wata dabba da ke kula da shi ba.
Kafin mu tattauna asalin HCoVs a cikin dabbobi, zai zama da amfani mu tattauna ma'anoni da halaye na masu karɓar HCoVs masu haɓaka, na halitta, masu riƙewa, masu tsaka-tsaki da masu haɓaka.
A cikin waɗannan lokuta, cutar ta iya zama mai saurin kamuwa da cutar ta hanyar cutar HCoV.
Kwayar cutar ta asali sau da yawa tana da kyau kuma ba ta haifar da cututtuka ga mai masaukin.
A cikin wannan yanayin, mai karɓar bakuncin yana riƙe da HCoV a cikin dogon lokaci.
A gefe guda, HCoVs na iya daidaitawa zuwa mai watsa shiri na tsakiya har ma da kafa ƙarancin lokaci.
A wannan yanayin, mai watsa shiri na tsakiya ya zama mai watsa shiri na halitta.
Musamman, tun da kashi 80 cikin ɗari na dabbobin da ke kasuwar Guangzhou suna da ƙwayoyin cuta masu hana SARS-CoV, ba za a iya hana yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa da yawa na iya zama masu karɓar bakuncin masu haɓaka ba.
Waɗannan bera suna da ƙwayoyin rigakafin SARS-CoV da jerin kwayoyin SARSr-Rh-BatCoV HKU3.
Waɗannan binciken sun kafa tushen sabon ra'ayi cewa jemage ne ke ɗauke da ƙwayoyin cuta na ɗan adam.
An san cewa ƙwayar cuta ta SARS-CoV tana da ƙwayoyin cuta da yawa.
Duk da kamanceceniya tsakanin ƙwayoyin cuta biyu, ana ganin cewa WIV1 ba dangin SARS-CoV ba ne kuma cewa barbashi ba shine mai karɓar bakuncin SARS-CoV ba.
Saboda haka, barbashi ba zai iya zama mai karɓar bakuncin MERS-CoV ba.
Bugu da ƙari, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuma suna da ƙwayoyin cuta na musamman da ke kawar da MERS-CoV, kamar raƙuma da ke Gabas ta Tsakiya da ke ƙasashe da yawa na Afirka.
Bugu da ƙari, raƙuma masu cutar suna fitar da kwayar cutar ba kawai ta hanyar numfashi ba amma ta hanyar ƙwayoyin cuta, wanda kuma shine babbar hanyar fitar da bera.
Ba za mu iya kawar da yiwuwar cewa pangolin yana ɗaya daga cikin dabbobi masu karɓar bakuncin SARS-CoV-2 ba.
Bugu da ƙari, nesa tsakanin SARS-CoV-2 da RaTG13 ba ta da yawa kamar ta raba SARS-CoV-2 da SARS-CoV-2 beta-CoVs daga pangolin.
Ƙarin haɗuwa shine babban abin da ke haifar da juyin halittar beta-CoVs.
Masana kimiyya sun rabu biyu game da asalin SARS-CoV-2 na dabbobi.
Bugu da ƙari, an gano cewa cutar ta HCoVs da ke da alaƙa da ƙwayar cuta ta HCoVs da ke da alaƙa da cutar ta HCoVs da ke da alaƙa da cutar ta HCoVs.
Bayanan ilimin halitta sun nuna cewa duka HCoV-NL63 da HCoV-229E na iya samo asali ne daga CoV na bera, yayin da aka sami ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin rodents.
A gefe guda, an danganta HCoV-229E da wani kwayar cutar CoV ta bera, da ake kira Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, yayin da ake zargin cewa wasu camellids ma masu watsawa ne.
Lokacin da HCoV-OC43 ya ƙetare shingen jinsuna don ya kamu da mutane daga dabbobi a kusan 1890, an ba da rahoton yaduwar cutar numfashi.
A cikin wannan yanayin, cutar ta kamu da cutar a cikin mutane da yawa.
An gano wasu alpha-CoVs na bera da ke da alaƙa da HCoV-229E.
Da farko, ba kamar alpacas ba, maza suna iya haɗuwa da ƙudaje a cikin wani wuri mai kyau.
Amma, mutane suna da dangantaka ta kud da kud da alpacas.
Bayan haka, alpha-CoVs na bera da ke da alaƙa da HCoV-229E suna da yawa kuma ba su da cutar a cikin bera, yayin da alpha-CoVs na alpaca sun haifar da barkewar cutar numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a sami alpha-CoV na alpaca a cikin dabbobin daji ba.
A gaskiya, ƙuda ce tushen ƙwayoyin cuta da ke shafan mutane, kamar su cutar hauka, Ebola, Nipah, da kuma Hendra.
Saboda haka, ba abin mamaki ba ne cewa jemage na iya watsa HCoV-229E kai tsaye ga mutane.
Wataƙila, yayin da alpha-CoVs na bera ke aiki a matsayin wurin ajiyar kwayoyin HCoV-229E, alpacas da camels na iya zama masu watsawa tsakanin waɗanda ke watsa ƙwayoyin cuta ga mutane, kamar yadda yake a cikin MERS-CoV.
MERS-CoV misali ne mai kyau na yaduwar jinsuna daga bera zuwa rakumi da kuma daga rakumi zuwa mutane.
An san asalin juyin halitta na MERS-CoV da aka samo a cikin bera ta hanyar gano shi da farko kuma an kuma ƙarfafa shi ta hanyar binciken da aka yi daga baya.
A gefe guda kuma, MERS-CoV ya kasance a cikin rakuma shekaru da yawa.
Ya yi amfani da raƙuman da suka zama matsakaitan baƙi kuma suka zama masu riƙe da abinci.
Ba kamar yadda raƙuma suke da alhakin watsa MERS-CoV ba, dangolin suna da alhakin watsa SARS-CoV-2, idan suna da ɗaya.
Musamman, beta-CoVs na pangolin suna da cutarwa sosai a cikin pangolins.
Akwai yiwuwar yaduwar SARS-CoV-2 tsakanin dabbobi zuwa mutane a cikin bincike na gaba.
Na farko, ƙuda na iya zama mai karɓar bakuncin kwayar cutar SARS-CoV-2 mai kama da SARS-CoV-2.
Mutane za su iya zama tare da waɗannan ƙudaje ta wajen yin kiwo ko kuma hakar ma'adinai.
Na biyu, pangolins na iya zama ɗaya daga cikin masu karɓar bakuncin masu haɓaka tsakanin waɗanda aka gabatar da kwayar cutar SARS-CoV-2 kwanan nan.
Mutane suna kamuwa da cutar ta hanyar cin nama da kuma cin naman farauta.
Akwai yiwuwar dabbobi masu shayarwa da yawa ciki har da dabbobin gida su kamu da SARS-CoV-2.
Na uku, kamar yadda aka ambata a sama, sake haɗuwa da daidaitawa na SARS-CoV-2 na iya faruwa a cikin nau'in na uku wanda ya kasance tare da jemage da pangolins.
Ana ci gaba da bincike kan asalin SARS-CoV-2 daga dabbobi.
Idan aka kwatanta da sauran ƙwayoyin RNA guda ɗaya, ƙididdigar canjin canjin CoVs za a iya ɗauka  matsakaici  zuwa  mai girma  tare da matsakaicin canjin canji na ~ 10-4 sauyawa a kowace shekara a kowane wuri, dangane da matakin daidaitawar CoV zuwa sabbin runduna.
Duk da haka, yawan canjin CoV ya fi na masu karɓar su sau miliyan ɗaya.
Bugu da ƙari, yawan canjin jini yakan yi yawa idan CoVs ba su daidaita da mai gidan ba.
Idan aka kwatanta da SARS-CoV, wanda ke da yawan canjin jini, yawan canjin jini na SARS-CoV-2 ya fi ƙasa, wanda ke nuna cewa ya fi dacewa da mutane.
Wataƙila ya riga ya saba da wani ɗan adam.
Ban da SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya daidaita da kyau ga rakuma.
A ka'idar, ba zai yiwu ba cewa maye gurbin kwayoyin halitta zai sa alluran rigakafi da maganin SARS-CoV-2 su zama marasa tasiri a cikin ɗan gajeren lokaci.
Na uku, CoVs suna canza tsarin su a bazuwar kuma sau da yawa yayin da suke yin kwafin RNA ta hanyar hanyar zaɓi-kwafin-kwafin.
An sami shaidar kwayoyin halitta na sake haɗuwa ta halitta don duka HCoV-HKU1 da HCoV-OC43, da CoVs da aka gani a cikin dabbobi, kamar SL-CoV da batCoV-HKU9.
Hadin gwiwar kwayar cuta da mai watsawa dangane da watsawa
Baya ga waɗannan abubuwa uku na kwayar cutar da aka ambata a sama, hulɗar kwayar cutar da mai karɓar mai karɓar ita ce wani muhimmin abu da ke shafar watsawar jinsuna.
Ana amfani da sake haɗuwa da SARS-CoV a matsayin misali na yau da kullun a nan; kuma yana nuna shaidar zaɓi mai kyau yayin abubuwan watsawa tsakanin jinsuna.
A wasu kalmomi, waɗannan maye gurbin amino acid biyu na iya zama manyan abubuwan da ke haifar da ƙwayoyin cuta a cikin ɗan adam.
Yana da ban sha'awa cewa SARS-CoV-2 yana da mai karɓar ƙwayar halitta ɗaya da SARS-CoV.
Bambanci na kashi 30 tsakanin SARS-CoV-2 da SARS-CoV a cikin S1 na S-protein yana nufin cewa haɗin haɗin wannan S-protein zuwa ACE2 na ɗan adam na iya zama ya lalace.
A zahiri, binciken da aka yi ta hanyar cryomicroscopy na lantarki ya nuna kusancin wannan haɗin sau 10 zuwa 20 fiye da wanda aka gani tsakanin ACE2 na ɗan adam da furotin S na SARS-CoV.
Hakanan zai zama mai ban sha'awa don gano ko za a iya buƙatar wani mai karɓar mai karɓar don watsa SARS-CoV-2.
Abin mamaki, HCoV-NL63 kuma yana ɗaure da ACE2 amma tare da wani ɓangare na S-protein.
Akwai wasu masu karɓar HCoV da yawa, kamar aminopeptidase N don HCoV-229E, da 9-O-acetyl sialic acid don HCoV-OC43.
Bambancin sunadarai tsakanin mutane da kuma masu riƙe da HCoVs na halitta, kamar barbashi, rakumi da rodents, na iya zama shinge ga yaduwar jinsuna.
Sabuwar Kwayar HCoV ta bayyana: Komawa ga Farawa
A cikin wannan yanayin, yawancin kwayoyin cutar sun kasance masu haɗari ga ƙwayoyin cuta.
A wannan yanayin, CoVs na bera sune kayan adana kwayoyin HCoVs.
Daga cikin sunadarai masu taimako na SARS-CoV, an yi la'akari da ORF8 a matsayin mai mahimmanci wajen daidaitawa ga mutane, saboda ƙwayoyin cuta na bera da ke da alaƙa da SARS-CoV an ware su amma suna da sunadarai daban-daban na ORF8.
Wannan cirewa ya raba ORF8 zuwa ORF8a da ORF8b kuma ana ganin yana da maye gurbi wanda ke ba da damar canza mai karɓar.
An kuma gano wuraren sake haɗuwa a cikin nsp9, a cikin yawancin nsp10, da wasu nsp14.
Hakanan, an nuna cewa barkewar MERS-CoV ta sami abubuwan haɗuwa tsakanin zuriyoyi daban-daban, waɗanda suka faru a cikin raƙuman a Saudi Arabiya.
Yayin da ORF4 aka iya gani a cikin ƙwayoyin cuta na bera da raƙumi da ke da alaƙa da HCoV-229E, alpha-CoV na alpaga yana da shigar da nucleotide mai sauƙi, wanda ke haifar da canjin tsarin karatu.
A ƙarshe, ana kuma sa sabon HCoV ya ci gaba ta hanyar matsin lamba a cikin masu riƙe da su.
An gano wasu marasa alamun cutar ko kuma alamun rashin lafiya lokacin da CoVs suka kamu da bera, wanda ke nuna cewa CoVs da bera sun daidaita.
Da alama cewa ƙudaje sun daidaita da CoVs sosai a fannin ilimin halitta da kuma ilimin jiki.
Alal misali, rashin daidaito a cikin kunnawar amsawar ƙonewa a cikin bera yana rage cutar da CoV ke haifar da ita.
Bugu da ƙari, babban matakin masu amfani da iskar oxygen (ROS) wanda ke haifar da ƙarancin ƙwayar cuta na ƙwari na iya hana CoV ya sake maimaitawa kuma ya shafi "sake karantawa" ta hanyar exoribonuclease, wanda zai haifar da matsin lamba mai zaɓi kuma ya haifar da ƙwayoyin cuta masu cutarwa sosai lokacin da aka kawo su cikin sabon mai masaukin.
Ƙarin ƙwayar CoV mai cutarwa na iya canzawa ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don karɓar mai karɓar.
Saboda haka, ba daidaituwa ba ne cewa sababbin HCoVs uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da alamun rashin lafiya a cikin masu riƙe su kamar barbashi da raƙuma.
Suna iya yin kwafi sosai ba tare da sa jikin mai shan maganin ya yi tsananin faɗa ba.
Wannan shi ne asirin gano masu dauke da cutar da ba su nuna alamun cutar ba da kuma abin da ke haifar da kamuwa da cutar a cikin mutane.
Abubuwan da ke haifar da cututtuka masu tsanani sune sakamakon haɓakar amsawar rigakafi da harin cytokine; mafi ƙarfin amsawar rigakafi, mafi tsananin lalacewar huhu.
A wani ɓangare kuma, a cikin masu ɗauke da cutar ba tare da alamomi ba, an cire amsar rigakafi daga kwayar cutar CoV.
Wannan dabarar ta ware amsar rigakafi na iya samun fa'idodi masu amfani wajen maganin SARS-CoV-2.
Saboda haka, ana tsammanin bayar da nau'in interferon na farko aƙalla a farkon lokacin kamuwa da SARS-CoV-2 zai zama da amfani.
Bugu da ƙari, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
A cikin wannan tunani, hana NLRP3 tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
Duk da yake an gano beta-CoV na bera wanda ke da kashi 95% na kwayar halittar nucleotide tare da SARS-CoV, akwai kuma CoV na bera wanda ke da kashi 96% na kwayar halittar nucleotide tare da SARS-CoV-2.
An gano wasu nau'ikan kwayar cutar ta pangolin da suka yi kama da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗaya daga cikin masu karɓar baƙi na tsakiya ko kuma pangolin beta-CoV na iya ba da gudummawa ga ɓangarorin kwayoyin halittar SARS-CoV-2 na ƙarshe.
CoVs sun sake dawowa cikin haske saboda barkewar cutar SARS-CoV-2 kwanan nan.
A gefe guda kuma, MERS-CoV ya daɗe yana cikin raƙuma.
Waɗannan raƙuma suna da muhimmanci wajen sufuri kuma suna kawo nama, madara, fata, da ulu ga mazauna yankin.
Suna da yawa a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a yanka dukan raƙuma don a hana MERS ba, kamar yadda aka yi a kasuwar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar MERS, ya kamata a ɗauki cikakkiyar hanyar samar da alluran rigakafi masu tasiri don MERS-CoV a cikin raƙuma, haɗe da sauran matakan kula da kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, sababbin ƙwayoyin halitta za su iya fitowa kuma su haifar da annoba.
Akwai wasu CoVs da ke haifar da cutar dabbobi a cikin yanayi.
Musamman CoVs na malam buɗe ido, waɗanda ke da ƙarfin cutar dabbobi sosai.
A wasu yankunan kasar Sin, ya kamata a daina cin namun daji domin rage hulɗar da ke tsakanin mutane da dabbobi.
A gaskiya, ƙwayoyin cuta da yawa sun daɗe suna wanzuwa a duniya.
Suna zama a cikin tafkunansu na halitta har sai sun sami zarafin kamuwa da cutar.
Ana buƙatar ci gaba da lura da dabbobi masu shayarwa don fahimtar yanayin CoV da kuma masu karɓar su na halitta, wanda zai taimaka wajen hana yaduwar dabbobi zuwa mutane da kuma barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci da mutane za su iya hana cututtukan da ke tattare da ƙwayoyin cuta ita ce ta guje wa wuraren da ke da ƙwayoyin cuta.
Na farko, idan jemage suna watsa kwayar cutar SARS-CoV-2 daga iyayensu zuwa ga pangolins, zai zama da ban sha'awa a lura da yanayin da jemage da pangolins za su iya zama a cikin yanayin muhalli ɗaya.
Na biyu, idan ƙudaje suna da matsayi na musamman wajen yaduwar cutar ga mutane, za a bukaci a gano yadda mutane suke haɗuwa da ƙudaje.
Na uku, idan dabba ta uku tana zama mai ba da abinci, ba a san yadda take shafar mutane da kuma dabbobi kamar su maza da ƙuda da kuma pangolins ba.
Ko ɗan doki ne, ko kuma ɗan dabba mai shayarwa, ya kamata a iya gano SARS-CoV-2 ko kuma ƙwayoyin cuta na asali da suka yi kama da juna a cikin mahaifinsu.
Za ka iya kamuwa da cututtukan numfashi kamar mura ko sanyi idan ba ka wanke hannu kafin ka taɓa idanunka, hanci ko bakinka (wato, mucous membranes).
Babban manufar wanke hannu a fannin kiwon lafiya shine kawar da kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da ke iya haifar da cuta) da sunadarai, waɗanda za su iya zama masu cutarwa ko haifar da cuta.
Wanke hannu yana da fa'idodi masu yawa ga lafiyar jiki, ciki har da rage yaduwar mura, coronavirus da sauran cututtuka masu yaduwa; hana cututtukan da ke haifar da zawo; rage kamuwa da cututtukan numfashi;
Ƙari ga haka, za a rage yawan mutuwar yara a gida.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da gudawa ta wajen yin wasu canje-canje a yadda suke rayuwa, kamar wanke hannu da sabulu.
Ciwon huhu, wanda shi ne babban dalilin mutuwar yara, shi ne sanadin mutuwar yara 'yan ƙasa da shekara biyar, kuma yana kashe kusan mutane miliyan 1.8 a kowace shekara.
Cutar gudawa da ciwon huhu suna kashe yara kusan miliyan 3.5 kowace shekara.
Wanke hannu yana kuma kāre mutum daga cutar impetigo, wadda ake yaduwa ta hanyar taɓa jiki kai tsaye.
Idan aka yi wanka da hannu sau da yawa, zai iya ɓata fata kuma ya sa ta bushe.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu zai iya haifar da cutar eczema ko cututtukan fata a hannu, wanda ke nuna fatar jiki da ƙaiƙayi, musamman ma a tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin wanke hannu sau da yawa yana ɗaya daga cikin alamun cuta ta obsessive-compulsive disorder (OCD).
Ana amfani da maganin kashe ƙwayoyin cuta sau biyu a shekara, tare da wanke hannu da sabulu da kuma goge haƙori da man goge baki da fluoride a kowace rana.
An kuma yi amfani da shi da kyau a ƙasar Indonesia.
Babban aikin sabulu da kayan wanki shine rage shingen bayani da kuma kara narkewa.
Ruwa kaɗai ba shi da amfani wajen wanke fata domin mai ƙanshi da furotin da ke cikin ƙasa ba sa narkewa cikin ruwa.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, na iya ƙunsar ƙwayoyin cuta daga amfani da baya.
Har zuwa yau, babu wata shaida da ta nuna cewa amfani da maganin kashe ƙwayoyin cuta ko kuma maganin kashe ƙwayoyin cuta da aka ba da shawarar zai iya kai wa ga ƙwayoyin cuta masu jurewa a cikin yanayi.
Saboda haka, ko da yake maganin rigakafi ba ya haifar da sabulu na antibacterial, sabulu na antibacterial bazai iya zama tasiri kamar yadda aka sanar ba.
Baya ga maganin shafawa da kare fata, magungunan da suka fi rikitarwa na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) da ke daidaita pH, benzoic acid, wanda ke da aikin rigakafin ƙwayoyin cuta, da sauran magungunan kariya (aloe vera, bitamin, menthol, tsire-tsire masu tsire-tsire).Binciken da aka yi a Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun suna da tasiri kamar sabulu na gida wanda ke dauke da triclosan don hana cututtuka da kawar da ƙwayoyin cuta daga hannaye.
Ruwa mai zafi da ake amfani da shi wajen wanke hannu bai isa ya kashe ƙwayoyin cuta ba.
Kwayoyin ƙwayoyin cuta suna ƙaruwa da sauri idan jiki yana da zafin jiki mai ɗumi.
Amma, ruwan sabulu mai ɗumi ya fi ruwan sanyi da sabulu kyau wajen kawar da mai da ke ɗauke da ƙazanta da ƙwayoyin cuta.
Amma sabanin abin da mutane da yawa suke tsammani, binciken kimiyya ya nuna cewa shan ruwan dumi ba ya rage ƙwayoyin cuta a hannayenmu.
Maganin kashe ƙwayoyin cuta na hannu ko maganin kashe ƙwayoyin cuta na hannu ne da ba ya ɗauke da ruwa.
Yawancin suna da isopropyl alcohol ko ethanol da aka haɗa da wani mai kauri kamar carbomer (polymer na acrylic acid) don samun gel, ko kuma mai laushi kamar glycerin don samun ruwa ko kumfa don sauƙin amfani da rage tasirin bushewar barasa.
Ƙara hydrogen peroxide mai narkewa yana ƙara ƙarfin ƙwayoyin cuta. Magungunan kashe ƙwayoyin cuta na hannu waɗanda ke da kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta sosai.
Maganin ruwa yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu jurewa (SARM da ERV), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura da hepatitis), da kuma naman gwari.
Maganin ruwa mai shan giya kusan ba shi da tasiri a kan ƙwayoyin cuta irin su norovirus (ko Norwalk), babban dalilin cututtukan gastroenteritis. Ya kamata a yi amfani da isasshen maganin kashe ƙwayoyin cuta na hannu ko maganin ruwa mai shan giya don a yi rigar hannu biyu ko kuma a rufe su.
Ƙara amfani da waɗannan kayayyakin saboda sauƙin amfani da kuma saurin kawar da ƙwayoyin cuta; duk da haka, bai kamata su maye gurbin wanke hannu da kyau ba sai dai idan ba ku da sabulu da ruwa a hannu.
Yin amfani da ruwan sha sau da yawa zai iya sa fata ta bushe idan ba a ƙarfafa ruwan ba da kayan shafawa da kuma/ko na'urar da ke sa fata ta yi laushi.
Za a iya rage ko kawar da ƙwayar barasa ta hanyar ƙara glycerin da/ko wasu abubuwa masu saurin wankewa a cikin samfurin.
A cikin gwaji na asibiti, maganin ruwa mai shan giya wanda ke ɗauke da kayan shafawa ya haifar da ƙarancin ƙonewa da bushewar fata fiye da sabulu ko kayan wanke cututtukan ƙwayoyin cuta.
Allergic contact dermatitis, contact urticaria ko rashin jin daɗin barasa ko ƙari a cikin maganin ruwa-ruwa ba safai ba.
Ko da yake suna da amfani sosai, magungunan da ba su da ruwa ba sa kawar da ƙwayoyin da ke hannayenku, amma suna kashe ƙwayoyin cuta ne kawai.
Saboda wannan dalili, maganin kashe ƙwayoyin cuta na hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta da yawa, saboda waɗannan sun kasance a kan hannaye.
Amfani da maganin wanke hannu ba tare da barasa ba ya dogara sosai da sinadarai da kuma tsari, kuma koyaushe yana da ƙasa da na barasa da kuma na maganin wanke hannu.
A kwanan nan, magungunan da ke amfani da benzalkonium chloride sun nuna ci gaba da aiki na antimicrobial bayan amfani, sabanin barasa, wanda tasirinsa ya ragu bayan amfani da shi sau da yawa, mai yiwuwa saboda ci gaba da rashin lafiyar fata.
Ƙura da toka suna iya yin aiki fiye da ruwa kaɗai, amma ba su da amfani kamar sabulu.
Ƙari ga haka, idan ƙwayoyin cuta sun shiga ƙasa ko toka, hakan zai sa cutar ta yaɗu maimakon ta hana ta.
Kamar sabulu, toka tana kuma amfani da ita wajen kashe ƙwayoyin cuta domin idan ta haɗu da ruwa, tana zama ruwan gishiri.
WHO ta ce ana iya amfani da toka ko yashi a madadin sabulu idan babu sabulu.
Wanke hannuwanka da ruwan sanyi ko mai dumi.
Ana ba da shawarar ruwan da ke gudana saboda haɗarin gurɓataccen ruwan da ke tsaye, yayin da zafin ruwan bai bayyana ya bambanta ba).
Ka yi amfani da sabulu mai yawa a kan hannayenka, ka shafa su da juna, ka kuma shafa su a bayan hannayenka, tsakanin yatsun hannu da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna yawan wanke hannayensu sosai idan suna amfani da sabulu fiye da ruwa kawai.
Ka yi amfani da shi na akalla dakika 20.
Idan ka shafe fatar jikinka, za ka sami ƙwayoyin cuta da yawa.
Ka wanke shi sosai da ruwa mai gudu.
Wankewa a cikin tafkin ruwa mai tsayawa zai iya sake gurɓata hannaye.
Ka bushe shi da tawul mai tsabta ko kuma a waje.
Hannun da suke da rigar suna sake kamuwa da cutar. Yankunan da aka fi mantawa da su sune babban yatsu, wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin ƙusa.
Ƙwaƙwalwar da aka yi da ƙusa da kuma ƙusa da aka yi da ƙusa za su iya ɗauke da ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da maganin shafawa don hana hannayenka bushewa.
Akwai hanyoyi masu yawa na wanke hannu idan babu ruwan famfo da sabulu. Misali, zubar da ruwa daga gwangwani ko bututun da aka rataye da kuma yin amfani da toka idan ya cancanta, a ƙasashe masu tasowa. A cikin yanayi inda akwai iyakancewar samar da ruwa (kamar a makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin adana ruwa, kamar  tippy-taps  da sauran zaɓuɓɓukan tattalin arziki.
Tip-tap fasaha ce mai sauƙi da ke amfani da tukunyar da aka rataye da igiya da kuma ƙafa don zuba ruwa kaɗan a hannayenka da kuma sabulu.
Drying hannaye yadda ya kamata wani muhimmin bangare ne na aikin tsabtace hannu, amma hanya mafi kyau don bushe hannaye a bayan gida na jama'a yana da muhawara.
Bincike da yawa ya nuna cewa tawul ɗin takarda sun fi na lantarki tsabta da ake samu a bayan gida.
Bayan wankewa da bushewa da na'urar bushe hannu da iska mai zafi, an gano cewa yawan kwayoyin sun karu da kashi 194 cikin ɗari a kan yatsunsu da kashi 254 cikin ɗari a kan dabino.
Drying da na'urar busar hannu ta iska ya haifar da ƙaruwar ƙwayoyin cuta a kan yatsunsu da kashi 42 cikin ɗari da kuma hannayen hannu da kashi 15 cikin ɗari.
Bayan bushe hannuwan, an lura da waɗannan canje-canje a cikin ƙididdigar ƙwayoyin cuta:
Akwai masu sana'a da yawa na na'urar busar hannu, kuma an kwatanta na'urar busar hannu da na'urar busar hannu da takarda.
Wanke hannu da tawul ɗin kashe ƙwayoyin cuta wani zaɓi ne yayin tafiya, idan babu sabulu da ruwa.
Za a iya amfani da ruwa mai shan giya a cikin ruwa mai shan ruwa don a samu ruwa mai yawa.
Akwai na'urorin lantarki da ke faɗakar da ma'aikatan asibiti idan sun manta da wanke hannu.
Wanke hannu na likita ya kamata ya ɗauki aƙalla dakika 15, ta amfani da sabulu da ruwa ko gel mai yawa don busawa da shafa kowane ɓangaren hannu.
A shafa hannayenku a tsakanin yatsunsu.
Bayan bushewa, dole ne a yi amfani da tawul ɗin takarda don rufe famfo (kuma buɗe ƙofar fitarwa idan ya cancanta).
Manufar wanke hannu a cibiyoyin kiwon lafiya shine cire ƙwayoyin cuta ( ƙwayoyin cuta ) da hana yaduwar su.
Whitby et al. sun yi bincike mai kyau.
bayan an yi amfani da jini/wani ruwa mai rai;
kafin aikin aseptic; kuma
Dole ne a cire dukan kayan ado.
A wannan aikin, ana bukatar wanke hannu da hannayen gaba har zuwa gwiwar hannu, yawanci na minti 2 zuwa 6.
Idan aka wanke hannu, kada ruwa ya shiga hannu.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannu ko amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da mai ciwo.
A game da kula da kamuwa da cutar staph a asibitoci, an gano cewa mafi yawan fa'idodin wanke hannu ana samun su ne a farkon kashi 20 na wanke hannu, kuma akwai ƙananan fa'idodi na ƙara yawan wanke hannu sama da kashi 35.
Ana bukatar ƙarin bincike don sanin hanyoyin da suka fi dacewa a wurare dabam dabam na kiwon lafiya.
Alal misali, a yawancin yankunan karkara na Afirka, ba a yawan samun famfunan wanke hannu kusa da bayan gida ko na jama'a, duk da cewa akwai zaɓuɓɓukan da ba su da tsada don gina tashoshin wanke hannu.
Duk da haka, ƙananan yawan wanke hannu na iya zama sanadiyar ɗabi'a mai ɗorewa, maimakon rashin sabulu ko ruwa.
Da zarar an cika ƙa'idodin, za a iya ɗaukaka makarantu daga tauraro ɗaya zuwa uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na inganta tsabtace hannu da ake gudanarwa don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ake da'awar zai kawo canji a dabi'u. Bayan annobar cutar coronavirus ta 2019-2020, UNICEF ta ƙarfafa amfani da hoton emoji da ke nuna wanke hannu.
Amma, wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu ya fi sauran hanyoyin tsabtace ruwa da tsaftacewa.
A lokacin, mutane da yawa suna ganin cewa ƙamshi ne ke jawo cututtuka.
Alal misali, a Jamus, an saka allon talla da ke nuna  hanyoyin wanke hannu  kusa da wankin wanka a bayan gida da kuma bayan gida a ofisoshin gine-gine da filayen jirgin sama.
Furucin  wanke hannu  yana nufin ƙin yarda da alhakin ko kuma kasancewa cikin wani abu.
Ƙari ga haka, waɗanda aka ƙyale su su wanke hannuwansu bayan sun yi irin wannan tunanin ba sa son su yi wasu ayyukan da za su taimaka musu su tsabtace kansu, kamar yin aikin sa kai.
Hakazalika, addinai kamar su Hindu, Buddha, Sikh, Yahudanci, da kuma Musulunci suna bukatar a wanke hannu kafin a ci abinci da kuma bayan an ci abinci.
kuma duk wani ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman ma a shekarunka
musamman idan kana da zazzabi
kuma cholesterol da jini kuma dole ne a duba
kuma kuna da zazzabi a yanzu?
kuma kana da wani daga cikin wadannan alamun ban da ciwon kirji?
kuma hancinka yana zub da ruwa?
kuma ciwon yana motsawa daga kirjinka?
kuma ku sha ruwa mai yawa
Kuma yawan zazzabi da kuka yi?
kuma ina tari ma
kuma ina da ɗan sanyi kuma ina tari
kuma ina da ciwon kirji sosai yau
kuma ina da wannan ciwon a kirji
kuma ina ganin ina da zazzabi kadan
kuma tana da alamun iri daya
kuma ka gaya mini, waɗanne cututtuka kake da su a yanzu?
kuma suna da zazzabi kadan suma
da kuma tarihin ciwon sukari
kuma kun san ina jin kamar kirji na zai fashe
kuma kun san mutane suna tari a kaina a koda yaushe
kuma kana da ciwo a kirji
kuma alamun cutarka basu bace cikin kwana biyar
kuma ka ce kana jin matsin lamba a kirjinka
kuna da wasu alamomi ko matsaloli ban da ciwon tsoka?
ciwo mai tsanani a gefen hagu na kirjinka?
akwai wasu marasa lafiya a gidanku da ke da alamun cutar?
kana da wahalar numfashi a yanzu?
kuna da wasu alamun cutar?
Shin kana da numfashi?
har yanzu kuna da ciwon kirji?
saboda lokacin mura ne
Ya kamata a lura cewa zabin wucin gadi na iya taimakawa wajen sauya kwayoyin halittar kwayar cutar, wanda wataƙila sakamakon matsin lamba ne yayin zaɓar, musamman ta tsarin garkuwar jiki na mai karɓar baƙi.
Misali na wannan shine asarar cikakken ORF4 a cikin samfurin HCoV-229E, saboda cire nucleotide biyu.
Yayin da ORF4 aka iya gani a cikin ƙwayoyin cuta na bera da raƙumi da ke da alaƙa da HCoV-229E, alpha-CoV na alpaga yana da shigar da nucleotide mai sauƙi, wanda ke haifar da canjin tsarin karatu.
A ƙarshe, ana kuma sa sabon HCoV ya ci gaba ta hanyar matsin lamba a cikin masu riƙe da su.
An gano wasu marasa alamun cutar ko kuma alamun rashin lafiya lokacin da CoVs suka kamu da bera, wanda ke nuna cewa CoVs da bera sun daidaita.
Da alama cewa ƙudaje sun daidaita da CoVs sosai a fannin ilimin halitta da kuma ilimin jiki.
Alal misali, rashin daidaito a cikin kunnawar amsawar ƙonewa a cikin bera yana rage cutar da CoV ke haifar da ita.
Bugu da ƙari, ana hana ayyukan ƙwayoyin halitta a cikin ƙwayoyin ƙwayoyin halitta ta hanyar ƙwayoyin halitta na NKG2/CD94 da ƙananan ƙwayoyin halitta na manyan kwayoyin halitta na Class I.
Bugu da ƙari, babban matakin masu amfani da iskar oxygen (ROS) wanda ke haifar da ƙarancin ƙwayar cuta na ƙwari na iya hana CoV ya sake maimaitawa kuma ya shafi "sake karantawa" ta hanyar exoribonuclease, wanda zai haifar da matsin lamba mai zaɓi kuma ya haifar da ƙwayoyin cuta masu cutarwa sosai lokacin da aka kawo su cikin sabon mai masaukin.
Ƙarin ƙwayar CoV mai cutarwa na iya canzawa ta hanyar sake haɗuwa, wanda ke haifar da samun sabbin sunadarai ko halayen sunadarai don karɓar mai karɓar.
Saboda haka, ba daidaituwa ba ne cewa sababbin HCoVs uku sun bayyana a cikin shekaru ashirin da suka gabata.
CoVs ba su da cutar ko kuma suna haifar da alamun rashin lafiya a cikin masu riƙe su kamar barbashi da raƙuma.
Suna iya yin kwafi sosai ba tare da sa jikin mai shan maganin ya yi tsananin faɗa ba.
Wannan shi ne asirin gano masu dauke da cutar da ba su nuna alamun cutar ba da kuma abin da ke haifar da kamuwa da cutar a cikin mutane.
Abubuwan da ke haifar da cututtuka masu tsanani sune sakamakon haɓakar amsawar rigakafi da harin cytokine; mafi ƙarfin amsawar rigakafi, mafi tsananin lalacewar huhu.
A wani ɓangare kuma, a cikin masu ɗauke da cutar ba tare da alamomi ba, an cire amsar rigakafi daga kwayar cutar CoV.
Wannan dabarar ta ware amsar rigakafi na iya samun fa'idodi masu amfani wajen maganin SARS-CoV-2.
Amsar interferon tana da ƙarfi sosai a cikin ƙuda.
Saboda haka, ana tsammanin bayar da nau'in interferon na farko aƙalla a farkon lokacin kamuwa da SARS-CoV-2 zai zama da amfani.
Bugu da ƙari, ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
A cikin wannan tunani, hana NLRP3 tare da MCC950 na iya zama da amfani wajen maganin COVID-19.
SARS-CoV-2 ya samo asali ne ta hanyar bin tsarin da SARS-CoV da MERS-CoV suka samo asali.
Duk da yake an gano beta-CoV na bera wanda ke da kashi 95% na kwayar halittar nucleotide tare da SARS-CoV, akwai kuma CoV na bera wanda ke da kashi 96% na kwayar halittar nucleotide tare da SARS-CoV-2.
Duk da yake an gano cewa wasu dabbobi da ke kasuwa suna dauke da kwayar cutar da ta yi kama da SARS-CoV, ba a gano wani mai karɓar SARS-CoV-2 ba.
An gano wasu nau'ikan kwayar cutar ta pangolin da suka yi kama da SARS-CoV-2, wanda ke nuna cewa pangolin na iya zama ɗaya daga cikin masu karɓar baƙi na tsakiya ko kuma pangolin beta-CoV na iya ba da gudummawa ga ɓangarorin kwayoyin halittar SARS-CoV-2 na ƙarshe.
Ko da yake akwai wasu tambayoyi, babu wata shaida da ta nuna cewa SARS-CoV-2 mutum ne ya kirkireshi, ko da gangan ne ko kuma ba da gangan ba.
CoVs sun sake dawowa cikin haske saboda barkewar cutar SARS-CoV-2 kwanan nan.
Binciken CoVs a cikin beraye da sauran dabbobi ya canza ra'ayinmu game da rawar da asalin dabbobi da wuraren ajiyar dabbobi ke takawa wajen watsa HCoVs ga mutane.
Akwai hujjoji da yawa da suka nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun samo asali ne daga bera kuma ana yada su ga mutane ta hanyar masu karɓar baƙi.
Tun da yake kamuwa da SARS-CoV ya samo asali ne daga haɗuwa tsakanin mutane da civets a kasuwanni, rufe kasuwanni na kayan sabo da kashe civets a can zai iya kawo ƙarshen barkewar SARS.
A kan wannan dalili, ya kamata a cire pangolins daga kasuwar kayan sabo don hana yaduwar cututtukan dabbobi, saboda gano yawancin layin beta-CoV na pangolins da ke da alaƙa da SARS-CoV-2.
Koyaya, ko SARS-CoV-2 yana yaduwa ga mutane daga pangolins da sauran dabbobi masu shayarwa, kuma idan haka ne, ta yaya wannan yaduwar ke faruwa, zai kasance a cikin binciken da zai biyo baya.
A gefe guda kuma, MERS-CoV ya daɗe yana cikin raƙuma.
Waɗannan raƙuma suna da muhimmanci wajen sufuri kuma suna kawo nama, madara, fata, da ulu ga mazauna yankin.
Suna da yawa a Gabas ta Tsakiya da Afirka.
Saboda haka, ba zai yiwu a yanka dukan raƙuma don a hana MERS ba, kamar yadda aka yi a kasuwar dabbobi a China don hana yaduwar SARS-CoV da SARS-CoV-2.
Don dakatar da sake barkewar MERS, ya kamata a ɗauki cikakkiyar hanyar samar da alluran rigakafi masu tasiri don MERS-CoV a cikin raƙuma, haɗe da sauran matakan kula da kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin cuta ba, sababbin ƙwayoyin halitta za su iya fitowa kuma su haifar da annoba.
Akwai wasu CoVs da ke haifar da cutar dabbobi a cikin yanayi.
Musamman CoVs na malam buɗe ido, waɗanda ke da ƙarfin cutar dabbobi sosai.
Akwai dama ga waɗannan CoVs na dabbobi su sake canzawa da haɗuwa, suna haifar da sababbin CoVs waɗanda za su iya yaduwa da kuma / ko kashe mutane a nan gaba.
A wasu yankunan kasar Sin, ya kamata a daina cin namun daji domin rage hulɗar da ke tsakanin mutane da dabbobi.
A yayin da ake fuskantar bala'in SARS, MERS da COVID-19, ya kamata a samar da shiri da kuma shirin da ya fi dacewa.
A gaskiya, ƙwayoyin cuta da yawa sun daɗe suna wanzuwa a duniya.
Suna zama a cikin tafkunansu na halitta har sai sun sami zarafin kamuwa da cutar.
Ko da yake jemage suna da halaye da yawa da ke sa su yada ƙwayoyin cuta, ana iya rage yiwuwar ɗan adam ya haɗu da jemage da sauran dabbobin daji idan an sanar da mutane game da buƙatar nisantawa.
Ana buƙatar ci gaba da lura da dabbobi masu shayarwa don fahimtar yanayin CoV da kuma masu karɓar su na halitta, wanda zai taimaka wajen hana yaduwar dabbobi zuwa mutane da kuma barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci da mutane za su iya hana cututtukan da ke tattare da ƙwayoyin cuta ita ce ta guje wa wuraren da ke da ƙwayoyin cuta.
Har yanzu ba a san duk asirin asalin SARS-CoV-2 ba.
Na farko, idan jemage suna watsa kwayar cutar SARS-CoV-2 daga iyayensu zuwa ga pangolins, zai zama da ban sha'awa a lura da yanayin da jemage da pangolins za su iya zama a cikin yanayin muhalli ɗaya.
Na biyu, idan ƙudaje suna da matsayi na musamman wajen yaduwar cutar ga mutane, za a bukaci a gano yadda mutane suke haɗuwa da ƙudaje.
Na uku, idan dabba ta uku tana zama mai ba da abinci, ba a san yadda take shafar mutane da kuma dabbobi kamar su maza da ƙuda da kuma pangolins ba.
A ƙarshe, saboda dabbobi masu shayarwa da yawa, musamman dabbobin gida, suna iya kamuwa da SARS-CoV-2, ya kamata a gudanar da sa ido da kuma gwajin kamuwa da cutar.
Ko ɗan doki ne, ko kuma ɗan dabba mai shayarwa, ya kamata a iya gano SARS-CoV-2 ko kuma ƙwayoyin cuta na asali da suka yi kama da juna a cikin mahaifinsu.
Bincike na gaba a wannan fannin zai ba da haske game da yanayin juyin halitta na SARS-CoV-2 a cikin dabbobi kuma zai sami tasiri mai mahimmanci kan rigakafi da sarrafa COVID-19 a cikin mutane.
Ana buƙatar sabunta ƙa'idodin ganewar asali na  masu cutar da ake zargi  da  masu cutar da aka tabbatar  na COVID-19
A ranar 6 ga watan Fabrairun 2020, ƙungiyarmu ta wallafa Shawarwarin gaggawa don ganewa da kuma maganin sabon kamuwa da cutar coronavirus 2019 (2019-nCoV) kuma wannan shawarar ta bayyana kwarewarmu da kuma samar da nassoshi don magance wannan annoba a duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwa ce, iliminmu da iliminmu suna ci gaba a hankali bisa sakamakon binciken da ake yi da kuma ƙwarewar aikin asibiti; saboda haka, ana ci gaba da sabunta hanyoyin ganowa da magani.
A cikin wannan wasiƙar, mun amsa ga bayanin da aka yi game da jagororinmu kuma mun ba da sababbin ka'idojin ganewar asali don  wanda ake zargi da cutar  da kuma  wanda aka tabbatar da cutar  bisa ga sababbin ka'idojin ganewar asali da magani na COVID-19 (sashi na bakwai) da Hukumar Lafiya ta Jama'ar Sin ta buga.
A watan Disamba na 2019, sabon coronavirus 2019 (2019-nCoV) ya haifar da barkewar cutar da yanzu ake kira cutar coronavirus 2019 (COVID-19), kuma an kira kwayar cutar coronavirus mai tsanani mai tsanani 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta tsara shawarwari masu sauri waɗanda aka buga akan layi akan Binciken Likitancin Soja a ranar 6 ga Fabrairu, 2020.
An yi amfani da shi sosai tun lokacin da aka wallafa shi.
Amma, ka lura cewa COVID-19 sabuwar cuta ce, kuma iliminmu da iliminmu suna ci gaba a hankali bisa sakamakon binciken da ake yi da kuma ƙwarewar asibiti; saboda haka ana ci gaba da sabunta hanyoyin ganowa da magani.
Alal misali, Hukumar Lafiya ta Jama'ar Sin ta fitar da jagororin gano da kuma kula da cutar COVID-19 (http://www.nhc.gov.cn/) an yi ta sau bakwai a tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, wasu daga cikin abubuwan da aka yi amfani da su sun canza sosai.
Bayan da aka ba da bayani daga Zhou et al., sun ba da shawara don yin nazari mai sauƙi bisa ga kwarewarsu.
Aikin da suka yi ya kawo sabon tabbaci ga umarninmu kuma yana da amfani sosai a wannan annoba ta duniya.
Muna yaba musu don aikin da suke yi kuma muna gode musu.
Koyaya, aikin su kuma yana buƙatar sabuntawa bisa ga Sabbin Jagororin Ganowa da Kula da COVID-19 (gwajin sigar bakwai) da kuma binciken kwanan nan.
A cikin fitowar ta bakwai (3 ga Maris 2020), tabbatar da yanayin da ake zargi dole ne ya haɗa ɗayan abubuwan da ke cikin tarihin annobar tare da abubuwa biyu na bayyanar asibiti don samar da cikakken bincike, ko ya dace da abubuwa uku na bayyanar asibiti idan babu bayyanar cutar:
Tarihin cututtuka: (1) tarihin tafiya ko zama a birnin Wuhan da kewaye ko a wasu al'ummomin da aka samu rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar alamun cutar; (2) tarihin tuntuɓar masu kamuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid mai kyau); (3) tarihin tuntuɓar marasa lafiya da zazzabi ko alamun numfashi daga birnin Wuhan ko yankunan da ke kusa ko wasu al'ummomin da aka samu rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar alamun cutar; (4) tarihin tuntuɓar rukuni na mutane da aka tabbatar da cutar (tare da zazzabi da alamun numfashi a cikin makonni 2 ko fiye a cikin aji, ofishin gida, da sauransu).
Abubuwan da ke faruwa a asibiti: (1) zazzabi da/ko alamun numfashi; (2) hotunan da ke nuna alamun kamuwa da COVID-19; (3) yawan adadin farin jini da ke nuna adadin ƙwayoyin lymphocytes na al'ada, raguwa ko raguwa a farkon bayyanar cututtuka.
Binciken cutar da aka tabbatar ya kamata ya dogara ne akan yanayin da ake zargi tare da duk wani abu na rashin lafiya ko tabbacin ƙwayar cuta da ke biyowa: (1) gwajin PCR na lokaci-lokaci mai kyau don SARS-CoV-2; (2) jerin kwayoyin halittar kwayar cuta tare da daidaito mai ƙarfi tare da sabbin cututtukan coronavirus da aka sani; (3) gwajin ƙwayar cuta mai kyau don ƙwayoyin cuta na IgM da IgG na SARS-CoV-2; ko canji na ƙwayoyin cuta na IgG na SARS-CoV-2 na musamman daga mara kyau zuwa tabbatacce ko ƙaruwa ≥ 4 sau a lokacin murmurewa idan aka kwatanta da lokacin tsananin.
Za mu iya ganin cewa an ƙara gwajin PCR na ainihin lokacin nucleic acid a cikin hanyoyin numfashi ko a cikin samfurin jini a bugu na biyu (Janairu 18, 2020) da kuma bugu na uku (Janairu 22, 2020).
An ƙara gwajin cututtukan cututtuka daga samfurin jini a bugu na huɗu (Janairu 27, 2020) da kuma na biyar (Fabrairu 8, 2020); sannan an ƙara tabbacin ƙwayar cuta a bugu na bakwai.
Waɗannan canje-canjen suna gina kan ci gaba da aikin masu bincike don nemo mafi kyawun kayan gano nucleic acid don saurin ganewa, da kuma samfurori na numfashi waɗanda suka haɗa da ɗaukar jini, tare da ƙarin wadatar samfura daban-daban, kuma sun taimaka don ƙara tabbataccen sakamakon ƙwayoyin cuta na musamman a cikin ƙa'idodin da aka tabbatar.
Bugu da ƙari, akwai ƙarin shaida da ke tunatar da mu mu yi hankali game da marasa lafiya da ke da alamun rashin lafiya da marasa lafiya da ba su da alamun cutar.
Saboda haka, ya kamata a sabunta zane na Zhou et al. saboda sun sanya mutane ba tare da alamun asibiti a matsayin  masu ƙarancin haɗari .
Dole ne a gwada tsarin kimantawa a cikin aikin asibiti da kuma a cikin nazarin gaba.
A ƙarshe, muna fatan za a sami ƙarin shaida kai tsaye kuma muna gayyatar masu karatu su ba da ra'ayoyinsu.
Game da ganewar asali na  masu cutar da ake zargi  da  masu cutar da aka tabbatar , muna ba su shawarar su bi kuma su bi sababbin ka'idoji a ƙasarsu.
Ƙungiyarmu za ta kuma sabunta umurninmu a kan lokaci don ta taimaka.
Bangladesh ta samu karin mutane biyar da suka mutu a rana daya sakamakon COVID-19
A jiya, Bangladesh ta tabbatar da wasu sabbin mutuwar COVID-19 biyar a rana guda.
Wannan shi ne adadin mutane da cutar ta kashe a rana guda.
A jiya, Cibiyar Kula da Cututtuka da Bincike ta Bangladesh (IEDCR) ta ba da rahoton cewa adadin mutanen da suka kamu da cutar sun haɗa da masu cutar 114 da kuma 33 da suka warke, waɗanda ke cikin gida.
An samu mutuwar mutane 17.
An fara rufe hanyoyin sufuri a ranar 26 ga watan Maris kuma an shirya za a rufe su a ranar Asabar, 4 ga watan Afrilu.
Har ila, an ba da izinin kai kayayyaki na musamman kamar su magani da mai da kuma abinci.
A ranar 19 ga watan Maris, mutanen uku sun warke.
A ranar Alhamis, jimlar adadin masu kamuwa da cutar coronavirus SARS-CoV-2 ya zarce miliyan a duniya, a cewar bayanan Jami'ar Johns Hopkins.
A duk faɗin duniya, ƙasashe sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya tsawaita dokar hana fita ta birnin har zuwa ranar 1 ga watan Mayu.
Majalisar dokokin Portugal ta amince da tsawaita dokar ta baci ta kasa na kwanaki 15; an amince da kuri'un 215 a kan haka, 10 sun ki amincewa da ita, daya kuma ya ki amincewa da ita.
Asalin cutar coronavirus ta dabbobi
Cutar SARS da MERS sun nuna yadda kamuwa da kwayar cutar HCoV ke da lahani da kuma kisa.
Yawancin HCoVs sun fito ne daga bera waɗanda ba su da cutar.
A cikin wannan yanayin, akwai wasu nau'ikan HCoVs da ke da alamun cutar.
Gano ƙwayoyin dabbobi yana da tasiri kai tsaye wajen hana cututtukan mutane.
Nazarin hulɗar CoV da mai masauki a cikin dabbobi na iya ba da damar fahimtar CoV a cikin mutane.
Dangane da bambance-bambance a cikin jerin sunayen sunadarai, an rarraba CoVs zuwa jinsuna huɗu (alpha-CoV, beta-CoV, gamma-CoV, da delta-CoV).
Shaidar ilimin halitta ta nuna cewa bera da rodents suna da asalin asalin yawancin alpha-CoVs da beta-CoVs, yayin da tsuntsaye sune babban wurin ajiyar gamma-CoVs da delta-CoVs.
A yau, an san mutane bakwai da ke da cutar CoV (HCoV).
Daga cikin waɗannan, HCoV-229E da HCoV-NL63 sune alpha-CoVs.
Sauran beta-CoVs biyar sun haɗa da HCoV-OC43, HCoV-HKU1, Cutar numfashi mai tsanani (SARS-CoV), Cutar numfashi ta Gabas ta Tsakiya (MERS-CoV), da SARS-CoV-2.
A cikin wannan yanayin, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace, a cikin yanayin da ya dace.
Hakanan yana iya jagorantar ko sauƙaƙa binciken mai karɓar baƙi, matsakaici da haɓaka SARS-CoV-2, tare da mahimman ma'anoni don hana kamuwa da cutar a nan gaba.
An san CoVs a cikin dabbobi tun daga ƙarshen shekarun 1930.
A cikin shekarun da suka gabata, an gano HCoV bakwai.
An gano HCoV-229E na farko a cikin hanyoyin numfashi na marasa lafiya da ke fama da kamuwa da cutar ta sama a shekara ta 1966, kuma daga baya ya daidaita don girma a cikin ƙwayoyin WI-38 na huhu.
Marasa lafiya da ke dauke da HCoV-229E suna nuna alamun sanyi na yau da kullun, gami da ciwon kai, hancin, rashin lafiya da ciwon makogwaro, tare da zazzabi da tari a cikin kashi 10 zuwa 20 cikin ɗari na masu cutar.
HCoV-229E da HCoV-OC43 duka suna ko'ina cikin duniya kuma suna nuna ana yaduwa a lokacin sanyi, a ƙasashe masu yanayin zafi.
Shaguna a Ostareliya sun rage yawan takardar wanka da za a saya
A ranar Lahadi da Asabar da yamma, manyan shagunan sayar da kayayyaki na Woolworths da Coles na Australiya sun rage takunkumin sayen takarda na bayan gida zuwa biyu da kuma fakiti ɗaya a kowane sayayya a duk shagunan ƙasar.
A ranar Litinin, ALDI ta kuma kafa iyaka kan wani kunshin.
An saka waɗannan iyaka a cikin saƙonni a tashoshin kuɗi da kuma a shafukan Facebook na tashoshin.
Masu sayayya sun yi ajiyar kaya saboda tsoron COVID-19 da kuma bukatar rufe kansu.
A ranar Laraba, Woolworths ta kuma iyakance sayen takardar wanka don isar da kaya zuwa gida zuwa kunshin ɗaya a kowane tsari.
Waɗannan matakan sun biyo bayan ƙuntatawa na kunshin guda huɗu da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, bi da bi.
Coles a cikin sanarwar manema labarai ta 8 ga Maris, ta ce tare da ƙuntatawa na fakiti huɗu a cikin aiki,  shagunan da yawa har yanzu suna cikin kaya a cikin awa ɗaya bayan isarwa , kuma ta kira buƙatar  ba a taɓa gani ba , yayin da ALDI, a cikin rubutun Facebook a ranar Talata, ta kira shi  ba zato ba tsammani .
An samu ƙaruwa sosai a cikin sayarwa a makon da ya gabata, in ji wani mai magana da yawun Woolworths.
Shagon Costco a Canberra ya rage adadin da aka yarda da shi zuwa fakiti biyu a makon da ya gabata.
Don rage ƙarancin, Coles ta ba da umarnin manyan kaya daga masu samar da kayayyaki kuma ta ƙara yawan isar da kayayyaki, Woolworths ta ba da umarnin ƙarin kaya, yayin da ALDI ta ba da kaya da wuri don tallatawa a ranar Laraba.
Russell Zimmerman, darektan zartarwa na Ƙungiyar Masu Sayarwa ta Ostiraliya, ya ce masu sayarwa suna ƙoƙarin ƙara kaya, amma ƙuntatawa na majalisar gari game da lokutan isar da kaya ta manyan motoci yana sa aikin ya zama da wahala.
Yana nufin cewa farashin kayayyaki zai ƙaru yayin da masu kawo kayayyaki suke ƙoƙarin biyan bukatar, kuma za a rage tallace-tallace.
A ranar Talata, ALDI ta sanar da cewa bayan da aka buɗe kaya a gaba, wasu shaguna ba za su iya biyan kuɗin ranar Laraba ba.
A wani labarin da aka wallafa a News.com.au, Dr. Gary Mortimer, masanin harkokin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya bayyana cewa shagunan suna cika kayayyaki a kowane dare.
Ya ce takardar wanka abu ne mai girma, wanda ke haifar da karancin kayayyaki, wanda idan aka gama, zai bar manyan wuraren da babu kome a kan ɗakunan ajiya, yana ƙara nuna cewa akwai karancin kayayyaki.
 Coles da Woolworths sun yi imanin cewa idan aka cika ɗakunan ajiya, idan za a iya [saya] kayayyaki kamar takarda na bayan gida da kuma maganin kashe ƙwayoyin cuta kuma ana samun su da yawa, hakan zai rage tsoro , Russell Zimmerman ya bayyana wa ABC News.
Kamfanin da ke kera takardar wanka mai suna Who Gives a Crap ya ce a ranar Laraba da ta gabata sun rasa kayayyakin da suke da su.
Kamfanin Kimberly-Clark, wanda ke kera takardar wanka ta Kleenex, da Solaris Paper wanda ke kera takardar Sorbent, sun ce suna aiki a ko'ina a duniya don ci gaba da samar da takarda, a cewar rahoton News.com.au.
Wani shafin yanar gizo mai suna Domain.com ya ruwaito cewa wasu masu sayar da gidaje suna ba da takardar bayan gida kyauta ga wanda ya fara sayarwa a gwanjon da ake yi a Melbourne, yayin da ake samun karancin gwanjo saboda masu sayen suna hutu a karshen mako na ranar aiki.
A ranar Alhamis, jaridar NT News da ake bugawa a Darwin ta buga takarda mai shafuffuka takwas da za a yanke don a yi amfani da ita a matsayin takardar bayan gida.
Da farko, shagunan ba su son saka takunkumi, a cewar wani rahoto na ABC Australia na ranar 3 ga Maris inda suka sanar da cewa ba su da shirin sanya takunkumin sayayya.
Russell Zimmerman ya kara da cewa akwai bukatar wasu kayayyaki da suka hada da abin rufe fuska, maganin kashe ƙwayoyin cuta, kayan bushe, kayan tsabtace hannu da gari.
Hakazalika, a waje da Ostiraliya, an lura a daren Lahadi cewa babban kanti na kan layi na Burtaniya Ocado ya iyakance sayen takardar wanka ta Andres zuwa fakiti biyu na 12 na takarda.
Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta bayyana barkewar cutar COVID-19 (cuta da cutar coronavirus SARS-CoV-2 ke haifarwa) a matsayin annoba.
Ko da yake kalmar  annoba  tana nufin yadda cutar ta yadu ne kawai, ba yadda hatsarin ke da shi ba, WHO ta nuna bukatar tilasta wa gwamnatoci su ɗauki mataki:
 Duk ƙasashe suna iya canja yanayin annobar.
Idan ƙasashe sun gano, gwada, bi da, ware, ganowa da kuma tattara jama'arsu a matsayin wani ɓangare na amsawar , in ji Tedros Adhanom Ghebreyesus, Darakta Janar na WHO.
 Muna da damuwa sosai, ba kawai game da yawan yaduwar cutar da kuma yadda ta tsananta ba, amma kuma game da rashin aiki. 
A cewar Dr. Tom Frieden, tsohon darektan Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka, annobar  ba ta taɓa faruwa ba .
Ya ce a cikin wata sanarwa da CNN ta wallafa a watan Fabrairu cewa  banda mura, babu wani kwayar cutar numfashi da aka gano tun lokacin da ta fara har zuwa lokacin da ta ci gaba da yaduwa a duniya. 
Ghebreyesus ya nuna irin wannan ra'ayi, yana cewa  ba mu taɓa ganin annobar da cutar coronavirus ta haifar ba. 
Ya kara da cewa: "Ba mu taba ganin annoba da za a iya sarrafa ta a lokaci guda ba".
Sabon matsayin annobar ya biyo bayan shawarar da Hukumar Lafiya ta Duniya ta yanke a watan Janairu ta ayyana cutar a matsayin gaggawa ta kiwon lafiyar jama'a ta duniya.
Daraktan Cibiyar Kula da Cututtuka da ke Shafar Mutane a Amirka, Dokta Anthony Fauci ya ce game da annobar: "A takaice dai, yanayin zai daɗa muni".
A ranar Alhamis, Associated Press ta ba da rahoton cewa akwai aƙalla mutane 126,000 da suka kamu da COVID-19 a duniya, kuma fiye da 4,600 sun mutu.
Annobar cutar korona ta 2019-20 annobar cutar korona ce da ke ci gaba tun daga shekarar 2019 (COVID-19), wadda cutar coronavirus mai tsanani ta 2 (SARS-CoV-2) ke haifarwa.
An gano annobar a Wuhan, China a watan Disamba na 2019, an ayyana ta a matsayin gaggawa ta lafiyar jama'a a duniya a ranar 30 ga Janairu, 2020 kuma an ayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
Har zuwa 10 ga Afrilu, 2020, an samu kusan mutane miliyan 1.61 da suka kamu da COVID-19 a ƙasashe 210 da yankuna, kuma kusan mutane 97,000 sun mutu.
Mutane kusan 364,000 ne suka warke.
An kiyasta yawan mutuwar a China ya kai kashi 4 cikin ɗari, yayin da a sauran duniya ya bambanta daga kashi 13.04 cikin ɗari a Aljeriya zuwa kashi 0.08 cikin ɗari a New Zealand.
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, tari da kuma numfashi.
Matsaloli na iya haɗa da ciwon huhu da kuma ciwon numfashi mai tsanani.
Yawancin lokaci lokaci tsakanin kamuwa da cutar da bayyanar cututtuka kusan kwanaki biyar ne, amma zai iya zama tsakanin kwanaki biyu zuwa 14.
Babu wani rigakafi ko magani na musamman da aka sani.
Babban magani shine maganin alamun cuta da tallafi. Matakan rigakafin da aka ba da shawarar sun haɗa da wanke hannu, rufe baki don tari, nisantawa da wasu mutane, da saka idanu da kuma keɓe waɗanda ake zargi da kamuwa da cutar.
Hukumomi a duk faɗin duniya sun amsa ta hanyar kafa takunkumin tafiya, keɓewa, dokar hana fita, sarrafa haɗari a wuraren aiki da rufe cibiyoyi.
Cutar ta haifar da mummunan rikicewar zamantakewar tattalin arziki a duniya, jinkirta ko soke wasanni, addini, siyasa da al'adu, da kuma ƙarancin abinci da aka ƙara ta hanyar sayayya.
Makarantu da jami'o'i sun rufe a ƙasashe 193 ko kuma a yankuna, wanda ya shafi kusan kashi 99.4 na ɗaliban duniya.
Labaran karya game da cutar sun bazu a intanet, kuma akwai ƙiyayya da nuna bambanci ga Sinawa, da sauran mutanen da suka fito daga Gabas da Kudu maso Gabashin Asiya da kuma waɗanda suka zo daga yankunan da ke da yawan kamuwa da cutar.
Saboda raguwar tafiye-tafiye da rufewa a masana'antar nauyi, an sami raguwar gurɓatar iska da fitar da carbon.
Hukumomin kiwon lafiya a Wuhan, China (babban birnin lardin Hubei) sun ba da rahoton wani ciwo na ciwon huhu da ba a san dalilinsa ba a ranar 31 ga Disamba, 2019, kuma an fara bincike a farkon Janairu, 2020.
Yawancin masu cutar sun kasance a kasuwar sayar da abincin teku ta Huanan, saboda haka ana tsammanin cutar ta samo asali ne daga dabbobi.
Kwayar cutar da ta haifar da annobar ana kiranta SARS-CoV-2, kwayar cutar da aka gano kwanan nan kuma tana da alaƙa da coronavirus na bera, pangolin coronavirus, da SARS-CoV. Daga baya, an gano cewa mutum na farko da aka sani da alamun cutar ya kamu da rashin lafiya a ranar 1 ga Disamba, 2019, kuma wannan mutumin ba shi da wata alaƙa da bayyanar cutar daga baya a kasuwar kayan sabo.
Daga cikin masu cutar da aka fara ganowa a watan Disamba na 2019, kashi biyu bisa uku sun kasance masu alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba a jaridar South China Morning Post ya nuna cewa ana iya samun mutum na farko da cutar a ranar 17 ga Nuwamba, 2019, wanda ke da shekara 55 a lardin Hubei. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa, yayin da sabbin masu cutar ke raguwa a China amma ba zato ba tsammani suna ƙaruwa a Italiya, Iran, da Koriya ta Kudu, yawan sabbin masu cutar a wajen China ya zarce adadin sabbin masu cutar a China a karon farko.
Za a iya ƙididdige yawan masu cutar, musamman waɗanda ke da alamun rashin lafiya.
A ranar 26 ga watan Fabrairu, an samu ƙananan ƙwayoyin cuta a tsakanin matasa, waɗanda shekarunsu ba su kai 19 ba sun kai kashi 2.4 cikin ɗari na masu cutar a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya, Patrick Vallance, ya kiyasta cewa kashi 60 cikin ɗari na mutanen Burtaniya dole ne su kamu da cutar kafin su sami rigakafin garken da ya dace.
Cutar ta shafi yawan mutanen da aka gwada su da COVID-19 kuma aka tabbatar da sun kamu da cutar bisa ga ƙa'idodin hukuma.
Har zuwa 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma ƙasashe da yawa suna da manufofin hukuma na ba da gwaji ga waɗanda ke da alamun rashin lafiya, kamar Italiya, Netherlands, Spain da Switzerland.
Wani bincike da aka buga a ranar 16 ga watan Maris ya nuna cewa a China, har zuwa 23 ga watan Janairu, an kiyasta kashi 86 cikin ɗari na masu kamuwa da COVID-19 ba a gano su ba, kuma waɗannan kamuwa da cutar da ba a yi rajista da su ba ne tushen kamuwa da kashi 79 cikin ɗari na masu kamuwa da cutar.
Wani bincike na kididdiga da aka buga a ranar 30 ga Maris ya nuna cewa adadin masu kamuwa da cutar a Italiya ya fi na waɗanda aka ruwaito yawa.
Ƙididdigar farko na ƙimar haifuwa ta asali (R0) na COVID-19 ya kasance daga 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amirka ta wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna warkewa.
Ga waɗanda ba su warke ba, lokaci tsakanin bayyanar cututtuka da mutuwa yana tsakanin kwanaki 6 zuwa 41, mafi yawanci kwanaki 14.
Har zuwa 10 ga Afrilu, 2020, kusan mutane 97,000 ne suka mutu sakamakon COVID-19.
A China, a ranar 5 ga Fabrairu, kusan kashi 80 cikin ɗari na waɗanda suka mutu sun haura shekara 60, kuma kashi 75 cikin ɗari suna fama da cututtukan da suka riga sun kamu da su kamar cututtukan zuciya da ciwon sukari. Ƙididdigar mutuwar da ke da nasaba da annobar COVID-19 ta al'ada tana nufin mutanen da suka mutu da cutar COVID bisa ga ƙa'idodin doka.
Adadin mutanen da COVID-19 ta kashe a zahiri na iya zama mafi girma, saboda ba zai haɗa da waɗanda suka mutu ba tare da an gwada su ba - kamar a gida, gidajen tsofaffi, da sauransu.
Bayanai na ɗan lokaci daga Italiya sun nuna cewa yawan mutuwar mutane a lokacin annobar ya ninka na COVID sau 4-5.
Wata mai magana da yawun Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta Amurka (CDC) ta amince da cewa  Mun san cewa [adadin mutuwar da aka sanar] an rage shi , wata sanarwa da rahotanni na rashin daidaito a Amurka suka tabbatar. Irin wannan rashin daidaito yakan faru a lokacin annoba, kamar annobar cutar naman alade ta H1N1 ta 2009. An fara tabbatar da mutuwar a Wuhan a ranar 9 ga Janairu, 2020.
Mutum na farko da ya mutu a wajen babban yankin China ya faru ne a ranar 1 ga Fabrairu a Philippines, kuma mutum na farko da ya mutu a wajen Asiya ya faru ne a Faransa a ranar 14 ga Fabrairu.
A ranar 28 ga watan Fabrairu, ban da babban yankin China, an samu mutuwar mutane fiye da 12 a kowace ƙasa a Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga Maris, ƙasashe da yankuna sama da arba'in sun ba da rahoton mutuwar a duk nahiyoyi sai Antarctica. Ana amfani da alamomi da yawa don ƙididdige yawan mutuwar.
Waɗannan ƙididdigar sun bambanta tsakanin yankuna da lokaci, kuma ana rinjayar su da yawan gwaje-gwaje, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta fara, da kuma yanayin alƙaluma kamar shekaru, jinsi, kuma musamman lafiyar jiki.
A cewar kididdigar Jami'ar Johns Hopkins, adadin mutuwar a duniya ya kai kashi 6.0 (97,039/1 617,204) a ranar 10 ga Afrilu, 2020.
Adadin yana dabam dabam a kowane yanki.
A China, ƙididdigar yawan masu kamuwa da cutar da suka mutu ya ragu daga kashi 17.3 cikin ɗari (waɗanda ke da alamun cutar a tsakanin 1 ga Janairu zuwa 10 ga 2020) zuwa kashi 0.7 cikin ɗari (waɗanda ke da alamun cutar bayan 1 ga Fabrairu, 2020). Sauran alamun sune yawan mutuwar (ƙimar mutuwa), wanda shine yawan mutanen da aka gano sun mutu daga cutar, da kuma yawan kamuwa da cutar (ƙimar kamuwa da cuta), wanda shine yawan mutanen da ke da cutar (wanda aka gano da waɗanda ba a gano su ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyaka a lokaci kuma suna bin takamaiman yawan mutane daga kamuwa da cutar zuwa ƙarshen cutar.
Masana kimiyya da yawa sun yi ƙoƙari su lissafa waɗannan adadi don wasu mutane.
Cibiyar Nazarin Magunguna ta Jami'ar Oxford ta kiyasta yawan kamuwa da cutar a cikin annobar gaba ɗaya tsakanin kashi 0.1 zuwa 0.39%.
Matsayin mafi girma a cikin wannan zangon ya yi daidai da sakamakon gwajin COVID-19 na farko a Jamus, da kuma nazarin ƙididdigar da ke nazarin tasirin gwaji akan kimanta yawan mutuwar.
Hukumar Lafiya ta Duniya ta ce za a iya sarrafa cutar.
Ba a san lokacin da cutar za ta kai ƙwanƙolin da kuma tsawon lokacin da za ta ci gaba da yaduwa ba kuma hakan zai iya bambanta a yankuna.
Maciej Boni na Jami'ar Jihar Pennsylvania ya ce: "Idan ba a sarrafa cutar ba, yawanci cututtuka sukan daidaita kuma su soma raguwa idan ba a sami masu ɗauke da cutar ba.
Amma ba zai yiwu a yi annabci a kan lokacin da hakan zai faru ba.
Babban mai ba da shawara kan kiwon lafiya na gwamnatin China Zhong Nanshan ya ce  ana iya kammala wannan a watan Yuni  idan dukkan ƙasashe suka yi aiki don bin shawarwarin WHO kan matakan da za su hana yaduwar cutar.
A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Lafiya da Magungunan Yanayi na London ya ce SARS-CoV-2  zai ci gaba da yaduwa, mai yiwuwa har shekara ɗaya ko biyu .
A cewar wani bincike da Neil Ferguson ya gudanar a kwalejin Imperial, za a bukaci nisanta mutane da sauran matakan har sai an samu allurar rigakafi (wataƙila cikin watanni 18 ko fiye).
William Schaffner na Jami'ar Vanderbilt ya ce: "Ina ganin ba zai yiwu ba wannan cutar ta korona ta ɓace gaba ɗaya domin tana da saukin yaduwa kuma tana iya zama wata cuta ta yanayi, wadda za ta iya sake bayyana kowace shekara".
Ƙarfin wannan komawar zai dangana ne a kan tsaron garken da kuma girman canjin.
Alamun COVID-19 wani lokaci ba su da takamaiman bayani kuma mutanen da ke fama da cutar ba sa nuna alamun cutar.
Alamomin da aka fi gani biyu su ne zazzabi (kashi 88) da tari mai bushe (kashi 68).
Alamomin da aka saba gani sun haɗa da gajiya, samar da ɓoyayyen numfashi (mucous), rashin wari, numfashi, ciwon tsoka da haɗin gwiwa, ciwon makogwaro, ciwon kai, sanyi, amai, haemopsy, zawo, ko cyanosis. WHO ta ce kusan mutum ɗaya cikin shida yana da ciwo mai tsanani da wahalar numfashi.
Cibiyoyin Kula da Cututtuka da Rigakafin Cutar (CDC) na Amurka sun lissafa alamun gaggawa kamar wahalar numfashi, ciwo ko ciwon kirji mai ɗorewa, rikicewa kwatsam, wahalar farkawa, da fuska ko lebe mai launin shuɗi; ana ba da shawarar kula da likita nan da nan idan waɗannan alamun sun bayyana. Ciwon na iya haifar da ciwon huhu mai tsanani, ciwon numfashi mai tsanani, cutar sauro, cutar sauro, da mutuwa.
Wasu daga cikin mutanen da ke dauke da cutar ba za su iya nuna alamun cutar ba, ba tare da alamun asibiti ba amma sakamakon gwajin ya tabbatar da kamuwa da cutar, don haka masu bincike sun ba da shawarwari cewa mutanen da ke da kusanci da mutanen da aka tabbatar da kamuwa da cutar ya kamata a lura da su sosai kuma a bincika su don kawar da haɗarin kamuwa da cutar.
Ƙididdigar China game da yawan marasa alamun cutar ya bambanta daga kaɗan zuwa kashi 44 cikin ɗari.
Lokacin da aka saba da shi na kamuwa da cutar (lokacin da ke tsakanin kamuwa da cutar da bayyanar cututtuka) yana tsakanin kwana ɗaya zuwa 14; yawanci kwanaki biyar ne. Misali mai kyau na rashin tabbas, ƙididdigar yawan mutanen da ke dauke da COVID-19 waɗanda suka rasa ƙanshi ya kasance kashi 30 cikin ɗari kafin ya ragu zuwa kashi 15 cikin ɗari.
Har yanzu ba a san yadda cutar ke yaduwa ba.
Ana ganin cewa cutar tana yaduwa ne ta hanyar kusanci da kuma ƙananan ɗigon ruwa da ke fitowa daga tari, hancinsa, ko magana; wannan kusanci yana da nisan mita 1 zuwa 2.
Bincike ya nuna cewa idan mutum ya yi tari ba tare da ya kāre kansa ba, zai iya jefa ruwa daga nesa da ke tsakanin kafa 15 zuwa 8.2.
Wasu sun nuna cewa za a iya yada kwayar ta hanyar ƙananan ɗigon ruwa da ke cikin iska na tsawon lokaci, wanda za a iya fitarwa ta hanyar magana. Ana iya fitar da ɗigon numfashi lokacin numfashi, musamman ta hanyar magana, kodayake yawanci ba a ɗaukar kwayar cutar ta iska.
Ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin
Wasu hanyoyin likita kamar intubation da CPR na iya haifar da ɓoyayyen numfashi wanda aka yayyafa kuma don haka ya haifar da yaduwar iska.
Hakanan yana iya yaduwa idan mutum ya taɓa wani abu da ya kamu da cutar, musamman fata, kafin ya taɓa idanunsa, hanci, ko bakinsa.
Ko da yake wasu suna tsoron cewa za a iya yaduwa ta wajen fitsari, amma ba a yawan yin hakan.
Gwamnatin China ta ware yiwuwar yaduwar SARS-CoV-2 ta hanyar bargo. Kwayar cutar tana da saurin yaduwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, amma yana iya yaduwa kafin bayyanar cututtuka da kuma a lokacin da cutar ta ci gaba.
An gwada mutane da cutar har zuwa kwanaki uku kafin bayyanar cututtuka wanda ke nuna cewa ana iya yaduwa kafin bayyanar cututtuka masu mahimmanci.
Rahotanni kaɗan ne kawai na ƙwayoyin cuta marasa alamun da aka tabbatar a cikin dakin gwaje-gwaje, amma an gano watsawa ba tare da alamun cutar ba a wasu ƙasashe yayin binciken tuntuɓar.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa na sa'o'i ko ma kwanaki a kan abubuwa.
Musamman, an gano kwayar cutar bayan kwana uku a kan filastik (polypropylene) da bakin karfe 304, bayan kwana ɗaya a kan kwali, da kuma bayan awa huɗu a kan jan ƙarfe.
Duk da haka, ya dogara da zafi da zafin jiki. An gwada dabbobin gida da sauran dabbobi da cutar COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya yada cutar ga mutane, amma hukumomin Burtaniya sun ba da shawarar wanke hannu bayan taɓa dabbobi, kamar bayan tuntuɓar wasu wurare da masu kamuwa da cutar za su taɓa.
Cutar numfashi mai tsanani ta 2 (SARS-CoV-2) wata sabuwar cuta ce, da farko an gano ta a cikin mutane uku da ke fama da cutar huhu da ke da nasaba da cutar numfashi mai tsanani da ta bulla a Wuhan.
Dukkanin halaye na sabon kwayar cutar SARS-CoV-2 suna cikin coronaviruses masu alaƙa a cikin yanayi. A waje da jikin mutum, sabulu na gida yana lalata kwayar cutar, wanda ke narkar da murfin kariya. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
An yi zaton cewa cutar ta zo daga dabbobi.
Binciken kwayoyin halitta ya nuna cewa cutar korona tana cikin kwayar Betacoronavirus, wani kwayar cuta mai suna Sarbecovirus (B lineage) da ke da nasaba da nau'i biyu daga bera.
Ya yi daidai da kashi 96 cikin ɗari na dukan kwayoyin halittar wani samfurin kwayar cutar coronavirus na bera (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci amino acid guda daya a wasu sassan tsarin kwayoyin halittar mutum tsakanin ƙwayoyin cuta daga pangolins da na mutane.
Kwatanta dukkanin kwayoyin halitta ya nuna cewa har zuwa yau akwai kashi 92 cikin dari na kwayoyin halittar da ke tsakanin kwayar cutar coronavirus da SARS-CoV-2, wanda bai isa ya tabbatar da cewa pangolins ne mai karɓar bakuncin ba.
Ana iya gano kamuwa da cutar ta hanyar alamomi, amma ana tabbatar da tabbatacciyar hanyar ta hanyar sake fasalin maganin polymerase chain reaction (rRT-PCR) na ɓoyayyen ɓoyayyen ƙwayar cuta ko scan.
Wani bincike da aka yi a Wuhan da ya kwatanta PCR da scan ya nuna cewa scan ya fi PCR hankali sosai, ko da yake ba shi da cikakken bayani, saboda yawancin siffofinsa na hoto sun yi daidai da sauran cututtukan huhu da kuma hanyoyin cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da na'urar daukar hotan takardu don gano ko kuma a yi amfani da ita a matsayin gwajin farko don gano COVID-19.
WHO ta wallafa wasu hanyoyin gwajin RNA don SARS-CoV-2, tare da fitowar farko a ranar 17 ga Janairu.
Gwajin yana amfani da kwafin kwayar halittar polymerase a ainihin lokacin (rRT-PCR).
Ana iya gwadawa da numfashi ko jini.
Ana samun sakamako a cikin sa'o'i ko kwanaki.
Ana yin gwajin ne da ƙwayar hanci da hanci, amma ana iya yin amfani da ƙwayar makogwaro. A yanzu haka, wasu dakunan gwaje-gwaje da kamfanoni suna yin gwajin ƙwayar cuta da ke gano ƙwayoyin cuta.
A ranar 6 ga Afrilu, 2020, babu ɗayan waɗannan da aka tabbatar da cewa suna da inganci don yarda da amfani da su ko'ina.
A Amurka, an amince da gwajin cutar da Cellex ta samar don amfani da gaggawa ta hanyar dakunan gwaje-gwaje masu izini kawai.
Abubuwan da ke nunawa a cikin hotunan hoto da na CT na mutanen da ke da alamun sun haɗa da rashin daidaituwa na gilashin gilashi da rashin ɓarna.
A halin yanzu, Ƙungiyar Radiology ta Italiya tana samar da bayanan kan layi na duniya na sakamakon hoton da aka tabbatar.
Saboda haɗuwa da wasu cututtuka kamar adenovirus, hotuna ba tare da tabbatarwa ta PCR ba suna da iyakantaccen daidaito don gano COVID-19.
Wani babban bincike a China ya kwatanta sakamakon binciken kirji da PCR kuma ya nuna cewa ko da yake hoton bai da cikakken bayani game da kamuwa da cutar, yana da sauri kuma yana da hankali, yana ba da shawarar yin amfani da shi a matsayin kayan aikin bincike a wuraren da cutar ta ɓarke.
An samar da hanyoyin sadarwa na jijiyoyin jiki da ke amfani da ilimin kere kere don gano alamun cutar a cikin hotuna da kuma na scan.
Hanyoyin hana yaduwar cutar sun haɗa da tsabtace jiki, wanke hannu, kauce wa taɓa idanu, hanci ko baki da hannaye marasa wanki, da tari ko hancin cikin tawul sannan a jefa tawul ɗin kai tsaye cikin jakar shara.
An shawarci waɗanda aka ce sun riga sun kamu da cutar su sanya abin rufe fuska a fili.
An kuma ba da shawarar nisantawa don hana yaduwar cutar. Gwamnatoci da yawa sun hana ko kuma ba da shawarar duk wata tafiya da ba ta da mahimmanci zuwa ko daga ƙasashe da yankuna da cutar ta shafa.
Duk da haka, cutar ta kai ga yaduwar jama'a a wurare da yawa a duniya.
Wannan yana nufin cewa kwayar cutar tana yaduwa a cikin al'umma, kuma wasu daga cikin al'ummomin ba su san inda ko yadda suka kamu ba. Ana ba da shawara ga ma'aikatan kiwon lafiya da ke kula da wanda zai iya kamuwa da cutar su ɗauki matakan kariya na yau da kullun da kuma kariya ta tuntuɓar juna, da sanya tabarau na kariya. Binciken tuntuɓar mutane hanya ce mai mahimmanci ga hukumomin kiwon lafiya don gano tushen kamuwa da cuta da hana watsawa a nan gaba.
Amfani da gwamnatoci na bayanan wurin wayar salula a wannan batun ya haifar da matsalolin sirri, tare da Amnesty International da wasu kungiyoyi sama da 100 da suka fitar da wata sanarwa da ke kira da a sanya iyaka ga irin wannan sa ido.
An ƙaddamar da aikace-aikacen wayar hannu da yawa ko kuma an ba da su bisa ga aikin sa kai, kuma har zuwa 7 ga Afrilu 2020, ƙungiyoyin masana sama da dozin suna aiki kan hanyoyin magance sirrin sirri, kamar amfani da Bluetooth don yin rikodin kasancewar mai amfani kusa da wasu wayoyin hannu.
Masu amfani za su sami saƙo idan sun kasance kusa da wanda aka gwada yana da cutar COVID-19. A halin yanzu akwai ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cutar; misali, wanke hanci da kuma yin gargadi da wanke baki ba shi da tasiri.
Babu riga-kafin COVID-19, amma ƙungiyoyi da yawa suna aiki don samar da ɗaya.
Ana ba da shawarar wanke hannu don hana yaduwar cutar.
Hukumar CDC ta ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa aƙalla na dakika ashirin, musamman bayan sun je bayan gida ko kuma idan sun nuna cewa hannayensu suna da datti kafin su ci abinci da kuma bayan sun yi tari, tari ko hancin.
Wannan shi ne domin bayan jikin mutum, sabulu na gida yana kashe kwayar cutar, wanda ke karya murfinta na kariya.
CDC ta kuma ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta na hannu da ke ɗauke da giya da kashi 60 cikin ɗari na giya idan sabulu da ruwa ba su da sauƙi.
MUTANE suna ba da shawara cewa kada su taɓa idanunsu, hancinsu, ko bakinsu da hannayensu da ba a wanke ba.
Za a iya kashe ƙwayoyin cuta ta hanyoyi da yawa (a cikin minti ɗaya na fallasa maganin kashe ƙwayoyin cuta don farfajiyar ƙarfe), ciki har da 62% ethanol, isopropanol, 50%, sodium hypochlorite, 0.1%, hydrogen peroxide, 0.5%, da povidone iodine, 0.2%, 7.5%.
Wasu magunguna kamar su benzalkonium chloride da chlorhexidine gluconate ba su da amfani sosai.
CDC ta ba da shawarar cewa idan aka yi zargin ko an tabbatar da cutar COVID a cikin wani wuri kamar ginin ofis ko gidan yara, a kashe ƙwayoyin cuta a duk ɗakunan kamar ofisoshi, dakunan wanka, ɗakunan da mutane suke amfani da su, da kuma kayan lantarki na yau da kullun kamar allunan kwamfuta, allon taɓawa, mabuɗan rubutu, sarrafawa ta nesa, da na'urorin sayar da kaya da marasa lafiya ke amfani da su.
Kungiyoyin kiwon lafiya sun shawarci mutane su rufe bakinsu da hancinsu da lankwasa gwiwarsu ko kuma su rufe da tawul idan suna tari ko hancinsa, kuma su zubar da duk wani tawul nan da nan.
Ana ba da shawarar sanya abin rufe fuska na tiyata ga waɗanda ke da cutar, saboda sanya abin rufe fuska na iya rage ƙarar da nesa da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
WHO ta ba da umarnin inda da kuma lokacin da za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ƙwayoyin cuta a Jami'ar Leeds,  Saka abin rufe fuska na iya rage yiwuwar mutane su taɓa fuskokinsu, wanda babban tushen kamuwa da cuta ne idan ba a tsabtace hannaye ba.  An kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da wanda zai iya kamuwa da cutar.
WHO ta ba da shawarar cewa mutane masu lafiya su sa abin rufe fuska ne kawai idan suna fuskantar haɗari mai girma, kamar kula da mai cutar COVID-19, ko da yake ta yarda cewa saka abin rufe fuska zai iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara ƙarfafa jama'arsu su yi amfani da abin rufe fuska.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska na masana'anta wanda ba na likita ba. China ta ba da shawarar musamman don amfani da abin rufe fuska na likita da za a iya zubar da su ga mutane masu lafiya, musamman idan suna kusa da mutane (mita 1 (ƙafa 3) ko ƙasa da haka).
Hong Kong ta ba da shawarar sanya abin rufe fuska a cikin sufuri na jama'a ko wuraren da jama'a ke yawa.
A Thailand, hukumomin kiwon lafiya suna ƙarfafa mutane su yi abin rufe fuska a gida kuma su tsabtace su kowace rana.
Jamhuriyar Czech da Slovakia sun hana fita waje ba tare da rufe baki da hanci ba.
A ranar 16 ga watan Maris, Vietnam ta tilasta wa kowa ya sanya abin rufe fuska a wuraren jama'a, don kowa ya kare kansa da kuma wasu.
Gwamnatin Austria ta ba da umarnin cewa duk wanda ya shiga babban kanti ya sanya abin rufe fuska.
Isra'ila ta bukaci duk mazaunanta da su sanya abin rufe fuska a fili.
Taiwan, wadda ta samar da abin rufe fuska miliyan goma a kowace rana tun tsakiyar watan Maris, ta tilasta sanya abin rufe fuska ga fasinjojin jiragen kasa da bas na nesa a ranar 1 ga Afrilu.
Panama ta tilasta sanya abin rufe fuska a duk lokacin da za a fita, amma ta ba da shawarar yin abin rufe fuska na hannu ga waɗanda ba za su iya saya ba.
An kuma yi amfani da abin rufe fuska sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa tsakanin mutane (wanda kuma ake kira nisantar jiki) ya haɗa da matakan kula da kamuwa da cuta da aka tsara don rage yaduwar cutar ta hanyar rage hulɗa tsakanin mutane.
Hanyoyin sun haɗa da keɓewa, ƙuntatawa na tafiya da rufe makarantu, wuraren aiki, filayen wasa, gidajen wasan kwaikwayo da cibiyoyin kasuwanci.
Za a iya amfani da hanyoyin nisantar jama'a ta hanyar zama a gida, rage tafiye-tafiye, guje wa taron jama'a, gaishe-gaishe ba tare da taɓa juna ba, da nisantar jiki daga wasu.
Gwamnatoci da yawa yanzu suna ba da umarni ko kuma ba da shawarar nisantar da jama'a a yankunan da annobar ta shafa.
An rage yawan taron da hukumomin gwamnati da na kiwon lafiya na Amurka suka ba da shawarar daga mutane 250 (idan babu sanannen COVID-19 a yankin) zuwa mutane 50, daga baya zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane fiye da biyu. Tsofaffi da waɗanda ke da wasu cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, ko kuma rashin ƙarfin jiki suna fuskantar haɗarin kamuwa da cututtuka masu tsanani da rikitarwa. CDC ta shawarce su da su zauna a gida idan ya yiwu a wuraren da cutar ta shafa. A ƙarshen Maris, 2020, WHO da sauran cibiyoyin kiwon lafiya sun fara maye gurbin kalmar  nisantar zamantakewa  da  nisantar jiki , don bayyana manufar rage hulɗar jiki ta hanyar yanke alaƙar zamantakewa, ko dai ta hanyar kasancewa a nesa ko a zahiri.
Amfani da kalmar "nisanci" yana nufin cewa ya kamata a ware mutum gaba ɗaya daga mutane maimakon ƙarfafa mutane su ci gaba da yin hulɗa da wasu ta wasu hanyoyi. Wasu hukumomi sun ba da jagororin kiwon lafiyar jima'i a lokacin annobar.
Waɗannan sun haɗa da shawarar yin jima'i da wanda kake zama da shi da ba shi da cutar ko kuma alamun cutar.
An ba da shawarar keɓewa a gida ga mutanen da aka gano suna da COVID-19 da waɗanda ake zaton suna da cutar.
Hukumomin kiwon lafiya sun ba da cikakken umurni game da warewa da kyau. Gwamnatoci da yawa sun ba da umurni ko kuma sun ba da shawarar keɓewa ga mutane da ke zaune a yankunan da cutar ta shafa.
An ba da umarnin keɓewa mafi tsauri ga mutane daga cikin rukunin da ke cikin haɗari.
An shawarci mutanen da suka kamu da cutar COVID-19 da waɗanda suka yi tafiya zuwa wata ƙasa ko yanki da ke da yawan kamuwa da cutar su keɓe kansu na kwanaki 14 daga lokacin da suka kamu da cutar.
Hanyoyin da ake amfani da su wajen hana yaduwar cutar sune hanawa ko kawarwa da kuma rage yawan yaduwar cutar.
Ana aiwatar da hana yaduwar cutar a farkon lokacin annobar kuma ana nufin sa ido da ware mutanen da ke da cutar, da kuma gabatar da wasu matakan kula da kamuwa da cuta da allurar rigakafi don hana cutar yaduwa ga sauran jama'a.
Idan ba za a iya hana yaduwar cutar ba, sai a koma ga rage yaduwar cutar, wato a ɗauki matakan rage yaduwar cutar da kuma rage tasirin ta a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya yin amfani da matakan hana da kuma ragewa a lokaci guda.
Don kawar da cutar, ana bukatar a ɗauki matakai masu tsanani don a rage yawan waɗanda suke da cutar ta hanyar rage yawan haifuwa zuwa ƙasa da 1. Wani ɓangare na sarrafa cutar ta kamuwa da cuta shi ne ƙoƙarin rage yawan cutar: wannan shi ake kira daidaita yanayin cutar.
Hakan zai rage haɗarin cinkoson ayyukan kiwon lafiya kuma ya ba da lokaci don samar da alluran rigakafi da magunguna.
Wasu daga cikin hanyoyin da ba magunguna ba da za su iya magance annobar sun haɗa da matakan kariya na mutum kamar tsabtace hannu, sanya abin rufe fuska da keɓewa; matakan nisantar jama'a kamar rufe makarantu da wuraren ibada; ƙoƙarin jama'a don ƙarfafa karɓar irin waɗannan hanyoyin da shiga cikin su; da ayyukan muhalli kamar tsabtace wurare. An ɗauki ƙarin matakan tsauraran matakai don hana annobar a China da zarar ta zama sananne, kamar keɓewa da keɓaɓɓun birane da kuma tsauraran takunkumin hana tafiya.
Sauran ƙasashe ma sun ɗauki matakai daban-daban don rage yaduwar cutar.
Koriya ta Kudu ta gabatar da gwajin mutane da keɓewa a wurare dabam dabam, kuma ta ba da gargaɗi game da tafiye-tafiyen mutanen da ke da cutar.
Singapore ta ba da tallafi na kuɗi ga waɗanda suka kamu da cutar da suka keɓe kansu, kuma ta ba da manyan tarar waɗanda ba su yi hakan ba.
Taiwan ta ƙara samar da abin rufe fuska kuma ta hana ɗaukar kayayyakin kiwon lafiya.Gasar kwaikwayo da aka yi a Birtaniya da Amurka sun nuna cewa ragewa (ragewa amma ba kawar da yaduwar cutar ba) da kuma kawarwa (juyawa ci gaban cutar) suna fuskantar manyan ƙalubale.
Manufofin rage cutar da suka dace za su iya rage bukatar kiwon lafiya da kashi biyu bisa uku, kuma su rage mutuwar da rabi, amma ba za su iya hana dubban daruruwan mutane mutuwa ba, kuma tsarin kiwon lafiya ya cika da mutane.
Za a iya yin amfani da shi don kawar da cutar, amma dole ne a ci gaba da yin hakan muddin cutar tana cikin mutane (ko har sai an samu allurar riga-kafi, idan ta fara), in ba haka ba, saurin yaduwar cutar zai sake dawowa da sauri idan aka sassauta matakan.
Matakan da za su kawo ƙarshen annobar na da tsada a fannin tattalin arziki da zamantakewa.
Babu maganin rigakafin cutar da aka amince da ita don COVID-19, amma ana ci gaba da ƙoƙarin haɓaka, gami da gwajin magunguna na yanzu.
Yin amfani da magungunan sanyi da aka ba da takardar sayan magani ko shan giya da kuma hutawa za su iya taimaka maka ka rage ciwon.
Dangane da tsananin cutar, ana iya buƙatar maganin oxygen, allurar jini da taimakon numfashi.
Yin amfani da magungunan hana ɗaukar ciki zai iya sa ciwon ya yi muni sosai.
Yawancin mahaɗan da aka riga aka amince da su don magance wasu cututtukan ƙwayoyin cuta a halin yanzu ana nazarin su don maganin COVID-19.
WHO ta ce wasu  magungunan gargajiya da na gida  na iya rage alamun cutar SARS-CoV-19.
Ƙara iya aiki da daidaita kulawar kiwon lafiya don bukatun marasa lafiya da ke fama da COVID-19 an bayyana ta WHO a matsayin muhimmin matakin mayar da martani ga annobar.
ECDC da WHO Regional Office for Europe sun ba da jagorori ga asibitoci da cibiyoyin kula da lafiya na farko don sake tura albarkatu a matakai daban-daban, gami da sadaukar da ayyukan dakin gwaje-gwaje don gwajin COVID-19, soke ayyukan da ba na gaggawa ba idan ya yiwu, warewa da keɓe marasa lafiya da aka gwada sun sami COVID-19, da haɓaka ƙarfin kulawa ta musamman ta hanyar horar da ma'aikata da haɓaka adadin masu numfashi da gadaje.
Akwai ra'ayoyi da dama game da inda farkon wanda ya kamu da cutar ya fito (wanda ake kira mai haƙuri zero).
Ana iya cewa an fara gano mutum na farko da ya kamu da sabon kwayar cutar korona a ranar 1 ga Disamba, 2019, a Wuhan, lardin Hubei na kasar Sin.
A cikin wata guda, adadin masu kamuwa da cutar korona a Hubei ya karu a hankali.
Ana yawanci danganta su da kasuwar sayar da abincin teku ta Huanan, wanda kuma ke sayar da dabbobi masu rai. Wani ra'ayi shine cewa kwayar cutar ta fito ne daga ɗaya daga cikin waɗannan dabbobin; a wasu kalmomin, yana iya samo asali ne daga dabbobi. An gano cutar nimoniya da ba a san dalilin ta ba a ranar 26 ga Disamba kuma likita Zhang Jixian ya kula da ita a asibitin lardin Hubei, wanda ya sanar da CDC na Wuhan Jianghan a ranar 27 ga Disamba.
A ranar 30 ga Disamba, wasu likitoci a babban asibitin Wuhan sun gargadi abokan aikinsu game da cutar korona mai kama da SARS.
Likitoci takwas daga cikin likitocin, ciki har da Li Wenliang, 'yan sanda sun tsawata musu saboda yada jita-jita, wani kuma, Ai Fen, shugabanninsa sun tsawata masa saboda ya ba da labarin.
Hukumar Kiwon Lafiyar Birnin Wuhan ta fitar da sanarwar jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
Akwai isassun masu kamuwa da cutar sankarar bargo da aka ruwaito ga hukumomin kiwon lafiya na Wuhan don fara bincike a farkon watan Janairu. A farkon lokacin barkewar cutar, yawan masu kamuwa da cutar ya ninka sau biyu a kowace kwana bakwai da rabi.
A farkon da tsakiyar watan Janairun 2020, cutar ta yadu zuwa wasu lardunan China, wanda ya samu taimako daga ƙaurawar Sabuwar Shekarar China da kuma kasancewar Wuhan cibiyar sufuri da kuma babbar hanyar jirgin ƙasa.
A ranar 20 ga Janairu, kasar Sin ta samu kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a birnin Beijing da kuma ɗaya a birnin Shenzhen.
Bayanai na hukuma da aka samu daga baya sun nuna cewa mutane 6,174 sun riga sun kamu da alamun cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China da Italiya wajen samun adadin masu kamuwa da cutar da suka fi yawa a duniya. A ranar 9 ga Afrilu, 2020, an samu sama da mutane miliyan 1.61 a duniya; sama da mutane 97,000 sun mutu, kuma sama da 364,000 sun warke.
Aƙalla ƙasashe da yankuna 200 ne suka sami aƙalla mutum ɗaya da ya kamu da cutar.
Saboda annobar a Turai, ƙasashe da yawa na yankin Schengen sun hana tafiya kuma sun kafa matakan sarrafa kan iyakoki.
Amsoshin ƙasa sun haɗa da matakan kariya kamar keɓewa (wanda ake kira umarnin zama a gida, zama a gida ko kuma keɓewa) da dokar hana fita. Ya zuwa 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90 cikin ɗari na yawan jama'a, suna ƙarƙashin wasu nau'ikan keɓewa a Amurka, sama da mutane miliyan 50 a Philippines, kusan miliyan 59 a Afirka ta Kudu da biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wani irin yanayi na kullewa, adadin ya ƙaru zuwa biliyan 2.6 bayan kwana biyu  kusan kashi ɗaya bisa uku na yawan mutanen duniya.
An gano cewa an fara samun mutum na farko da ya kamu da COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; wani rahoto da ba a tabbatar da shi ba ya nuna cewa an samu mutum na farko a ranar 17 ga Nuwamba.
Likita Zhang Jixian ta lura da wani ciwo na ciwon huhu da ba a san dalilinsa ba a ranar 26 ga Disamba, kuma ta sanar da CDC na Wuhan Jianghan a ranar 27 ga Disamba.
Gwajin kwayoyin halitta na farko na samfuran marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna kasancewar coronavirus mai kama da SARS.
Hukumar Kula da Lafiya ta Birnin Wuhan ta ba da sanarwar jama'a a ranar 31 ga Disamba.
An sanar da WHO a ranar.
An gargadi likitoci a Wuhan saboda  yada jita-jita  game da annobar.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara da'awar cewa babu  hujja  ta yaduwar cutar tsakanin mutane.
A ƙarshen watan Janairu, gwamnatin China ta ƙaddamar da wani gagarumin yaƙi, wanda daga baya Babban Sakataren Jam'iyyar Kwaminis ta Sin Xi Jinping ya bayyana a matsayin  yaƙin mutane  don dakile yaduwar cutar.
A cikin abin da aka bayyana a matsayin  mafi girman keɓewa a tarihin ɗan adam , an sanar da dokar hana fita a ranar 23 ga Janairu don dakatar da tafiye-tafiye daga da zuwa Wuhan, wanda aka faɗaɗa zuwa birane 15 a Hubei, wanda ya shafi kusan mutane miliyan 57.
An haramta amfani da motocin mutane a birnin.
An soke bikin sabuwar shekara ta kasar Sin (Janairu 25) a wurare da dama.
Hukumomi sun kuma sanar da gina asibitin wucin gadi, Huoshenshan, wanda aka kammala a cikin kwanaki 10.
Daga baya, an gina wani asibiti a birnin Leishenshan don a kula da ƙarin marasa lafiya.
Baya ga sababbin asibitoci, China ta mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta kafa wasu sabbin matakan dakile yaduwar COVID-19, ciki har da bayar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An kuma rufe jami'o'i da makarantu a kasar.
Yankunan Hong Kong da Macao sun kafa wasu matakai, musamman a makarantu da jami'o'i.
An kafa matakan aiki a nesa a yankuna da dama na kasar Sin.
An kafa takunkumin hana tafiya a Hubei da kuma wasu yankuna.
An sauya hanyar sufuri ta jama'a kuma an rufe gidajen tarihi na kasar Sin na ɗan lokaci.
An kafa dokar hana tafiye-tafiye a birane da yawa, kuma an kiyasta cewa mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu irin takunkumin hana tafiya. Bayan barkewar cutar a duniya a watan Maris, hukumomin kasar Sin sun ɗauki tsauraran matakai don hana cutar shigowa daga wasu ƙasashe.
Alal misali, Beijing ta sanya keɓewa na kwanaki 14 ga duk matafiya na ƙasashen waje da ke shiga birnin. Har zuwa 23 ga Maris, a babban yankin China, mutum ɗaya ne kawai ya kamu da cutar a cikin kwanaki biyar da suka gabata, a wannan yanayin ta hanyar matafiyi da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga watan Maris, 2020, Firaminista Li Keqiang ya bayyana cewa an dakatar da yaduwar cututtukan da ke yaduwa a cikin kasar, kuma an sarrafa annobar a China.
A ranar, an sassauta takunkumin tafiye-tafiye a Hubei, ban da Wuhan, watanni biyu bayan an fara kulle-kulle. Ma'aikatar Harkokin Wajen China ta sanar a ranar 26 ga Maris, 2020 cewa za a dakatar da shigarwa ga masu biza ko izinin zama daga ranar 28 ga Maris, ba tare da bayyana lokacin da za a kawo ƙarshen wannan manufar ba.
Saboda haka, waɗanda suke son shiga ƙasar Sin dole ne su nemi biza a ofisoshin jakadancin ƙasar Sin.
Gwamnatin kasar Sin ta ƙarfafa kamfanoni da masana'antu su sake buɗewa a ranar 30 ga Maris, kuma ta ba da shirin ba da tallafi na kuɗi ga kamfanoni. Majalisar Harkokin Kasar ta sanar da ranar makoki da za a fara da yin shiru na minti uku a ranar 4 ga Afrilu da ƙarfe 10:00 na safe, wanda ya yi daidai da bikin Qingming, ko da yake gwamnatin tsakiya ta bukaci iyalai su yi wa juna biyayya ta kan layi don kiyaye nesa da juna da kuma hana sake barkewar COVID-19.
An tabbatar da cewa COVID-19 ya yadu a Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
Hukumar kiwon lafiya ta ƙasar ta ba da rahoton ƙaruwar yawan masu kamuwa da cutar a ranar 20 ga Fabrairu, wanda galibi ana danganta shi ne ga taron da wani sabon rukunin addini da ake kira Shincheonji Church of Jesus ya yi a Daegu.
Ana zargin cewa masu ibada a Shincheonji da suka zo Daegu daga Wuhan ne suka haddasa annobar.
A ranar 22 ga watan Fabrairu, daga cikin masu zuwa coci 9,336, 1,261 ko kusan kashi 13 cikin ɗari sun ba da rahoton alamun cutar.
A ranar 28 ga Fabrairu, an samu mutane sama da 2,000 da suka kamu da cutar a Koriya, sannan kuma a ranar 29 ga Fabrairu, an samu mutane 3,150.
An killace dukkan sansanonin soji na Koriya ta Kudu bayan da aka gano sojoji uku da cutar.
Har ila yau, an yi wa jadawalin jiragen sama tasiri kuma saboda haka an canza su. Koriya ta Kudu ta gabatar da abin da aka ɗauka a matsayin mafi girma kuma mafi kyawun tsari a duniya don gwada yawan jama'a don cutar, da ware duk mutanen da ke da cutar da kuma bin sawu da keɓe waɗanda suka taɓa saduwa da su.
Hanyoyin gwaji sun haɗa da buƙatar mutum ya ba da rahoton alamun cutar ta hanyar aikace-aikacen wayar hannu, gwajin cutar da ke ba da sakamako a rana mai zuwa, da haɓaka ƙarfin gwaji don ba da damar gwajin kusan mutane 20,000 kowace rana.
An yi la'akari da shirin Koriya ta Kudu a matsayin nasara wajen shawo kan annobar, duk da cewa ba a keɓe birane gaba ɗaya ba. Da farko an raba jama'ar Koriya ta Kudu game da yadda Shugaba Moon Jae-in ya amsa wannan rikici.
Mutane da yawa a Koriya sun sanya hannu kan takardun neman a tuhumi Moon saboda rashin kulawar da gwamnati ta yi da annobar ko kuma su yaba da yadda ya amsa.
A ranar 23 ga watan Maris, Koriya ta Kudu ta samu mafi ƙarancin adadin masu kamuwa da cutar a cikin makonni huɗu.
A ranar 29 ga watan Maris, an sanar da cewa daga ranar 1 ga Afrilu, duk mutanen da suka zo daga ƙasashen waje za a keɓe su na makonni biyu.
A cewar kafofin yada labarai, a ranar 1 ga Afrilu, Koriya ta Kudu ta samu buƙatun taimako don gano cutar daga ƙasashe daban-daban 121.
Iran ta bayar da rahoton mutum na farko da ya kamu da cutar SARS-CoV-2 a ranar 19 ga watan Fabrairu a Qom, inda ma'aikatar lafiya da ilimin likitanci ta ce mutane biyu sun mutu a wannan ranar.
Matakan farko da gwamnatin ta sanar sun hada da soke kide kide da sauran al'adu, wasanni da sallar Juma'a, da rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta kashe Riyal tiriliyan biyar wajen yaki da cutar.
Shugaba Hassan Rouhani ya ce a ranar 26 ga Fabrairu, 2020 cewa babu wani shiri na keɓe wuraren da cutar ta bulla, kuma mutane ne kawai za a keɓe.
An sanar da shirin hana tafiye-tafiye tsakanin birane a watan Maris, duk da cewa yawan zirga-zirgar ababen hawa tsakanin biranen ya ci gaba da kasancewa a lokacin bikin Sabuwar Shekarar Farisa ta Nowruz.
Wuraren ibada na Shi'a a Qom sun kasance a bude ga mahajjata har zuwa 16 ga Maris 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
Bayan zargin cewa ana iya ɓoye yaduwar cutar a Iran, sama da ƙasashe goma sun gano asalin cututtukansu a Iran a ranar 28 ga Fabrairu, wanda ke nuna cewa cutar na iya zama mafi tsanani fiye da 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, yayin da 23 daga cikin mambobi 290 suka ba da rahoton sun kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkuku da su saki masu kare hakkin dan adam da aka tsare saboda rashin amincewarsu da zaman lafiya ba tare da wani sharadi ba, kuma su saki duk fursunonin da suka cika wasu sharudda na dan lokaci.
Kungiyar ta ce akwai hadarin yaduwar cutar a wuraren da aka rufe kamar wuraren tsare mutane, waɗanda kuma ba su da kulawar likita.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a rana ɗaya, wanda shi ne mafi yawan adadin da aka samu a ƙasar tun lokacin da annobar ta fara.
Akalla 'yan siyasa 12 na Iran da suka gabata da kuma na yanzu da kuma mambobin gwamnati sun mutu daga cutar a ranar 17 ga Maris.
A ranar 23 ga watan Maris, Iran tana samun sabbin mutane 50 a kowace awa da kuma mutum ɗaya da ke mutuwa a kowace minti goma daga cutar korona.
Wani jami'in WHO ya ce akwai yiwuwar akwai mutane da suka kamu da cutar a Iran sau biyar fiye da adadin da aka ruwaito.
An kuma nuna cewa takunkumin Amurka na iya lalata ikon kuɗin ƙasar don magance cutar.
Ofishin Babban Kwamishinan Majalisar Dinkin Duniya kan 'Yancin Dan Adam ya nemi sassauta takunkumin tattalin arziki ga ƙasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da cewa annobar ta yadu zuwa Italiya a ranar 31 ga Janairu, lokacin da wasu masu yawon buɗe ido biyu daga China suka kamu da SARS-CoV-2 a Roma.
Masu kamuwa da cutar sun fara ƙaruwa cikin sauri, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen da ke zuwa da kuma zuwa China kuma ta ayyana dokar ta baci.
Daga baya an gano wani sabon kamuwa da cutar COVID-19 wanda ba shi da alaƙa, tare da tabbatar da kamuwa da cutar 16 a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta sanar da sabon dokar doka don hana barkewar cutar, gami da keɓe mutane sama da 50,000 a cikin birane daban-daban 11 a arewacin Italiya.
Firaministan kasar Giuseppe Conte ya ce:  A yankunan da annobar ta bulla, ba za a yarda kowa ya shiga ko ya fita ba.
An riga an ba da umarnin dakatar da ayyukan sana'a da kuma wasannin motsa jiki a waɗannan yankuna. A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a ƙasar gaba ɗaya yayin da Italiya ta sami mutuwar 100.
Duk manyan wasannin wasanni, ciki har da wasannin Serie A, an shirya su rufe har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da dukkan wasanni gaba ɗaya na aƙalla wata ɗaya.
A ranar 11 ga watan Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci, ban da manyan kantuna da kantunan magani. A ranar 6 ga Maris, Ƙungiyar Italiya ta Anesthesia, Analgesia, CPR da Kulawa ta Musamman (SIAARTI) ta ba da shawarwari game da ɗabi'ar likita game da hanyoyin da za a bi don rarrabuwa.
A ranar 19 ga watan Maris, Italiya ta zarce China a matsayin ƙasa da ta fi yawan mutanen da suka mutu sakamakon cutar korona a duniya bayan ta ba da rahoton mutuwar mutane 3,405 sakamakon annobar.
A ranar 22 ga watan Maris, an bayar da rahoton cewa Rasha ta aika da jiragen sama tara na soji dauke da kayan aikin likita zuwa Italiya.
A ranar 5 ga Afrilu, Italiya tana da mutane 128,948 da suka kamu da cutar, 15,887 da suka mutu, da kuma 21,815 da suka warke; yawancin waɗannan sun faru ne a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa yawan tsofaffi a Italiya da kuma rashin iya gwada duk waɗanda ke da cutar har zuwa yau na iya taimakawa wajen yawan mutuwar.
Amsar da Birtaniya ta bayar ga cutar ta fara bayyana a matsayin daya daga cikin mafi sassauci a cikin ƙasashen da cutar ta shafa, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya wani nau'i na nisantar jama'a ko kuma ta sanya mazauna cikin keɓewa ba.
Saboda haka, an soki gwamnati saboda rashin nuna himma da himma wajen amsa damuwar jama'a. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar, yana ba da shawarar duk balaguron da ba dole ba da kuma hulɗar zamantakewa, yana ba da shawarar mutane su yi aiki daga gida idan zai yiwu kuma su guji wurare kamar mashaya, gidajen abinci da wuraren wasan kwaikwayo.
A ranar 20 ga watan Maris, gwamnati ta sanar da cewa duk wuraren nishaɗi kamar mashaya da wuraren motsa jiki dole ne su rufe da wuri-wuri, kuma ta yi alkawarin biyan kashi 80 na albashin ma'aikata, a cikin iyakar £2,500 a wata, don kauce wa rashin aikin yi da ke tattare da rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nisantar zamantakewa, ya hana taron mutane sama da biyu kuma ya iyakance tafiya da ayyukan waje sai dai idan ya zama dole.
Ba kamar yadda aka yi a dā ba, ana iya hukunta mutane da tarurruka ta hanyar tara kuɗi da kuma tarwatsa mutane.
An umarci yawancin kamfanoni su rufe, sai dai kamfanonin da aka ce suna da muhimmanci, kamar su manyan kantuna, kantin magani, bankuna, kantunan sana'a, tashoshin mai da gidajen ajiye motoci.
A ranar 20 ga Janairu, an tabbatar da mutum na farko da ya kamu da COVID-19 a Arewa maso Yammacin Pacific, a jihar Washington, a cikin wani mutum da ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa rukunin aiki na fadar White House kan cutar korona a ranar 29 ga watan Janairu.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana gaggawa ga lafiyar jama'a kuma ta sanya takunkumi kan shiga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar cibiyar kiwon lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta samar da kayan gwajin kanta.
Duk da haka, Amurka ta jinkirta fara gwajin, wanda ya ɓoye ainihin yaduwar cutar a lokacin.
Gwaje-gwajen sun lalace saboda kayan gwaji da ba su da kyau da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga kayan gwaji na ba-gwamnati (jami'o'i, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙuntatawa don cancantar gwaji har zuwa farkon Maris (da aka ba da takardar likita a baya).
A ranar 27 ga watan Fabrairu, jaridar The Washington Post ta ruwaito cewa an yi gwajin ƙasa da 4,000 a Amurka.
A ranar 13 ga watan Maris, jaridar The Atlantic ta ruwaito cewa an yi gwaje-gwaje ƙasa da 14,000.
A ranar 22 ga Maris, Associated Press ta ruwaito cewa:  Mutane da yawa da ke da alamun cutar da kuma takardar likita sun jira na sa'o'i ko ma kwanaki don a gwada su. Da zarar an samu mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Inslee ya ayyana dokar ta baci, kuma wasu jihohi sun bi sahun nan da nan.
Makarantun yankin Seattle sun soke karatu a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantu a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar masana cututtuka a Kwalejin Imperial ta London sun sanar da Amurka game da tasirin sabon coronavirus a ƙasar.
A wannan ranar, Shugaba Trump ya rattaba hannu kan Dokar Ƙarin Kuɗaɗen Shirye-shiryen Cutar Korona da Amsa, wanda ke samar da kuɗin gaggawa na dala biliyan 8.3 don taimakawa hukumomin tarayya wajen magance annobar.
Kamfanoni sun hana ma'aikatansu tafiya, sun soke taron taro kuma sun ƙarfafa ma'aikatansu su yi aiki daga gida.
An soke abubuwan wasanni da lokutan wasanni. A ranar 11 ga Maris, Trump ya sanar da hana tafiye-tafiye ga yawancin Turai, ban da Burtaniya, na kwanaki 30 daga ranar 13 ga Maris.
Kashegari, ya faɗaɗa ƙuntatawa zuwa Ƙasar Ingila da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci ta kasa, wanda ya samar da kudaden tarayya don magance matsalar.
Tun daga ranar 15 ga watan Maris, kamfanoni da yawa sun rufe ko rage lokacin aiki a duk faɗin Amurka don ƙoƙarin hana yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da barkewar cutar a kowace jiha 50 da gundumar Columbia. A ranar 23 ga Maris, an samu mutum 10,700 da suka kamu da cutar korona a birnin New York, wanda ya fi yawan mutanen da ke Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce nisantar da mutane da jama'a kamar tana aiki ne yayin da ƙididdigar ninki biyu na masu cutar ta tashi daga kwanaki 2.0 zuwa kwanaki 4.7.
A ranar 28 ga watan Maris, an tabbatar da mutane 32,308 da cutar a New York City, kuma mutane 672 sun mutu. A ranar 26 ga Maris, Amurka ta ba da rahoton mutane da suka kamu da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, an tabbatar da mutane 400,335 da cutar a Amurka, kuma mutane 12,841 sun mutu.
A ranar 30 ga watan Maris, ta hanyar manema labarai, Shugaban Amurka Trump ya yanke shawarar tsawaita umarnin nisantar jama'a har zuwa 30 ga Afrilu.
A wannan ranar, jirgin ruwan asibiti mai gadaje 1,000 mai suna USNS Comfort ya sauka a birnin New York.
A ranar 3 ga Afrilu, Amurka ta samu mutuwar mutum 884 sakamakon cutar korona a cikin sa'o'i 24.
A jihar New York, adadin masu kamuwa da cutar ya wuce 100,000 a ranar 3 ga Afrilu. An soki Fadar White House don rage girman barazanar da kuma sarrafa sadarwa ta hanyar umarci jami'an kiwon lafiya da masana kimiyya su daidaita bayanan jama'a da wallafe-wallafe game da cutar tare da ofishin Mataimakin Shugaban Mike Pence.
A cikin wannan lokacin, akwai wasu bangarori da suka nuna rashin amincewarsu da yadda Trump ya magance matsalar.
Wasu jami'an Amurka da masu sharhi sun soki dogaro da Amurka kan shigo da kayayyakin aiki, musamman na'urorin kiwon lafiya, daga China.
An yi amfani da nazarin yanayin tafiye-tafiyen jirgin sama don zana taswira da hasashen yanayin yaduwar, kuma an buga shi a cikin Journal of Travel Medicine a tsakiyar Janairu 2020.
Bisa ga rahoton 2018 na Ƙungiyar Jiragen Sama ta Duniya, Bangkok, Hong Kong, Tokyo da Taipei sun fi yawan matafiya daga Wuhan.
Dubai, Sydney da Melbourne ma sanannun wurare ne ga mutanen da ke barin Wuhan.
Bali an ɗauka a matsayin mafi ƙarancin ƙwarewa a cikin shahararrun biranen 20 na masu zuwa don shiri, yayin da aka ɗauki biranen Ostiraliya sun fi dacewa. Ostiraliya ta fitar da shirin gaggawa na sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ya nuna cewa har yanzu akwai abubuwa da yawa da za a gano game da COVID-19 kuma Australia za ta ƙara ƙarfafa kula da kan iyakoki da sadarwa a cikin aikinta na magance cutar.
A ranar 21 ga watan Maris, an ayyana gaggawa ta lafiyar ɗan adam a Ostiraliya.
Saboda keɓewar sufuri na jama'a daga Wuhan da Hubei, ƙasashe da dama sun shirya kwashe 'yan ƙasa da ma'aikatan diflomasiyya daga yankin, galibi ta jiragen da ƙasar ta yi hayar su, tare da izinin hukumomin China.
Kasashen Kanada, Amurka, Japan, Indiya, Sri Lanka, Ostareliya, Faransa, Argentina, Jamus da Thailand sun kasance cikin ƙasashe na farko da suka fara kwashe 'yan ƙasarsu.
Pakistan ta ce ba za ta kwashe 'yan kasar ta daga China ba.
A ranar 7 ga watan Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko danginsu da kuma 'yan Poland huɗu, da wani ɗan China da kuma wani ɗan Indiya.
'Yan kasar Poland, China da Indiya sun sauka a Poland, inda jirgin na Brazil ya tsaya kafin ya ci gaba da tafiya zuwa Brazil.
An killace 'yan ƙasar Brazil da suka ziyarci Wuhan a wani sansanin soji kusa da Brasília.
A ranar, an kwashe 'yan Kanada 215 (mutanen 176 a cikin jirgin farko da 39 a cikin jirgin sama na biyu da gwamnatin Amurka ta yi hayar) daga Wuhan zuwa BFC Trenton don keɓewa na makonni biyu.
A ranar 11 ga watan Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a BFC Trenton.
Hukumomin Australia sun kwashe 'yan ƙasa 277 a ranakun 3 da 4 ga watan Fabrairu zuwa cibiyar tsare mutane a tsibirin Kirsimeti, wanda aka mai da shi wurin keɓewa, inda suka zauna na kwanaki 14.
Jirgin sama na kwashe mutane daga New Zealand ya isa Auckland a ranar 5 ga watan Fabrairu; an killace fasinjojinsa (musamman daga Australia da Pacific) a sansanin jiragen ruwa na Whangaparaoa, arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar cewa za ta kwashe Amurkawa a cikin jirgin ruwan Diamond Princess.
A ranar 21 ga Fabrairu, jirgin da ke ɗauke da fasinjojin Kanada 129 da aka kwashe daga jirgin Diamond Princess ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar ta daga Iran. A ranar 14 ga Maris, jirgin saman South African Airways da gwamnatin Afirka ta Kudu ta yi hayar ya dawo da 'yan Afirka ta Kudu 112.
An yi gwajin lafiya kafin tashi kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus a wurin don rage haɗarin.
Sai kawai 'yan Afirka ta Kudu da gwajin su ya nuna ba su da lafiya ne aka mayar da su gida.
Sakamakon gwajin ya ba da izinin duk 'yan Afirka ta Kudu, gami da ma'aikatan jirgin, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da ke cikin aikin agaji, waɗanda, a matsayin matakin kariya, duk sun kasance a cikin kulawa da keɓewa na kwanaki 14 a Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye wasu dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Waje ta kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun aika da taimako zuwa kasar Sin.
Wasu ɗaliban Sinawa da ke karatun jami'o'in Amurka sun haɗu don taimakawa wajen aika taimako zuwa yankunan da cutar ta shafa na China, tare da ƙungiyar haɗin gwiwa daga yankin Greater Chicago da aka ba da rahoton cewa ta aika da abin rufe fuska N95 50,000 zuwa asibitocin lardin Hubei a ranar 30 ga Janairu. Ƙungiyar agaji ta Direct Relief, tare da haɗin gwiwar FedEx, ta aika da abin rufe fuska 200,000 da sauran kayan kariya na mutum, gami da safar hannu da riguna, ta hanyar gaggawa ta iska zuwa Asibitin Union na Wuhan a ranar 30 ga Janairu.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da bayar da gudummawar dala miliyan 100 ga WHO don tallafawa binciken allurar rigakafi da ƙoƙarin magani da kare  mutanen da ke cikin haɗari a Afirka da Kudancin Asiya .
Interaksiyon ta ruwaito cewa gwamnatin China ta ba da gudummawar abin rufe fuska 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Singapore ta sanar da cewa za ta aika da tallafin da ya kai dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da takunkumin rufe fuska miliyan 1 ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da sama da tan 13 na kayan aikin likita zuwa Wuhan, Malaysia ta sanar da ba da hannayen riga na likita miliyan 18 ga China, Jamus ta ba da kayan aikin likita daban-daban ciki har da Hazmat su 10,000, kuma Amurka ta ba da tan 17.8 na kayan aikin likita ga China kuma ta yi alkawarin ƙarin dala miliyan 100 na tallafin kuɗi ga ƙasashen da cutar ta shafa. Da zarar an daidaita lamura a China, ƙasar ta aika da taimako ga ƙasashe da dama da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da masana don taimakawa Italiya wajen magance annobar coronavirus.
Wani dan kasuwa mai suna Jack Ma ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6, da rigunan kariya 60,000 zuwa Addis Ababa, Habasha don tarayyar Afirka ta rarraba su.
Daga baya ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin numfashi 5 zuwa Panama.
Ma ya kuma ba da kayan aikin likita ga Kanada. Kasashen Netherlands, Spain, Turkey, Georgia da Jamhuriyar Czech sun nuna damuwa game da abin rufe fuska da kayan gwaji da aka yi a China.
Alal misali, Spain ta janye kayan gwaji na korona 58,000 da aka yi a China da ya yi daidai da kashi 30 cikin ɗari kawai, yayin da Netherlands ta dawo da abin rufe fuska 600,000 na kasar Sin da suka lalace.
Belgium ta dawo da abin rufe fuska 100,000 da ba za a iya amfani da su ba, wanda ake zaton sun fito ne daga China, amma a gaskiya sun fito ne daga Colombia.
A wani bangare kuma, an yi maraba da taimakon da kasar Sin ta bayar a yankunan Latin Amurka da Afirka.
Hukumar lafiya ta duniya ta yaba wa kokarin da hukumomin kasar Sin ke yi wajen sarrafa da kuma dakile annobar.
WHO ta lura da bambanci tsakanin barkewar cutar SARS ta 2002-2004, inda aka zargi hukumomin China da ɓoyewa da hana ƙoƙarin rigakafi da hanawa, da rikicin yanzu inda gwamnatin tsakiya  ta ba da rahotanni na yau da kullun don hana firgici a jajibirin Sabuwar Shekarar Lunar .
A ranar 23 ga watan Janairu, a lokacin da ya amsa shawarar da hukumomin tsakiya suka yanke na hana tafiya daga Wuhan, wakilin WHO Gauden Galea ya nuna cewa ko da yake wannan ba shawarar WHO ba ce, amma wata muhimmiyar alama ce ta sadaukar da kai ga hana barkewar cutar a inda ta fi yawa kuma ya yi magana game da abin da ba a taɓa gani ba a tarihin kiwon lafiyar jama'a. A ranar 30 ga Janairu, bayan tabbatar da yaduwar cutar daga mutum zuwa mutum a China da kuma karuwar mutane a wasu ƙasashe, WHO ta ayyana cutar a matsayin gaggawa ta kiwon lafiyar jama'a ta duniya (USPPI), matakin na 10 da aka ɗauka tun lokacin annobar mura ta 2009.
Darakta Janar na WHO Tedros Adhanom ya ce USPPI ya samo asali ne daga hadarin yaduwar cutar a duniya, musamman ga ƙasashe masu karamin kuɗi da masu matsakaitan kuɗi ba tare da ingantaccen tsarin kiwon lafiya ba.
A cikin martani ga dokar hana tafiye-tafiye, Tedros ya ce:  babu dalilin da zai sa a hana tafiye-tafiye da kasuwanci na duniya  kuma  WHO ba ta ba da shawarar hana kasuwanci da tafiye-tafiye .
A ranar 5 ga watan Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da dala miliyan 675 don tallafawa shirye-shiryen da ake yi a ƙasashe masu karamin kuɗi, ta nuna cewa akwai bukatar gaggawa don tallafa wa ƙasashen da  ba su da tsarin da ya dace don gano mutanen da suka kamu da cutar, ko da yake cutar ta kusa bayyana .
Tedros ya ci gaba da cewa muna  kamar yadda muke da ƙarfi kamar yadda muke da rauni  kuma ya aririci al'ummar duniya  su saka hannun jari a yau  ko kuma su biya ƙarin gobe . A ranar 11 ga Fabrairu, WHO ta bayyana a wani taron manema labarai cewa cutar tana da sunan COVID-19.
A wannan rana, Tedros ya ce Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince da haɗa  ƙarfin dukan tsarin Majalisar Dinkin Duniya cikin amsa .
Don haka an kunna ƙungiyar kula da rikice-rikice ta Majalisar Dinkin Duniya, don daidaita dukkanin amsar Majalisar Dinkin Duniya, wanda WHO ta ce zai ba su damar  mai da hankali kan amsar kiwon lafiya yayin da sauran hukumomin za su iya ba da ƙwarewar su don magance tasirin zamantakewa, tattalin arziki da ci gaban cutar .
A ranar 14 ga watan Fabrairu, an tura tawagar aikin hadin gwiwa ta WHO zuwa China don tura masana na duniya da WHO zuwa China don tallafawa gudanar da aikin ƙasa da kuma tantance  tsananin cutar da yaduwar cutar  ta hanyar gudanar da bita da tarurruka tare da manyan cibiyoyin ƙasa da kuma gudanar da ziyarar ƙasa don tantance  tasirin ayyukan amsawa a larduna da gundumomi, gami da birane da karkara . A ranar 25 ga Fabrairu, WHO ta ce  duniya ta kamata ta yi ƙarin shirye-shirye don cutar coronavirus , tana mai nuna cewa  ko da yake ba a daɗe ba don yin magana game da cutar, duk da haka kowace ƙasa  ya kamata ta shiga cikin shirin .
Dangane da ci gaban annobar a Iran, WHO ta tura ƙungiyar haɗin gwiwa don tantance yanayin. A ranar 28 ga Fabrairu, jami'an WHO sun ce ƙimar barazanar coronavirus a duniya ta tashi daga  mai girma  zuwa  mai girma , matakin gargadi da ƙimar haɗari mafi girma.
Mike Ryan, darektan shirin kula da gaggawa na lafiya na WHO, ya yi gargadi a cikin wata sanarwa cewa: "Wannan ya zama abin da ya kamata ga kowace gwamnati a duniya: farka.
Wataƙila cutar tana kan hanyarsa kuma kuna buƙatar kasancewa a shirye , yana ƙara cewa matakan da suka dace na iya taimaka wa duniya ta guji  mafi munin .
Ryan ya ci gaba da cewa bayanan da ake da su yanzu ba sa ba jami'an kiwon lafiya damar sanar da annobar duniya, yana mai cewa irin wannan sanarwar na nufin cewa  mun yarda da cewa kowane mutum a duniya yana fuskantar cutar .
A ranar 11 ga watan Maris, WHO ta ce za a iya kiran annobar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO  tana da matukar damuwa game da yadda cutar ke yaduwa da kuma tsanani da kuma yadda ba a kula da cutar . WHO ta fuskanci zargi mai tsanani game da yadda ta gudanar da annobar, wanda aka ce bai dace ba, musamman saboda jinkirin sanar da gaggawa na lafiyar jama'a da kuma rarraba cutar a matsayin annobar.
Wannan mummunan martani ya samu goyon baya daga wata takarda mai neman babban darektan WHO Tedros Adhanom ya yi murabus, wanda mutane 733,000 suka sanya hannu a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, masana da dama kan hakkin bil'adama na Majalisar Dinkin Duniya sun mai da hankali kan girmama haƙƙin kowane mutum a lokacin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun agajin gaggawa kuma gwamnati ce ke da alhakin hakan.
Ƙungiyar ta nace cewa rashin albarkatu ko inshorar lafiya ba za su taɓa zama hujja ba don nuna bambanci ga wani rukuni na musamman.
Masana sun jaddada cewa kowane mutum yana da hakkin samun lafiya, gami da nakasassu, 'yan tsiraru, tsofaffi, mutanen da aka kora daga gidajensu, marasa gida, waɗanda ke cikin matsanancin talauci, fursunoni, da 'yan gudun hijira da sauran kungiyoyin da ba a ambata ba waɗanda ke buƙatar tallafin gwamnati.
Ƙungiyoyin gwamnati na duniya suna kula da tasirin tattalin arziki da zamantakewar al'umma na rikicin COVID-19.
Kungiyar Tattalin Arziki ta Ƙasa ta ƙaddamar da wani dandamali wanda ke ba da cikakken bayani game da yadda ake magance matsalolin siyasa a ƙasashe daban-daban a duniya, da kuma ra'ayoyi da shawarwari.
Daga manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya da kuma amsawa ga tasirin kullewa da ƙuntatawa na tafiya, dandamali na dijital ya haɗa da kayan aikin bin diddigin manufofin ƙasa don taimakawa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen martani na duniya ga ƙalubalen coronavirus.
Gwamnatin China ta sha suka daga Amurka, Ministan Ofishin Ministan Birtaniya Michael Gove da dan Shugaban Brazil Jair Bolsonaro, Eduardo Bolsonaro, kan yadda ta gudanar da annobar, wadda ta fara a lardin Hubei na China.
An cire wasu shugabannin jam'iyyar kwaminis ta kasar Sin (CCP) daga mukaman su sakamakon yadda suka gudanar da dokar killacewa a tsakiyar kasar Sin, a matsayin wata alama ta rashin jin daɗi game da yadda jami'an siyasa ke amsa cutar a yankunan.
Wasu masu sharhi sun yi imanin cewa an yi wannan ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a game da annobar coronavirus.
Wasu manyan jami'an kasar Sin, kamar Zhao Lijian, sun yi watsi da ra'ayin farko cewa annobar coronavirus ta fara ne a Wuhan don su goyi bayan ra'ayoyin makirci cewa COVID-19 ta samo asali ne daga Amurka ko Italiya.
Gwamnatin Donald Trump ta Amurka ta kira coronavirus  kwayar cutar China  ko  kwayar cutar Wuhan , tana cewa  a China  ƙuntatawa ta ƙara cutar da ta zama annoba ta duniya , wanda daga baya wasu masu adawa suka yi da'awar wariyar launin fata kuma an yi niyyar  karkatar da hankali daga rashin ikon gwamnatinsa na dakile cutar .
Jaridar Daily Beast ta samu wata sakon waya daga gwamnatin Amurka da ke bayyana wani shiri na sadarwa da ake ganin ya fito ne daga majalisar tsaron kasa, wanda dabarar da aka ambata ita ce:
An nemi mu yi ƙoƙari mu isar da wannan saƙo ta kowane hanya da za mu iya, musamman a taron manema labarai da kuma a talabijin. Ƙungiyoyin labarai kamar su Politico, Foreign Policy da Bloomberg sun yi iƙirarin cewa ƙoƙarin da China ke yi na aika taimako ga ƙasashen da cutar ta shafa wani ɓangare ne na yaɗa labarai don samun rinjaye a duniya.
Shugaban EU Josep Borrell ya yi gargadin cewa akwai wani bangare na siyasa wanda ya shafi gwagwarmayar samun tasiri ta hanyar maganganu da kuma 'siyasa ta karimci'.
Borrell ya kuma ce  China tana dagewa kan cewa, sabanin Amurka, ita abokiyar aiki ce mai dogaro da abin dogaro .
China ta kuma yi kira ga Amurka da ta ɗage takunkumin da ta kakaba wa Syria, Venezuela da Iran, yayin da take aika taimako ga waɗannan ƙasashe biyu.
An dakatar da takunkumin Amurka kan takunkumin da Jack Ma ya bayar na takunkumin rufe fuska 100,000 da aka ba Cuba a ranar 3 ga watan Afrilu.
An kuma zargi hukumomin Amurka da karkatar da tallafi ga wasu ƙasashe zuwa ƙasarsu.
Kuma an kuma samu rahotanni game da wasu rikice-rikice da suka shafi abin rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria da Switzerland, da Jamhuriyar Czech da Italiya.
Bugu da ƙari, Turkiyya ta kwace ɗaruruwan na'urorin numfashi da aka tura Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin haɗin kai na Tarayyar Turai ga Italiya, wadda cutar korona ta shafa.
Maurizio Massari, jakadan Italiya a EU, ya ce China ce kawai ta mayar da martani ta bangarorin biyu.
Wannan ba kyakkyawan alama ba ne ga haɗin kan Turai .
A ranar 22 ga watan Maris, bayan ya yi magana da Firaministan Italiya Giuseppe Conte, Shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika likitocin soja, motocin kashe ƙwayoyin cuta na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta kawo wani  babban majiyar siyasa  wanda ba a bayyana sunansa ba wanda ya ce kashi 80 cikin dari na taimakon Rasha  kadan ne ko kuma ba shi da amfani ga Italiya .
Majiyar ta zargi Rasha da shiga wani mummunan aiki na siyasa da diflomasiyya.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun musanta rahoton da aka yi a kafofin yada labarai kuma sun nuna godiyarsu.
Rasha ta kuma aika da jirgin sama mai jigilar kayayyaki da kayan aikin likita zuwa Amurka.
Kakakin Kremlin Dmitry Peskov ya ce  a cikin bayar da taimakonsa ga abokan aikinsa na Amurka, [Putin] yana zaton cewa idan masana'antun Amurka na kayan aiki da kayan aikin likita suka sami saurin aiki, za su iya mayar da su idan an buƙata .
Za a rage girman atisayen sojin NATO na Defender 2020 da aka shirya yi a Jamus, Poland da Baltic, wanda shi ne mafi girma daga NATO tun bayan ƙarshen Cold War.
Babban sakataren Kamfen na Yaki da Makaman Nukiliya Kate Hudson ta soki atisayen Defender 2020:  A cikin matsalar lafiyar jama'a da ake ciki yanzu, ba wai kawai sojojin Amurka da kasashen Turai da ke halartar taron ba ne ke cikin haɗari, har ma da mutanen da ke cikin ƙasashen da suke aiki . Gwamnatin Iran ta yi fama da cutar sosai, tare da kusan 'yan majalisa 20 da suka kamu da cutar, da kuma wasu manyan jami'an siyasa 15 da ke aiki a yanzu da kuma waɗanda suka gabata.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika a bude ga shugabannin duniya don neman taimako a ranar 14 ga Maris, 2020, yana mai cewa kasarsa na gwagwarmaya don magance cutar saboda rashin samun damar shiga kasuwannin duniya saboda takunkumin Amurka kan Iran. Cutar ta haifar da kira ga Amurka da ta aiwatar da manufofin zamantakewar da aka saba da sauran ƙasashe masu arziki, gami da tsarin kula da lafiya na duniya, shirin kula da yara na duniya, izinin iyaye da aka biya, da kuma ƙarin matakan tallafawa lafiyar jama'a.
Masu nazarin siyasa suna tsammanin hakan zai shafi damar da Donald Trump zai samu na sake zaɓe a zaɓen shugaban ƙasa na 2020. Dangantaka ta diflomasiyya tsakanin Japan da Koriya ta Kudu ta lalace saboda annobar.
Koriya ta Kudu ta soki  ƙoƙarin keɓewa da ba a bayyana ba  na Japan bayan da ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a keɓe shi na makonni biyu a wuraren da gwamnati ta sanya.
Tun farko dai jama'ar Koriya ta Kudu sun rabu biyu kan yadda za a magance rikicin da Shugaba Moon Jae-in ya yi.
Mutane da yawa a Koriya sun sanya hannu kan takardun neman a tuhumi Moon saboda rashin kulawar da gwamnati ta yi da annobar ko kuma su yaba da yadda ya amsa.
Wasu masu sharhi sun nuna damuwa cewa hakan zai sa gwamnatoci su ƙara iko.
A Hungary, majalisar dokokin kasar ta kada kuri'ar ba Firaminista Viktor Orbán damar mulki ta hanyar doka har sai an ba da umarni, dakatar da majalisar da kuma zabukan, da kuma hukunta duk wanda aka zargi da yada labaran karya game da cutar da kuma yadda gwamnati ta gudanar da rikicin.
An zargi annobar coronavirus da yawan katsewar samar da kayayyaki, sakamakon karuwar amfani da kayan aiki a duniya don magance annobar, sayayya cikin firgici da katsewar masana'antu da ayyukan samar da kayayyaki.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargaɗi game da ƙarancin magunguna da kayan aikin likita saboda ƙaruwar buƙatun masu amfani da kuma katsewar masu samarwa.
Ƙauyuka da dama sun fuskanci matsalar sayen kaya da ke sa kayayyakin rayuwa kamar abinci, takarda na bayan gida da kuma kwalaben ruwa su ɓace daga kan kantuna, kuma hakan ya haifar da ƙarancin kayayyaki.
Musamman masana'antar fasaha sun yi ta faɗakarwa game da jinkirin jigilar kayayyakin lantarki.
A cewar Darakta Janar na WHO Tedros Adhanom, bukatar kayan kariya na mutum ya karu sau 100.
Wannan buƙatar ta haifar da farashin da ya kai sau 20 na farashin al'ada kuma ya haifar da jinkiri a cikin samar da na'urorin kiwon lafiya na tsawon watanni hudu zuwa shida.
Hakan kuma ya haifar da karancin kayan kariya na mutum a duk duniya kuma WHO ta yi gargadin cewa hakan zai jefa ma'aikatan lafiya cikin hadari.
A Ostareliya, annobar ta ba da wata dama ga masu sayar da kayayyaki na Australiya a China.
Wannan aikin ya haifar da karancin madarar jarirai a wasu manyan kantuna kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan masu cutar COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma yawan bukatar abinci, waɗannan yankuna biyu ba su sami karancin abinci ba.
Matakan da China da Italiya suka dauka na hana adana kayayyaki da kuma cinikin kayayyaki na musamman sun yi nasara sosai, kuma hakan ya hana ƙarancin abinci da aka yi hasashen zai faru a Turai da kuma Amirka ta Arewa.
Saboda yawan amfanin gona da ake samarwa, arewacin Italiya bai yi raguwa ba, amma masana'antu sun ce farashin zai iya ƙaruwa.
An yi watsi da kantunan abinci na ɗan lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin China suka saki naman alade don tabbatar da wadataccen abinci ga jama'a.
Ana da irin waɗannan dokokin a ƙasar Italiya don a sa masu sayar da abinci su ajiye abinci don irin wannan gaggawa.
An ji mummunan tasiri a kan tattalin arzikin duniya a China: a cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin China ya sha wahala sosai a farkon watanni biyu na 2020 saboda matakan da gwamnati ta ɗauka don hana yaduwar cutar, kuma tallace-tallace na siyarwa ya ragu da kashi 20.5.
Tun da China babbar cibiyar tattalin arziki da masana'antu ce, an ga cewa annobar kwayar cutar ta zama babbar barazana ga tattalin arzikin duniya.
Agathe Demarais na Economist Intelligence Unit ta yi hasashen cewa kasuwanni za su ci gaba da zama marasa tsaro har sai an sami cikakken bayani game da yadda za a magance matsalar.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa tasirin tattalin arzikin annobar kan ci gaban duniya zai iya wuce na annobar SARS ta 2002-2004.
Wani ƙwararre a Jami'ar Washington da ke St. Louis ya kiyasta cewa hakan zai shafi kayayyakin da ake samarwa a duniya da ya kai dala biliyan 300 kuma zai iya wucewa shekara biyu.
An ce kungiyar kasashen da ke fitar da man fetur ta OPEC ta yi  rikici  bayan da farashin man ya fadi kasa sosai sakamakon raguwar bukatar da kasar Sin ke yi.
Kasuwannin hannayen jari na duniya sun fadi a ranar 24 ga Fabrairu sakamakon ƙaruwar yawan masu kamuwa da COVID-19 a wajen babban yankin China.
A ranar 27 ga watan Fabrairu, saboda ƙaruwar damuwa game da annobar cutar coronavirus, wasu alamun kasuwancin Amurka da suka haɗa da NASDAQ-100, S&amp;P 500 da Dow Jones Industrial Average sun nuna raguwar da suka fi gani tun daga 2008, tare da Dow Jones ya faɗi zuwa maki 1,191, raguwar mafi girma a rana ɗaya tun rikicin kuɗi na 2007-08.
Dukkanin alamun sun ƙare makon da raguwar sama da kashi 10.
A ranar 28 ga Fabrairu, Scope Ratings GmbH ta tabbatar da darajar bashin kasar Sin, amma ta ci gaba da nuna rashin amincewa.
Hannun jari sun sake faduwa saboda fargabar cutar korona, inda aka samu raguwa mafi girma a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai koma baya.
Masanin tattalin arziki Mohamed El-Erian ya yaba da matakan gaggawa da manyan bankuna da gwamnatoci suka dauka a kan lokaci.
Bankunan tsakiya sun yi saurin amsawa fiye da yadda suka yi a lokacin matsalar kudi ta 2008.
Yawon shakatawa yana ɗaya daga cikin ɓangarorin da aka fi shafa saboda ƙuntatawa na tafiya, rufe wuraren jama'a, musamman wuraren yawon buɗe ido, da shawarwarin gwamnatoci game da duk tafiya a duniya.
Sakamakon haka, kamfanonin jiragen sama da dama sun soke zirga-zirgar jiragen sama saboda raguwar bukatar, ciki har da British Airways, China Eastern Airlines da Qantas, yayin da kamfanin jirgin sama na yankin Flybe na Burtaniya ya yi fatarar kuɗi.
Sakamakon da aka samu a kan masana'antar jirgin ruwa ya kai matakin da ba a taɓa gani ba.
An kuma rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta barke ne a daidai lokacin da ake bikin Chunyun, babban lokacin yawon bude ido da ke da nasaba da sabuwar shekara ta kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke wasu abubuwan da suka shafi manyan mutane, gami da bikin Sabuwar Shekara na shekara-shekara, kuma kamfanoni masu zaman kansu sun rufe shagunan su da wuraren yawon buɗe ido, kamar Hong Kong Disneyland da Shanghai Disneyland.
An soke abubuwan da suka shafi sabuwar shekara ta wata da yawa kuma an rufe wuraren shakatawa da yawa don hana taron jama'a, gami da birnin da aka hana na Beijing da kuma bikin haikalin gargajiya.
A larduna 24, gundumomi da yankuna 31 na kasar Sin, hukumomi sun tsawaita hutun Sabuwar Shekara har zuwa 10 ga Fabrairu, suna umurtar yawancin wuraren aiki da kada su sake buɗewa kafin wannan ranar.
Waɗannan yankuna sun kai kashi 80 cikin ɗari na ƙimar ƙasa da ƙasa da kuma kashi 90 cikin ɗari na kayayyakin da ake fitarwa.
Hong Kong ta kai matakin da ya fi girma na magance cututtuka masu yaduwa kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa watan Maris kuma ta soke bukukuwan Sabuwar Shekara. An yi tasiri a kan masana'antar sayar da kayayyaki a duniya, tare da rage lokutan buɗe shaguna ko rufewa na ɗan lokaci.
Ziyarar da ake yi wa 'yan kasuwa a Turai da Latin Amirka ya ragu da kashi 40 cikin ɗari.
A Amirka ta Arewa da Gabas ta Tsakiya, yawan masu sayar da kayayyaki ya ragu da kashi 50 zuwa 60 cikin ɗari.
Hakan ya kuma haifar da raguwar zirga-zirgar ƙafafun a cikin manyan kantuna da kashi 33 zuwa 43 cikin ɗari a watan Maris idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin kasuwanci a duniya sun ɗora ƙarin matakan kamar ƙara yawan tsabtace, sanya na'urorin duba zafin jiki don kula da zafin jiki na abokan ciniki, da soke abubuwan da suka faru. Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka ta kiyasta cewa koma bayan tattalin arziki da annobar ta haifar na iya barin mutane miliyan 14 zuwa 22 a cikin matsanancin talauci a Latin Amurka idan aka kwatanta da yanayin da babu annobar.
A watan Janairu da Fabrairu na 2020, a lokacin da annobar ta kai kololuwa a Wuhan, mutane kusan miliyan 5 a China sun rasa ayyukansu.
A China, yawancin ma'aikatan karkara masu ƙaura miliyan 300 sun makale a gidajensu a lardunan ciki ko kuma a lardin Hubei. A watan Maris na shekarar 2020, sama da Amirkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar coronavirus za ta iya kashe ayyuka miliyan 47 a Amurka kuma yawan rashin aikin yi zai iya kaiwa kashi 32%, a cewar kimantawar Babban Bankin Tarayya na St. Louis. Kullewar Indiya ta bar dubban miliyoyin ma'aikatan Indiya masu ƙaura (suna karɓar albashi na yau da kullun) ba tare da aikin yi ba. Binciken Cibiyar Angus Reid ya gano cewa kashi 44 cikin ɗari na gidajen Kanada sun sami wani nau'in rashin aikin yi. Kusan ma'aikata 900,000 sun rasa ayyukansu a Spain tun lokacin da aka sanya kullewar a tsakiyar Maris 2020.
A cikin rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi tallafin rashin aikin yi na ɗan lokaci, kuma ma'aikata miliyan 1 na Birtaniya sun nemi tallafin bashi na duniya. Kusan kamfanoni miliyan rabin na Jamus sun sauya ma'aikatansu zuwa tsarin aikin ɗan lokaci da gwamnati ke tallafawa da ake kira Kurzarbeit.
Faransanci da Ingila sun bi tsarin biyan kuɗi na ɗan lokaci na Jamus.
Masana'antar wasan kwaikwayo da al'adun gargajiya sun sami mummunan tasiri ta hanyar cutar, wanda ya shafi yadda ƙungiyoyi da mutane ke aiki, ma'aikata da masu zaman kansu, a duniya.
Kungiyoyin al'adu da al'adu sun yi ƙoƙarin ci gaba da aikinsu (wanda galibi gwamnati ke tallafawa) don samar da damar al'adun al'adu ga al'umma, tabbatar da amincin ma'aikatansu da jama'a, da tallafawa masu fasaha a duk inda zai yiwu.
A watan Maris na 2020, a duk faɗin duniya da kuma a matakai daban-daban, an rufe gidajen tarihi, ɗakunan karatu, wuraren wasan kwaikwayo da sauran cibiyoyin al'adu har sai an ba da ƙarin sanarwa kuma an soke ko kuma an jinkirta baje kolin su, abubuwan da suka faru da kuma wasan kwaikwayon su.
A sakamakon haka, an yi ƙoƙari sosai don samar da madadin sabis ta hanyar dandamali na dijital. Wani sakamako na kwanan nan da ya hanzarta cutar shine soke ayyukan coci, manyan wasannin motsa jiki da sauran abubuwan zamantakewa, kamar bukukuwa da kide kide da wake-wake, taron fasaha da nunin kayan kwalliya.
Har ila yau, masana'antar fim ma ta samu matsala, kuma Vatican ta sanar da cewa an soke bukukuwan mako mai tsarki a Roma, wanda ake yi a makon ƙarshe na lokacin tuba na Kirista na azumin azumi.
Diocese da yawa sun shawarci tsofaffi Kiristoci su zauna a gida maimakon halartar ibadar ranar Lahadi; wasu majami'u suna watsa ayyukan addininsu ta rediyo, intanet da kai tsaye ko talabijin yayin da wasu ke ba da damar yin ibada a cikin  drive-in .
Kamar yadda Diocese na Roman Katolika a Roma ya rufe majami'unsu da ɗakunan sujada da kuma St. Peter's Square da ya rasa dukan Kiristoci mahajjata, wasu addinai ma sun soke ayyukansu kuma sun hana taron jama'a a majami'u, masallatai, majami'u, haikalin, da gurdwaras.
Ministan Lafiya na Iran ya sanar da soke sallar Juma'a a yankunan da annobar ta shafa kuma daga baya an rufe wuraren ibada, yayin da Saudiyya ta hana mahajjata na kasashen waje da mazauna cikinta shiga wuraren ibada na Makka da Madina.
Cutar ta haifar da babbar katsewar kalandar wasanni ta duniya tun bayan Yaƙin Duniya na Biyu.
An soke ko kuma an dage manyan wasannin wasanni, ciki har da gasar zakarun Turai ta 2019-20, gasar kwallon kafa ta Ingila ta 2019-20, gasar zakarun Turai ta UEFA ta 2020, kakar NBA ta 2019-20, da kakar NHL ta 2019-20.
Cutar ta katse shirya wasannin Olympics na bazara na 2020, wanda aka shirya fara a ƙarshen Yuli; Kwamitin Olympics na Duniya ya sanar a ranar 24 ga Maris cewa za a sake shirya taron bayan 2020, amma ba a baya ba a lokacin bazara na 2021. An rufe gidajen caca da sauran wuraren caca a duk duniya kuma an jinkirta ko kuma an soke wasannin karta kai tsaye.
Wannan ya sa 'yan wasa da yawa suka yi rajista a kan layi, kuma shafukan wasan kan layi da yawa sun ga ƙaruwar sabbin rajista.
Ƙari ga haka, manyan gidajen wasan kwaikwayo da yawa, kamar waɗanda ke Broadway, sun daina yin wasan kwaikwayon.
Wasu masu fasaha sun nemi hanyoyin ci gaba da ƙirƙirar da raba ayyukansu akan Intanet a madadin wasan kwaikwayo na rayuwa na gargajiya, kamar wasan kwaikwayo na kan layi da raye-raye ko  bukukuwa  na kan layi waɗanda aka ƙirƙira don masu fasaha su yi, watsawa da haɓaka ayyukansu.
A kan intanet, an samu mutane da yawa da ke yin magana game da cutar korona a kan intanet domin mutane da yawa suna son raha da kuma nishadantarwa maimakon rashin tabbas.
Tun barkewar COVID-19, an samu karuwar nuna bambanci, ƙin baƙi da wariyar launin fata ga mutanen da suka fito daga China da Gabashin Asiya, da kuma mutanen da suka fito daga yankuna masu saurin kamuwa da cutar a Turai, Amurka da wasu ƙasashe.
An samu wasu abubuwa da suka shafi tsoro, tuhuma da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, gabashin Asiya, Arewacin Amirka da kuma yankin Asiya Pacific.
Rahotanni tun daga watan Fabrairu (lokacin da yawancin masu kamuwa da cutar ke cikin China) sun nuna bambancin launin fata a tsakanin ƙungiyoyi daban-daban a duniya cewa Sinawa sun cancanci kamuwa da cutar ko kuma an hukunta su daidai.
Wasu ƙasashen Afirka ma sun ga ƙaruwar ƙiyayya da China.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton nuna bambanci bisa asalin yankin.
An ba da tallafi ga Sinawa, ta hanyar intanet da wajen layi, da kuma mutanen da ke yankunan da cutar ta shafa.
Yayin da annobar ta ci gaba zuwa wasu ƙasashe masu saurin yaduwa, Italiya, ƙasa ta farko a Turai da ta fara fuskantar mummunar annobar COVID-19, na iya fuskantar shakku da ƙiyayya da baƙi. 'Yan ƙasa daga ƙasashe kamar Malaysia, New Zealand, Singapore da Koriya ta Kudu sun fara sanya hannu kan takardun neman hana Sinawa shiga ƙasarsu don dakatar da cutar.
A Japan, hashtag #ChineseDontComeToJapan ya zama ruwan dare a shafin Twitter.
Sinawa da sauran mutanen Asiya da ke zaune a Burtaniya da Amurka sun ba da rahoton karuwar cin mutuncin wariyar launin fata da kuma hare-hare.
Shugaban Amurka Donald Trump ya fuskanci suka saboda ya kira coronavirus  kwayar cutar Sin , kalmar da masu sukar sa ke ganin wariyar launin fata ne da kuma ƙin China.
A Ukraine, masu zanga-zanga sun kai hari kan bas da ke dauke da 'yan Ukraine da kuma 'yan gudun hijira daga kasashen waje tsakanin Wuhan da Novi Sanzhary.
An bayar da rahoton cewa an yi wa ɗalibai daga arewa maso gabashin Indiya, wanda ke da iyaka da China, da ke karatu a manyan biranen Indiya cin zarafi dangane da annobar coronavirus.
Shugaban jam'iyyar Bharatiya Janata a jihar Bengal, Dilip Ghosh ya ce, 'Suna lalata muhalli, don haka Allah ya rama musu.'
Daga baya ofishin jakadancin China da ke Kolkata ya yi tir da maganganun, yana mai cewa  ƙarya . A China, cutar ta ƙara ƙiyayya da wariyar launin fata da ke nuna wa mutanen da ba Sinawa ba, inda aka kwatanta baƙi a matsayin  ɓarnar ƙasashen waje  da ya kamata  a kawar .
Jaridu da yawa da ke biyan kuɗi sun cire su daga dukan ko wasu labaran da suka yi game da cutar korona.
Masu wallafa littattafai da yawa sun ba da littattafansu na kimiyya da suka shafi annobar a matsayin littattafan da za su iya karantawa.
Wasu masana kimiyya sun zaɓi su raba sakamakon da suka samu da sauri a kan sabobin da aka riga aka buga kamar bioRxiv.
Cutar cututtuka mai tasowa  Cutar cututtuka daga wata cuta mai tasowa, sau da yawa sabon abu a cikin yanayin annoba ko hanyar watsawa
Duniya da Cutar  Bayani Game da Duniya da Cutar Cutar
Jerin cututtuka da annoba  Jerin yawan mutanen da cututtuka masu saurin yaduwa suka kashe
 Cinikin dabbobi da cututtukan dabbobi  Hadarin lafiya da ke tattare da cinikin dabbobi na waje
Binciken dakin gwaje-gwaje na cutar numfashi ta coronavirus 2019 (COVID-19) da kuma cutar SARS-CoV-2 da ke tattare da ita ya haɗa da hanyoyin gano kwayar cutar da gano ƙwayoyin cuta da aka samar don amsa kamuwa da cuta.
Ana tabbatar da cutar a cikin samfuran ta hanyar RT-PCR, wanda ke gano RNA na coronavirus.
Wannan gwajin an tsara shi musamman don gano RNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cututtuka na kwanan nan ko masu aiki.
Ana iya amfani da gano ƙwayoyin cuta (serology) don tantancewa da kuma lura da yawan jama'a.
Gwajin rigakafi yana nuna yawan mutanen da suka kamu da cutar, har da waɗanda alamun cutar ba su da tsanani sosai da za a iya bayyana su ko kuma waɗanda ba su da alamun cutar.
Ana iya sanin ainihin yawan mutuwar cutar da kuma yawan rigakafin garken a cikin jama'a daga sakamakon wannan gwajin.
Saboda ƙarancin gwaji, babu wata ƙasa da ke da tabbataccen bayani game da yaduwar cutar a cikin jama'arta a watan Maris na 2020.
A ranar 23 ga watan Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin ɗari na yawanta, kuma akwai bambance-bambance masu yawa a yawan gwaje-gwajen da aka yi a kowace ƙasa.
Wannan bambancin yana iya shafar yawan mutuwar da aka ruwaito, wanda zai iya zama mafi girma a wasu ƙasashe.
Ta amfani da rubutun baya sannan kuma a yi amfani da tsarin sarrafawa na lokaci-lokaci (rRT-PCR), ana iya yin gwajin akan samfurori na numfashi da aka samu ta hanyoyi daban-daban, ciki har da hanci da hanci ko samfurin ƙura.
Ana samun sakamako a cikin sa'o'i da yawa zuwa kwanaki biyu.
Gwajin RT-PCR da aka yi daga ruwan hanci yana da inganci a cikin makon farko na cutar.
Bayan haka, kwayar cutar za ta iya fita daga makogwaro yayin da take ci gaba da yawaita a cikin huhu.
A cikin mutane masu kamuwa da cutar da aka gwada a mako na biyu, ana iya ɗaukar samfurin daga zurfin numfashi ta hanyar catheter na tsotsa, ko kuma ana iya amfani da tofa (tsotsa).
Wani gwajin PCR na farko ya samo asali ne daga Charité a Berlin a watan Janairun 2020 ta hanyar amfani da rubutun baya da kuma sa'an nan kuma a cikin ainihin lokacin polymerization chain reaction (rRT-PCR), kuma ya zama tushen kayan aiki 250,000 da Hukumar Lafiya ta Duniya (WHO) ta rarraba.
Ƙasar Ingila ta kuma samar da gwaji a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya samar da kayan aikin gano SARS-CoV-2 na asibiti bisa PCR (PowerChek Coronavirus) a ranar 28 ga Janairu, 2020.
Yana gano kwayar halitta  E  da dukkanin kwayoyin cutar beta-coronavirus ke da ita, da kuma kwayar halitta ta RdRp da ke da alaƙa da SARS-CoV-2.A China, BGI Group na ɗaya daga cikin kamfanoni na farko da aka ba da izinin gaggawa daga Hukumar Kula da Kayayyakin Kiwon Lafiya ta ƙasar Sin don kayan bincike na SARS-CoV-2 bisa PCR.A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) suna rarraba na'urar gano sabon coronavirus 2019 (2019-nCoV) na RT-PCR na ainihi ga dakunan gwaje-gwaje na kiwon lafiya ta hanyar ReinterInternational Resource.
A cikin tsofaffin kayan gwajin, ɗaya cikin uku na gwajin kwayoyin halitta ya ba da sakamako mara kyau saboda rashin ingantattun abubuwa, da kuma matsalar gwaji a CDC na Atlanta. Sakamakon haka, a matsakaita, ƙasa da samfura 100 a kowace rana aka yi nasara a cikin watan Fabrairu 2020.
Ba a amince da gwaje-gwaje masu amfani da abubuwa biyu ba har zuwa 28 ga Fabrairu, 2020, kuma sai lokacin ne aka ba da izinin dakunan gwaje-gwaje na tarayya da na gida don fara gwaji.
Hukumar Kula da Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin amfani da gaggawa. Dakunan gwaje-gwaje na kasuwanci a Amurka sun fara gwajin a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa akwai gwajin COVID-19 na RT-PCR a duk ƙasar.
Quest Diagnostics ta kuma rarraba gwajin COVID-19 a duk ƙasar a ranar 9 ga Maris, 2020.
Babu iyakancewar adadi da aka sanar. Dole ne a tattara da sarrafa samfuran daidai da bukatun CDC.
A Rasha, Cibiyar Nazarin Kwayoyin Cutar da Fasaha ta VECTOR ta Ƙasa ce ta haɓaka da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an sanar da cewa Mayo Clinic ta haɓaka gwajin gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami izinin FDA don gwajin da za a iya yin shi a cikin adadi mai yawa a cikin awanni 3.5, yana ba da damar na'urar yin gwaje-gwaje kusan 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa (USA) ga Abbott Laboratories don gwaji akan tsarin m2000 na Abbott. FDA ta ba da irin wannan izinin ga Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma sami EUA daga FDA don gwajin da ya ɗauki kimanin minti 45.
Hukumar FDA ta amince da gwajin da ke amfani da fasahar isothermal amplification na nucleic acid maimakon PCR.
Tun da yake ba ya bukatar jerin zafin jiki na zagaye, wannan hanya na iya ba da sakamako mai kyau a cikin minti biyar kawai da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin 18,000 na waɗannan na'urori a Amurka, kuma Abbott na shirin haɓaka samarwa don samar da gwaje-gwaje 50,000 a kowace rana. Ana haɓaka gwaji ta amfani da ƙwayoyin cuta na monoclonal wanda ke ɗaure takamaiman ga furotin nucleocapsid (furotin N) na sabon coronavirus a Taiwan, tare da fatan zai iya samar da sakamako a cikin mintuna 15 zuwa 20, kamar gwajin saurin mura.
Wani bincike na wallafe-wallafen a watan Maris na 2020 ya kammala cewa  hotunan numfashi ba su da ƙimar ganewar asali a farkon matakan, yayin da sakamakon CT zai iya zama tabbatacce tun kafin bayyanar cututtuka .
Alamun da ake gani a DDM sun haɗa da ɓoyayyen gilashin gilashi mai yawa tare da rarrabawa ta gefe, asymmetrical da baya.
Ƙarƙashin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
Wani bincike da ya kwatanta PCR da DMT a Wuhan, inda cutar ta fara, ya nuna cewa DMT ta fi PCR hankali sosai, ko da yake ba ta da daidaito, saboda yawancin sakamakon hotonta sun yi daidai da sauran cututtukan huhu da cututtuka.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa  ba za a yi amfani da TDM don gwaji ko a matsayin gwajin farko don gano COVID-19 ba. A watan Maris na 2020, CDC ta ba da shawarar PCR don gwajin farko.
Samar da ƙwayoyin cuta, ciki har da IgM da IgG, yana cikin ɓangaren maganin rigakafi ga kamuwa da cuta.
Ana iya amfani da waɗannan don gano kamuwa da cuta a cikin mutane daga kimanin kwanaki 7 bayan bayyanar cututtuka, don ƙayyade rigakafi da kuma sa ido kan yawan jama'a. Ana iya yin gwaje-gwaje a cikin manyan dakunan gwaje-gwaje (TLC) ko ta hanyar gwajin wurin kula da marasa lafiya (PoCT).
Tsarin sarrafa kansa mai saurin aiki a dakunan gwaje-gwaje da yawa na iya yin waɗannan gwaje-gwajen, amma kasancewarsu zai dogara da yawan samar da kowane tsarin.
Don CTLD, ana amfani da samfurin jini guda ɗaya, ko da yake ana iya amfani da samfuran samfuri don bin diddigin amsawar rigakafi.
Don PoCT, ana ɗaukan jini guda ɗaya ta hanyar bugun fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar wani mataki na cirewa kafin bincike. A ranar 26 ga Maris, 2020, FDA ta sanya sunayen ƙungiyoyi 29 waɗanda suka sanar da hukumar yadda ya kamata kuma saboda haka yanzu za su iya rarraba gwajin rigakafin su.
A ranar 7 ga Afrilu, 2020, FDA ta amince da gwaji guda ɗaya ne kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don kayan gwajin su, waɗanda ke iya gano ƙwayoyin IgG da IgA da ke hana kwayar cutar a cikin samfuran jini.
Ana iya gwada ɗaruruwan samfurori a cikin sa'o'i kaɗan, wanda ya fi saurin gwajin PCR na RNA na kwayar cuta.
Ana iya gano ƙwayoyin cuta bayan kwanaki 14 bayan kamuwa da cutar. A farkon watan Afrilu, Burtaniya ta gano cewa babu wani kayan gwajin ƙwayoyin cuta da ta saya da ya isa amfani da su.
Hong Kong ta kafa wani shiri inda masu kamuwa da cutar za su iya zama a gidajensu,  sashen gaggawa zai samar wa marasa lafiya da bututun samfurin , marasa lafiya za su tofa a ciki, su mayar da shi, kuma daga baya su sami sakamakon gwajin. Hukumar NHS ta Burtaniya ta sanar da cewa tana gudanar da aikin gwaji don gwada masu kamuwa da cutar a gida, wanda ke kawar da haɗarin mai haƙuri ya kamu da wasu ta hanyar zuwa asibiti ko buƙatar kashe ambulanci idan ana amfani da shi.A cikin gwajin COVID-19 na tuki don masu kamuwa da cutar, ƙwararren likita yana ɗaukar samfurin ta hanyar kiyayewa.
Cibiyoyin  drive  sun ba Koriya ta Kudu damar yin ɗaya daga cikin gwaje-gwaje mafi sauri da cikakke a duniya. A Jamus, Ƙungiyar Likitocin Inshorar Lafiya ta Kasa ta ce a ranar 2 ga Maris tana da damar yin gwaje-gwaje kusan 12,000 a kowace rana a asibiti, kuma an gwada marasa lafiya 10,700 a makon da ya gabata.
In da likita ya rubuta wannan gwajin, inshorar lafiya ce ke biyan kuɗin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da ƙarfin gwaji 160,000 a mako.
A ranar 19 ga Maris, ana iya yin gwajin tuki a manyan birane da yawa.
Har zuwa 26 ga Maris, 2020, ba a san yawan gwaje-gwajen da aka yi a Jamus ba, saboda sakamakon da aka samu ne kawai ake bayar da rahoto.
Binciken farko na dakin gwaje-gwaje ya nuna cewa a cikin makon 12/2020, an gwada aƙalla samfura 483,295 har zuwa makon 12/2020 da ya haɗa da samfura 33,491 (kashi 6.9 cikin ɗari) da suka nuna cutar SARS-CoV-2. A Isra'ila, masu bincike a Technion da asibitin Rambam sun haɓaka da gwada hanyar nazarin samfurori daga marasa lafiya 64 a lokaci guda, haɗa samfurori kuma kawai suna gwada idan samfurin haɗin ya nuna cutar. A Wuhan, an buɗe dakin gwaje-gwaje na gaggawa mai girman murabba'in mita 2,000 da ake kira om Huo-Yan  (Faransa: 火眼, 眼火) a watan Fabrairu 2020 kuma zai iya sarrafa samfurori 5,000 a kowace rana.
An gina shi cikin kwanaki 5 a ƙarƙashin kulawar Wang Jian, wanda ya kafa BGI, samfurin ya nuna cewa masu kamuwa da cutar a lardin Hubei za su kasance da kashi 47% kuma farashin keɓewa zai ninka sau biyu ba tare da wannan ƙarfin gwaji ba.
Ba da daɗewa ba, dakunan gwaje-gwaje na Huo-Yan a Shenzhen, Tianjin, Beijing da Shanghai, a birane 12 na ƙasar Sin suka bi bayan dakin gwaje-gwajen Wuhan.
A ranar 4 ga Maris, 2020, jimlar ƙarfin gwajin yau da kullun ya kai 50,000 a kowace rana.An buga samfuran kyauta da aka haɓaka ta Origami Assays don gwada samfurori har zuwa 1,122 na marasa lafiya don COVID-19 ta amfani da gwaje-gwaje 93 kawai. Ana iya gudanar da waɗannan samfuran daidaitawa a cikin ƙananan dakunan gwaje-gwaje ba tare da na'urar sarrafa ruwa ba.
A watan Maris, karancin maganin da kuma karancin maganin ya zama wata matsala ga gwajin mutane a EU, Birtaniya da Amurka.
Wannan ya sa wasu marubuta suka yi la'akari da tsarin shirya samfurin wanda ya ƙunshi dumama samfurin zuwa 98 °C (208 °F) na minti 5 don sakin kwayoyin RNA don ci gaba da gwaji. A ranar 31 ga Maris, an sanar da cewa UAE yanzu ita ce ƙasa da ke gwada yawancin yawanta na Coronavirus, kuma suna kan hanyar haɓaka gwaji don isa ga yawancin jama'a.
An samu wannan sakamakon ne ta hanyar haɗa ikon gwajin tuki da sayen dakin gwaje-gwaje mai saurin gudu daga Group 42 da BGI (wanda aka kafa a kan dakin gwaje-gwajen gaggawa na Huo-Yan  a China).
An gina dakin gwaje-gwaje a cikin kwanaki 14, yana iya yin dubun dubatan gwaje-gwaje na RT-PCR a kowace rana kuma shine dakin gwaje-gwaje na farko da ke da wannan damar da ke aiki a wajen China.
An samar da wasu hanyoyin gwaji da ke nuna sassan kwayoyin cutar korona a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta yi amfani da tsarin Jamus don yin kayan aiki da za a aika zuwa ƙasashe masu ƙarancin kuɗi da ba su da isashen kuɗi don yin nasu kayan aiki.
An fitar da samfurin Jamus a ranar 17 ga Janairu, 2020. Cibiyar Kula da Cututtuka ta Amurka ta samar da tsarin gwajin ne kawai a ranar 28 ga Janairu, wanda ya jinkirta samar da gwaje-gwaje a Amurka. Kasashen China da Amurka sun fuskanci matsalolin amincin kayan gwajin a farkon barkewar cutar, kuma waɗannan ƙasashe, da Australia, ba su iya samar da isassun kayan aikin ba don biyan buƙatu da shawarwarin gwajin masana kiwon lafiya.
A gefe guda, masana sun ce yawan gwajin da ake samu a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon coronavirus.
Gwamnatin Koriya ta Kudu ta inganta ƙarfin gwaji, galibi a dakunan gwaje-gwaje na kamfanoni masu zaman kansu, a cikin shekaru da yawa.
A ranar 16 ga watan Maris, Hukumar Lafiya ta Duniya ta ba da shawarar ƙara yawan shirye-shiryen gwaji a matsayin hanya mafi kyau don rage saurin yaduwar cutar COVID-19. Yawan buƙatun gwaji saboda yaduwar cutar ya sa dubban daruruwan gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu a Amurka suka jinkirta, kuma an ƙare tanadin swabs da magungunan da ke sarrafa su.
A watan Maris na shekarar 2020, China ta ba da rahoton matsalolin da suka shafi amincin kayan gwajinta.
A Amurka, kayan gwajin da CDC ta samar suna da  nakasa . Gwamnati ta kawar da shingen hukuma da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Co Ltd na China, amma ta gano cewa sakamakon ba abin dogaro bane.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba zai iya kasancewa saboda rashin iya karɓar samfurori ko amfani da kayan aiki yadda ya kamata.
Ma'aikatar Spain ta ce za ta janye kayan gwajin da suka ba da sakamakon da ba daidai ba, kuma za ta maye gurbinsu da wani kayan gwajin da Shenzhen Bioeasy ta samar. Kashi 80% na kayan gwajin da Jamhuriyar Czech ta saya daga China sun ba da sakamakon ƙarya. Slovakia ta sayi kayan gwaji miliyan 1.2 daga China waɗanda suka nuna rashin aiki.
Firaminista Matovič ya ba da shawarar a jefar da su cikin Kogin Danube. Ateş Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta saya daga China suna da babban kuskuren kuskure kuma ba ta yi amfani da su ba. Birtaniya ta sayi kayan gwaji miliyan 3.5 daga China amma ta sanar a farkon Afrilu 2020 cewa ba za a iya amfani da su ba.
Gwajin, sannan keɓe waɗanda suka sami sakamako mai kyau da kuma gano mutanen da suka taɓa saduwa da masu ɗauke da SARS-CoV-2, sun ba da sakamako mai kyau.
Masu bincike da ke aiki a garin Vò na Italiya, inda mutum na farko ya mutu sakamakon cutar COVID-19 a Italiya, sun yi gwaje-gwaje biyu a kan dukan mutane kusan 3,400, a tsakanin kwanaki goma.
Kusan rabin mutanen da suka kamu da cutar ba su da alamun cutar, kuma an killace duk waɗanda aka gano.
Tare da ƙuntata zirga-zirga a cikin garin, wannan matakin ya kawar da sabbin kamuwa da cuta gaba ɗaya.
Ta hanyar bin diddigin lamba, ƙuntatawa kan balaguron shiga, gwaji da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta ci gaba da sauri fiye da sauran ƙasashe masu tasowa, amma ba tare da ƙuntatawa mai tsanani kamar tilasta rufe gidajen abinci da wuraren sayar da kayayyaki ba.
An soke abubuwa da yawa, kuma Singapore ta fara ba da shawara ga mazauna su zauna a gida daga 28 ga Maris, amma an sake buɗe makarantu a ranar da aka tsara don ƙarshen hutu a ranar 23 ga Maris.
Ƙasashe da dama sun kuma magance annobar ta hanyar bin sawun waɗanda suka kamu da cutar, ƙuntatawa kan balaguron shiga, gwaji da keɓewa, amma tare da ƙuntatawa da ba su da ƙarfi, kamar Iceland da Koriya ta Kudu.
Wani bincike ya gano cewa ƙasashen da suka yi gwaji sosai, dangane da yawan mutanen da suka mutu, suna da ƙananan adadin waɗanda suka mutu, wataƙila saboda waɗannan ƙasashe sun fi iya gano mutanen da ba su da alamun cutar ko kuma ba su da alamun cutar.
WHO ta ba da shawarar cewa ƙasashe da ba su da ƙarfin bincike kuma waɗanda dakunan gwaje-gwaje na ƙasa ba su da ƙwarewar COVID-19 sosai su aika da samfuran COVID-19 biyar na farko da samfuran COVID-19 goma na farko don ɗaya daga cikin dakunan gwaje-gwaje 16 na WHO don tabbatarwa.
Daga cikin dakunan gwaje-gwaje 16, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostareliya.
A cikin teburin da ke ƙasa, shafi  % na gwajin da ya nuna tabbatacce  ya dogara da manufofin gwajin ƙasa.
Ƙasar da ke gwada waɗanda ke asibiti kaɗai za ta sami kashi mafi girma na gwajin da aka yi da cutar fiye da ƙasa da ke gwada dukan 'yan ƙasa, ko suna da alamun cutar ko a'a, sauran abubuwa iri ɗaya ne.
Wanke hannu, wanda kuma ake kira tsabtace hannu, yana nufin wanke hannuwan don cire datti, mai, ƙwayoyin cuta ko wasu abubuwa marasa kyau.
Wanke hannu da sabulu a wasu "mahimman lokuta" na rana yana hana yaduwar cututtuka da yawa, kamar zawo da kwalara, waɗanda ke yaduwa ta hanyar baki da ƙura.
Za ka iya kamuwa da cututtukan numfashi kamar mura ko sanyi idan ba ka wanke hannu kafin ka taɓa idanunka, hanci ko bakinka (wato, mucous membranes).
Yana da muhimmanci a wanke hannuwanka da sabulu a muhimman lokatai biyar na rana: kafin da kuma bayan ka yi fitsari, bayan ka share wa jariri bayan ya yi barci ko kuma ka canja masa diaper, kafin ka ciyar da yaro, kafin ka ci abinci, kafin ka shirya abinci ko kuma bayan ka yi amfani da nama, kifi ko kaza.
Idan ba ku da sabulu da ruwa a hannu, za ku iya wanke hannuwanku da toka.
kafin, a lokacin da kuma bayan an shirya abinci;
kafin da kuma bayan kula da mara lafiya;
bayan ka canja kwalliyar jariri ko kuma ka wanke yaro bayan ya je bayan gida
bayan ya yi tari ko tari/hancinsa;
bayan ka taɓa dabba, abincin dabba ko ɓarnar dabba;
Tsabtace hannu a cikin aikin likita yana nufin ayyukan kiwon lafiya da ke da alaƙa da hanyoyin likita.
Wanke hannu kafin a ba da magani ko kuma a kula da likita zai iya hana ko rage yaduwar cututtuka.
Babban manufar wanke hannu a fannin kiwon lafiya shine kawar da kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta da ke iya haifar da cuta) da sunadarai, waɗanda za su iya zama masu cutarwa ko haifar da cuta.
Wannan yana da muhimmanci musamman ga waɗanda suke kula da abinci ko kuma waɗanda suke aikin likita da kuma jama'a.
Wanke hannu yana da fa'idodi masu yawa ga lafiyar jiki, ciki har da rage yaduwar mura, coronavirus da sauran cututtuka masu yaduwa; hana cututtukan da ke haifar da zawo; rage kamuwa da cututtukan numfashi;
Ƙari ga haka, za a rage yawan mutuwar yara a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa inganta tsabtace hannu zai iya sa yara 'yan kasa da shekara biyar su yi girma da kyau.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara da ke tattare da cututtukan numfashi da gudawa ta wajen yin wasu canje-canje a yadda suke rayuwa, kamar wanke hannu da sabulu.
Wannan hanya mai sauƙi za ta iya rage mutuwar da ke tattare da waɗannan cututtuka da kusan kashi hamsin cikin ɗari.
Ƙaddamar da ayyuka na wanke hannu zai iya rage yawan masu zazzaɓin jini da kashi ɗaya bisa uku, wanda ya yi daidai da wanda ake samu ta samar da ruwan sha mai tsabta a yankunan da ba su da kuɗi.
Wanke hannu da sabulu yana rage yawan zazzabin ciki da kashi 48 cikin ɗari kuma hanya ce mafi inganci da tsada don hana zazzabin ciki da cututtukan numfashi (ARI). Dole ne a yi hakan ta atomatik a gidaje, makarantu da al'ummomi a duniya.
Ciwon huhu, wanda shi ne babban dalilin mutuwar yara, shi ne sanadin mutuwar yara 'yan ƙasa da shekara biyar, kuma yana kashe kusan mutane miliyan 1.8 a kowace shekara.
Cutar gudawa da ciwon huhu suna kashe yara kusan miliyan 3.5 kowace shekara.
A cewar UNICEF, yin amfani da sabulu wajen wanke hannu kafin cin abinci da kuma bayan bayan gida zai iya ceton rayuka fiye da allurar riga-kafi ko kuma maganin da ake yi, kuma zai rage mutuwar masu zazzaɓin jini da kusan rabin kuma ya rage mutuwar masu kamuwa da cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana yawanci haɗa wanke hannu da sauran matakan kiwon lafiya a cikin shirin ruwa, tsaftacewa da tsaftacewa (WASH).
Wanke hannu yana kuma kāre mutum daga cutar impetigo, wadda ake yaduwa ta hanyar taɓa jiki kai tsaye.
Idan aka yi wanka da hannu sau da yawa, zai iya ɓata fata kuma ya sa ta bushe.
Wani bincike da aka yi a Denmark a shekara ta 2012 ya nuna cewa yawan wanke hannu zai iya haifar da cutar eczema ko cututtukan fata a hannu, wanda ke nuna fatar jiki da ƙaiƙayi, musamman ma a tsakanin ma'aikatan kiwon lafiya.
Ana kuma ganin wanke hannu sau da yawa yana ɗaya daga cikin alamun cuta ta obsessive-compulsive disorder (OCD).
Wanke hannu da sabulu a muhimman lokatai biyar na rana don rage yaduwar cututtuka ta hanyar bakin: kafin da bayan amfani da bayan gida (yin fitsari, zubar da ciki), bayan wanke bayan jariri (ko canza diapers), kafin ciyar da yaro, kafin cin abinci da kuma kafin da bayan shirya abinci ko sarrafa nama, kifi ko kaji.
Hakanan wanke hannu da kyau yana da kyau don hana yaduwar cututtuka, musamman kafin da bayan kula da rauni ko rauni, bayan yin fitsari, tari ko tari, bayan taɓa ɓarnar dabbobi ko sarrafa dabbobi da kuma bayan taɓa shara.
A ƙasashe da yawa, mutane ba sa wanke hannayensu da sabulu sosai.
A cewar wani bincike da aka yi a shekara ta 2015 a kan tsabtace hannu a ƙasashe 54, kashi 38.7 cikin ɗari na iyalai sun wanke hannayensu da sabulu. Wani bincike da aka yi a shekara ta 2014 ya nuna cewa Saudi Arabiya ce ke da mafi yawan kashi 97 cikin ɗari, Amurka tana tsakiyar matsayi (77 cikin ɗari), kuma China tana da mafi ƙarancin kashi 23 cikin ɗari. Akwai hanyoyi da yawa a yau da za su kawo canji a dabi'u da kuma inganta amfani da sabulu don wanke hannu a muhimman lokutan rana. A cikin ƙasashe masu tasowa, ana iya ba da shawarar ɗalibai su wanke hannayensu a wasu lokuta na rana don yara su zama masu yin hakan.
Alal misali, Ma'aikatar Ilimi ta ƙasar Filifin ta kafa  Shirin Kula da Kiwon Lafiya na Farko  don inganta lafiyar yara da iliminsu.
Ana amfani da maganin kashe ƙwayoyin cuta sau biyu a shekara, tare da wanke hannu da sabulu da kuma goge haƙori da man goge baki da fluoride a kowace rana.
An kuma yi amfani da shi da kyau a ƙasar Indonesia.
Don kawar da ƙwayoyin cuta da ke jikin fata, kana iya ƙara sabulu ko kuma kayan wanki a cikin ruwa.
Babban aikin sabulu da kayan wanki shine rage shingen bayani da kuma kara narkewa.
Ruwa kaɗai ba shi da amfani wajen wanke fata domin mai ƙanshi da furotin da ke cikin ƙasa ba sa narkewa cikin ruwa.
Amma idan akwai ruwa mai kyau, zai yi sauƙi a tsabtace wurin.
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, na iya ƙunsar ƙwayoyin cuta daga amfani da baya.
Wasu ƙananan bincike da aka yi game da canja kwayoyin cuta daga sabulu mai ƙazanta sun kammala cewa ba za a iya canja su ba domin ana wanke kwayoyin cuta da kumfa.
Cibiyar Kula da Cututtuka da Rigakafin Cutar (CDC) ta ce  na'urorin sayar da sabulu masu ruwa sun fi kyau .
An ba da shawarar sosai a yi amfani da sabulu da ke kashe ƙwayoyin cuta ga waɗanda suke damuwa da lafiyarsu.
Har zuwa yau, babu wata shaida da ta nuna cewa amfani da maganin kashe ƙwayoyin cuta ko kuma maganin kashe ƙwayoyin cuta da aka ba da shawarar zai iya kai wa ga ƙwayoyin cuta masu jurewa a cikin yanayi.
Amma, sabulu na kashe ƙwayoyin cuta yana ɗauke da wasu ƙwayoyin cuta kamar su triclosan, wanda ƙwayoyin cuta da yawa ba sa sha.
Saboda haka, ko da yake maganin rigakafi ba ya haifar da sabulu na antibacterial, sabulu na antibacterial bazai iya zama tasiri kamar yadda aka sanar ba.
Baya ga maganin shafawa da kare fata, magungunan da suka fi rikitarwa na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) da ke daidaita pH, benzoic acid, wanda ke da aikin rigakafin ƙwayoyin cuta, da sauran magungunan kariya (aloe vera, bitamin, menthol, tsire-tsire masu tsire-tsire).Binciken da aka yi a Jami'ar Oregon School of Public Health ya nuna cewa sabulu na yau da kullun suna da tasiri kamar sabulu na gida wanda ke dauke da triclosan don hana cututtuka da kawar da ƙwayoyin cuta daga hannaye.
Ruwa mai zafi da ake amfani da shi wajen wanke hannu bai isa ya kashe ƙwayoyin cuta ba.
Kwayoyin ƙwayoyin cuta suna ƙaruwa da sauri idan jiki yana da zafin jiki mai ɗumi.
Amma, ruwan sabulu mai ɗumi ya fi ruwan sanyi da sabulu kyau wajen kawar da mai da ke ɗauke da ƙazanta da ƙwayoyin cuta.
Amma sabanin abin da mutane da yawa suke tsammani, binciken kimiyya ya nuna cewa shan ruwan dumi ba ya rage ƙwayoyin cuta a hannayenmu.
Maganin kashe ƙwayoyin cuta na hannu ko maganin kashe ƙwayoyin cuta na hannu ne da ba ya ɗauke da ruwa.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, kayan tsabtace hannu na ruwa ba tare da barasa ba (wanda ake kira maganin ruwa, maganin saɓo na hannu ko maganin kashe ƙwayoyin cuta) ya fara zama sananne.
Yawancin suna da isopropyl alcohol ko ethanol da aka haɗa da wani mai kauri kamar carbomer (polymer na acrylic acid) don samun gel, ko kuma mai laushi kamar glycerin don samun ruwa ko kumfa don sauƙin amfani da rage tasirin bushewar barasa.
Ƙara hydrogen peroxide mai narkewa yana ƙara ƙarfin ƙwayoyin cuta. Magungunan kashe ƙwayoyin cuta na hannu waɗanda ke da kashi 60 zuwa 95% na barasa suna kashe ƙwayoyin cuta sosai.
Maganin ruwa yana kashe ƙwayoyin cuta, ƙwayoyin cuta masu jurewa (SARM da ERV), tarin fuka da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura da hepatitis), da kuma naman gwari.
Maganin ruwa mai shan giya wanda ya ƙunshi kashi 70 cikin ɗari na barasa yana kawar da kashi 99.97 cikin ɗari (ragewa da kashi 3.5, log daidai da rage decibel 35) na ƙwayoyin cuta a hannu 30 seconds bayan amfani da shi da kuma kashi 99.99 cikin ɗari zuwa kashi 99.999 cikin ɗari (ragewa da kashi 4 zuwa 5 log) na ƙwayoyin cuta a hannu minti 1 bayan amfani. Masu tsabtace hannu sun fi tasiri akan ƙwayoyin cuta kuma ba su da tasiri akan wasu ƙwayoyin cuta.
Maganin ruwa mai shan giya kusan ba shi da tasiri a kan ƙwayoyin cuta irin su norovirus (ko Norwalk), babban dalilin cututtukan gastroenteritis. Ya kamata a yi amfani da isasshen maganin kashe ƙwayoyin cuta na hannu ko maganin ruwa mai shan giya don a yi rigar hannu biyu ko kuma a rufe su.
A haɗa dabino da baya na hannaye biyu da kuma tsakanin yatsun hannu da ƙusa na kimanin dakika 30 har sai ruwan, kumfa ko kuma gel ya bushe.
Hakanan ya kamata a wanke yatsun hannu ta hanyar shafa su da hannu. Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka ta ba da shawarar wanke hannu maimakon amfani da maganin ruwa, musamman idan hannaye sun kasance da datti.
Ƙara amfani da waɗannan kayayyakin saboda sauƙin amfani da kuma saurin kawar da ƙwayoyin cuta; duk da haka, bai kamata su maye gurbin wanke hannu da kyau ba sai dai idan ba ku da sabulu da ruwa a hannu.
Yin amfani da ruwan sha sau da yawa zai iya sa fata ta bushe idan ba a ƙarfafa ruwan ba da kayan shafawa da kuma/ko na'urar da ke sa fata ta yi laushi.
Za a iya rage ko kawar da ƙwayar barasa ta hanyar ƙara glycerin da/ko wasu abubuwa masu saurin wankewa a cikin samfurin.
A cikin gwaji na asibiti, maganin ruwa mai shan giya wanda ke ɗauke da kayan shafawa ya haifar da ƙarancin ƙonewa da bushewar fata fiye da sabulu ko kayan wanke cututtukan ƙwayoyin cuta.
Allergic contact dermatitis, contact urticaria ko rashin jin daɗin barasa ko ƙari a cikin maganin ruwa-ruwa ba safai ba.
Da yake maganin shan ruwa ba ya sa mutum ya kamu da cutar fata, hakan ya sa ya fi kyau a yi amfani da shi fiye da wanke hannu da sabulu da ruwa.
Ko da yake suna da amfani sosai, magungunan da ba su da ruwa ba sa kawar da ƙwayoyin da ke hannayenku, amma suna kashe ƙwayoyin cuta ne kawai.
Saboda wannan dalili, maganin kashe ƙwayoyin cuta na hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar ƙwayoyin cuta da yawa, saboda waɗannan sun kasance a kan hannaye.
Amfani da maganin wanke hannu ba tare da barasa ba ya dogara sosai da sinadarai da kuma tsari, kuma koyaushe yana da ƙasa da na barasa da kuma na maganin wanke hannu.
A kwanan nan, magungunan da ke amfani da benzalkonium chloride sun nuna ci gaba da aiki na antimicrobial bayan amfani, sabanin barasa, wanda tasirinsa ya ragu bayan amfani da shi sau da yawa, mai yiwuwa saboda ci gaba da rashin lafiyar fata.
A ƙasashe da ba su da kuɗi, mutane da yawa ba sa iya sayan sabulu, maimakon haka, suna amfani da toka ko ƙasa.
Ƙura da toka suna iya yin aiki fiye da ruwa kaɗai, amma ba su da amfani kamar sabulu.
Ƙari ga haka, idan ƙwayoyin cuta sun shiga ƙasa ko toka, hakan zai sa cutar ta yaɗu maimakon ta hana ta.
Kamar sabulu, toka tana kuma amfani da ita wajen kashe ƙwayoyin cuta domin idan ta haɗu da ruwa, tana zama ruwan gishiri.
WHO ta ce ana iya amfani da toka ko yashi a madadin sabulu idan babu sabulu.
Cibiyar Kula da Cututtuka da Rigakafin Cutar Amurka ta ba da shawarar wanke hannu sosai don hana yaduwar cututtuka ta bin waɗannan matakai:
Wanke hannuwanka da ruwan sanyi ko mai dumi.
Ana ba da shawarar ruwan da ke gudana saboda haɗarin gurɓataccen ruwan da ke tsaye, yayin da zafin ruwan bai bayyana ya bambanta ba).
Ka yi amfani da sabulu mai yawa a kan hannayenka, ka shafa su da juna, ka kuma shafa su a bayan hannayenka, tsakanin yatsun hannu da kuma ƙarƙashin ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna yawan wanke hannayensu sosai idan suna amfani da sabulu fiye da ruwa kawai.
Ka yi amfani da shi na akalla dakika 20.
Idan ka shafe fatar jikinka, za ka sami ƙwayoyin cuta da yawa.
Ka wanke shi sosai da ruwa mai gudu.
Wankewa a cikin tafkin ruwa mai tsayawa zai iya sake gurɓata hannaye.
Ka bushe shi da tawul mai tsabta ko kuma a waje.
Hannun da suke da rigar suna sake kamuwa da cutar. Yankunan da aka fi mantawa da su sune babban yatsu, wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin ƙusa.
Ƙwaƙwalwar da aka yi da ƙusa da kuma ƙusa da aka yi da ƙusa za su iya ɗauke da ƙwayoyin cuta.
Ana yawan ba da shawarar yin amfani da maganin shafawa don hana hannayenka bushewa.
Akwai hanyoyi masu yawa na wanke hannu idan babu ruwan famfo da sabulu. Misali, zubar da ruwa daga gwangwani ko bututun da aka rataye da kuma yin amfani da toka idan ya cancanta, a ƙasashe masu tasowa. A cikin yanayi inda akwai iyakancewar samar da ruwa (kamar a makarantu ko yankunan karkara a ƙasashe masu tasowa), akwai hanyoyin adana ruwa, kamar  tippy-taps  da sauran zaɓuɓɓukan tattalin arziki.
Tip-tap fasaha ce mai sauƙi da ke amfani da tukunyar da aka rataye da igiya da kuma ƙafa don zuba ruwa kaɗan a hannayenka da kuma sabulu.
Drying hannaye yadda ya kamata wani muhimmin bangare ne na aikin tsabtace hannu, amma hanya mafi kyau don bushe hannaye a bayan gida na jama'a yana da muhawara.
Bincike da yawa ya nuna cewa tawul ɗin takarda sun fi na lantarki tsabta da ake samu a bayan gida.
A shekara ta 2008, wani bincike da masana'antar takarda ta yi, wato European Tissue Symposium, ya yi da Jami'ar Westminster da ke Landan, don kwatanta tsabtace jiki da takarda takarda, busar hannu da iska da kuma busar hannu da iska.
Bayan wankewa da bushewa da na'urar bushe hannu da iska mai zafi, an gano cewa yawan kwayoyin sun karu da kashi 194 cikin ɗari a kan yatsunsu da kashi 254 cikin ɗari a kan dabino.
Drying da na'urar busar hannu ta iska ya haifar da ƙaruwar ƙwayoyin cuta a kan yatsunsu da kashi 42 cikin ɗari da kuma hannayen hannu da kashi 15 cikin ɗari.
Bayan wankewa da bushe hannu da tawul na takarda, yawan kwayoyin sun ragu da kashi 76 cikin ɗari a kan yatsunsu da kuma kashi 77 cikin ɗari a kan hannayen hannu. Masana kimiyya sun kuma gudanar da gwaje-gwaje don gano ko akwai yiwuwar kamuwa da cuta tare da sauran masu amfani da bayan gida da kuma yanayin bayan gida dangane da kowace hanyar bushewa.
Na'urar busar da hannu ta iska, wadda ke busa iska daga cikin na'urar a saurin da aka yi sanarwa na 180 m/s (650 km/h; 400 mph), tana iya fitar da ƙwayoyin cuta daga hannaye da na'urar kuma tana iya gurɓata sauran masu amfani da bayan gida da kuma yanayin bayan gida har zuwa mita 2.
Yin amfani da na'urar busar hannu mai iska mai zafi yana ba da damar watsa ƙwayoyin cuta a nesa da na'urar busar hannu har zuwa mita 0.25.
Takardun takarda sun nuna cewa babu wata babbar yaduwar ƙwayoyin cuta. A cikin binciken da TÜV Produkt und Umwelt ya yi a shekara ta 2005, an kimanta hanyoyi daban-daban na bushe hannu.
Bayan bushe hannuwan, an lura da waɗannan canje-canje a cikin ƙididdigar ƙwayoyin cuta:
Akwai masu sana'a da yawa na na'urar busar hannu, kuma an kwatanta na'urar busar hannu da na'urar busar hannu da takarda.
Wanke hannu da tawul ɗin kashe ƙwayoyin cuta wani zaɓi ne yayin tafiya, idan babu sabulu da ruwa.
Za a iya amfani da ruwa mai shan giya a cikin ruwa mai shan ruwa don a samu ruwa mai yawa.
Wanke hannu a asibiti ya zama wajibi tun bayan da likitan Hungary Ignaz Semmelweis ya gano cewa yana da amfani (a shekara ta 1846) wajen hana kamuwa da cuta a asibiti.
Akwai na'urorin lantarki da ke faɗakar da ma'aikatan asibiti idan sun manta da wanke hannu.
Wani bincike ya nuna cewa yin amfani da waɗannan magungunan ya rage yawan kamuwa da cutar.
Wanke hannu na likita ya kamata ya ɗauki aƙalla dakika 15, ta amfani da sabulu da ruwa ko gel mai yawa don busawa da shafa kowane ɓangaren hannu.
A shafa hannayenku a tsakanin yatsunsu.
Idan akwai wasu abubuwa a ƙarƙashin ƙusa, za ka iya cire su da goga.
Tun da yake ƙwayoyin cuta da ke cikin ruwa za su iya kasancewa a hannayenku, yana da muhimmanci ku wanke hannuwanku da tsabta kuma ku goge su da tawul mai tsabta.
Bayan bushewa, dole ne a yi amfani da tawul ɗin takarda don rufe famfo (kuma buɗe ƙofar fitarwa idan ya cancanta).
Hakan zai taimaka wajen hana hannuwanka sake kamuwa da cutar idan ka taɓa wani abu.
Manufar wanke hannu a cibiyoyin kiwon lafiya shine cire ƙwayoyin cuta ( ƙwayoyin cuta ) da hana yaduwar su.
Jaridar New England Journal of Medicine ta ba da rahoton cewa rashin tsabtace hannu bai dace ba a yawancin cibiyoyin kiwon lafiya, da yawa daga cikin likitoci da ma'aikatan jinya suna mantawa da wanke hannayensu kafin su taɓa marasa lafiya, kuma hakan yana sa ƙwayoyin cuta su yadu.
Wani bincike ya nuna cewa wanke hannu da kyau da kuma wasu ayyuka masu sauƙi za su iya rage yawan kamuwa da cututtukan jini da ke tattare da amfani da katatar da kashi 66 cikin ɗari. Ƙungiyar Lafiya ta Duniya ta wallafa wata ƙasida da ta bayyana yadda za a wanke hannu da kuma shafawa a cikin kiwon lafiya.
Ana kuma iya samun shawarwari daga masu amfani da intanet a kan shafin yanar gizon da aka tsara na jagororin tsabtace hannu na Hukumar.
Whitby et al. sun yi bincike mai kyau.
Ana iya samun na'urori da ake amfani da su a kasuwa da za su iya auna kuma su tabbatar da tsabtace hannu idan an tabbatar da cewa an bi ƙa'idodin.
Hukumar Lafiya ta Duniya ta bayyana  Abubuwa biyar  da suka shafi tsabtace hannu:
bayan an yi amfani da jini/wani ruwa mai rai;
kafin aikin aseptic; kuma
Bayan sun taɓa mai haƙuri, ƙara sinadarai masu kashe ƙwayoyin cuta a sabulu (sabulu na "magunguna" ko "antimicrobial") yana sa wanke hannu ya kashe ƙwayoyin cuta.
Ana son a kawar da waɗannan ƙwayoyin cuta kafin a yi aiki ko a wuraren da ƙwayoyin cuta masu jurewa da ƙwayoyin cuta ke yaduwa. Don "shan hannu" kafin aikin tiyata, ana buƙatar samun famfo da za a iya buɗewa da rufewa ba tare da taɓa shi da hannu ba, kayan wanki na chlorhexidine ko iodine, tawul ɗin da ba su da ƙwayoyin cuta don bushe hannu bayan wankewa, goga mai ƙwayoyin cuta don shafawa da wani kayan aiki mai ƙwayoyin cuta don tsabtace ƙarƙashin kusoshi.
Dole ne a cire dukan kayan ado.
A wannan aikin, ana bukatar wanke hannu da hannayen gaba har zuwa gwiwar hannu, yawanci na minti 2 zuwa 6.
Ba lallai ba ne ka shafe minti 10 kana shafa hannayenka.
Idan aka wanke hannu, kada ruwa ya shiga hannu.
Bayan an wanke hannu, ya kamata a bushe hannuwan da tawul da ba a shafawa kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannu ko amfani da maganin kashe ƙwayoyin cuta kafin da kuma bayan kula da mai ciwo.
A game da kula da kamuwa da cutar staph a asibitoci, an gano cewa mafi yawan fa'idodin wanke hannu ana samun su ne a farkon kashi 20 na wanke hannu, kuma akwai ƙananan fa'idodi na ƙara yawan wanke hannu sama da kashi 35.
Idan aka kwatanta wanke hannu da sabulu na yau da kullum da wanke hannu da sabulu mai hana ƙwayoyin cuta, yawan cututtukan ƙwayoyin cuta da ke kamuwa da abinci ya ninka sau uku. Hakazalika, idan aka kwatanta wanke hannu da maganin barasa da wanke hannu da sabulu mai hana ƙwayoyin cuta na matsakaicin lokaci na dakika 30 kowannensu, ana ganin cewa wanke hannu da sabulu na hana ƙwayoyin cuta ya rage kamuwa da ƙwayoyin cuta da kashi 26 cikin ɗari idan aka kwatanta da na biyu.
Amma sabulu da ruwa sun fi maganin shan barasa tasiri wajen rage kwayar cutar mura ta A (H1N1) da kuma ƙwayoyin Clostridium difficile a hannaye. Don inganta tsabtace hannu a cibiyoyin kiwon lafiya, akwai hanyoyin da za a iya horar da ma'aikata wajen wanke hannu, samar da ƙarin maganin shan giya da kuma rubuta da kuma tunatar da su game da wannan.
Ana bukatar ƙarin bincike don sanin hanyoyin da suka fi dacewa a wurare dabam dabam na kiwon lafiya.
A ƙasashe masu tasowa, ana ɗaukan wanke hannu da sabulu a matsayin hanya mai sauƙi da kuma muhimmanci na kiyaye lafiya da kuma cin abinci mai kyau.
Amma, rashin isassun wuraren ruwa, sabulu, da kuma wurin wanke hannu a gida, makaranta, da kuma wurin aiki yana sa ya yi wuya a kafa al'ada na tsabtace hannu a dukan duniya.
Alal misali, a yawancin yankunan karkara na Afirka, ba a yawan samun famfunan wanke hannu kusa da bayan gida ko na jama'a, duk da cewa akwai zaɓuɓɓukan da ba su da tsada don gina tashoshin wanke hannu.
Duk da haka, ƙananan yawan wanke hannu na iya zama sanadiyar ɗabi'a mai ɗorewa, maimakon rashin sabulu ko ruwa.
Ƙarfafa wanke hannu da sabulu da kuma wayar da kan jama'a game da shi na iya shafar yanke shawara na siyasa, ya sanar da fa'idodin wanke hannu da sabulu, kuma ya kawo canji na dogon lokaci a cikin al'umma.
Don wannan ya zama nasara, ana bukatar gudanar da ayyukan sa ido da kimantawa.
Binciken bincike na bincike 70 ya gano cewa hanyoyin gida suna da tasiri wajen ƙara yawan wanke hannu a ƙasashe masu karamin kuɗi da matsakaitan kuɗi, kuma kamfen ɗin tallatawa na zamantakewa ba shi da tasiri sosai. Game da inganta wanke hannu a makarantu, misali shi ne "Hanyar Tauraruwa Uku" ta UNICEF, wanda ke ƙarfafa makarantu su ɗauki matakai masu sauƙi da araha don tabbatar da cewa ɗalibai suna wanke hannayensu da sabulu, yayin da suke bin wasu ƙa'idodin tsabta.
Da zarar an cika ƙa'idodin, za a iya ɗaukaka makarantu daga tauraro ɗaya zuwa uku.
Gina tashoshin wanke hannu na iya zama wani ɓangare na kamfen na inganta tsabtace hannu da ake gudanarwa don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya wani misali ne na kamfen na wayar da kan jama'a da ake da'awar zai kawo canji a dabi'u. Bayan annobar cutar coronavirus ta 2019-2020, UNICEF ta ƙarfafa amfani da hoton emoji da ke nuna wanke hannu.
Wasu nazarin da aka yi sun yi la'akari da yadda ake amfani da kuɗin wanke hannu a ƙasashe masu tasowa dangane da yawan shekarun rayuwa masu kyau da aka samu (watau DALY da aka kauce wa).
Amma, wani bincike ya nuna cewa ƙarfafa wanke hannu da sabulu ya fi sauran hanyoyin tsabtace ruwa da tsaftacewa.
Muhimmancin wanke hannu ga lafiyar ɗan adam, musamman ga mutane masu rauni kamar uwaye da suka haihu ko sojoji da aka ji rauni a asibitoci, an fara gano su ne a tsakiyar karni na 19 ta hanyar majagaba biyu na tsabtace hannu: likitan Hungary Ignaz Semmelweis wanda ke aiki a Vienna, Austria, da Florence Nightingale, wanda ta kafa kulawar jinya ta zamani a Burtaniya.
A lokacin, mutane da yawa suna ganin cewa ƙamshi ne ke jawo cututtuka.
A cikin shekarun 1980, cututtukan da ke zuwa ta abinci da cututtukan da ke faruwa a asibiti sun sa Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka na Amurka su ƙara ƙarfafa tsabtace hannu a matsayin hanya mai mahimmanci don hana yaduwar cututtuka.
Fashewar cutar mura ta alade a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun sa mutane da yawa a ƙasashe da yawa sun san cewa suna bukatar wanke hannayensu da sabulu don hana waɗannan cututtuka masu yaduwa.
Alal misali, a Jamus, an saka allon talla da ke nuna  hanyoyin wanke hannu  kusa da wankin wanka a bayan gida da kuma bayan gida a ofisoshin gine-gine da filayen jirgin sama.
Furucin  wanke hannu  yana nufin ƙin yarda da alhakin ko kuma kasancewa cikin wani abu.
An samo wannan furcin ne daga ayar Littafi Mai Tsarki a littafin Matta inda Bilatus Ba-Bunti ya wanke hannuwansa daga hukuncin gicciye Yesu Kristi, amma an yi amfani da wannan furcin sosai a wasu yankunan Turanci.
A cikin littafin Shakespeare, Macbeth, Lady Macbeth ta soma wanke hannaye a kan wani abu da ta yi tunanin cewa zai iya kawar da wani tabo. Wannan ya nuna cewa ta damu sosai da laifin da ta yi kuma ta sa mijinta ya yi.
An kuma gano cewa wasu mutane, bayan sun tuna da aikata ayyukan da ba su dace ba ko kuma suna tunanin yin hakan, suna yawan wanke hannayensu fiye da wasu kuma suna daraja na'urorin wanke hannu.
Ƙari ga haka, waɗanda aka ƙyale su su wanke hannuwansu bayan sun yi irin wannan tunanin ba sa son su yi wasu ayyukan da za su taimaka musu su tsabtace kansu, kamar yin aikin sa kai.
Wasu addinai suna ba da umarnin wanke hannu don dalilai na tsabta da na alama.Wasu addinai suna ba da umarnin wanke hannu don dalilai na tsabta, musamman a addinan Baha'i da Hindu, nutsewa (tevilah) da wanke hannu (Netilat Yadayim) a addinin Yahudanci, wanka a addinin Kirista, da wudhu a addinin Musulunci. Addinai kuma suna ba da umarnin wanke hannu don dalilai na tsabta, musamman bayan wasu ayyuka.
A addinin Hindu, Yahudanci da Musulunci, wanke hannu bayan wanka wajibi ne.
Hakazalika, addinai kamar su Hindu, Buddha, Sikh, Yahudanci, da kuma Musulunci suna bukatar a wanke hannu kafin a ci abinci da kuma bayan an ci abinci.
Kula da haɗarin COVID-19 a wurin aiki
Kula da haɗarin COVID-19 a wurin aiki yana nufin aiwatar da hanyoyin kiwon lafiya da aminci a wurin aiki don sarrafa haɗarin don hana cutar coronavirus ta 2019 (COVID-19).
Kulawa da haɗarin aiki da ya dace ya bambanta dangane da wurin aiki da kuma ayyuka, bisa la'akari da haɗarin daga wuraren da cutar ta fito, tsananin cutar a cikin al'umma, da kuma abubuwan haɗarin mutum na ma'aikata waɗanda za su iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aiki (OSHA) a Amurka, ayyuka da ke da ƙananan haɗarin kamuwa da cutar suna da iyakantaccen hulɗa da jama'a da sauran ma'aikata. A wannan yanayin, ana ba da shawarar kawai matakan hana kamuwa da cuta na asali, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ƙa'idodin numfashi da kiyaye tsabtace aiki da kuma tsabtace wuraren aiki.
Ayyukan da ke da haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar hulɗa sau da yawa ko kusanci da mutanen da ba a yi zaton ko san su da COVID-19 ba amma waɗanda za su iya kamuwa da cutar saboda yaduwar al'umma ko tafiya ta duniya.
Wannan ya hada da ma'aikata da ke hulɗa da jama'a musamman a makarantu, wuraren aiki masu yawan jama'a da kuma wasu wuraren sayar da kaya.
Kula da haɗari a cikin wannan rukuni, ban da matakan hana kamuwa da cuta, sun haɗa da samun iska mai ƙarfi, gilashin tsabtace jiki da kayan kariya na mutum idan kun haɗu da mutumin da ke da COVID-19.
Hukumar kula da lafiya ta LOSHA ta ɗauki ma'aikatan kiwon lafiya da na jana'iza da ke fuskantar haɗarin haɗari ga mutanen da ake zargi ko aka sani da cutar COVID-19 a matsayin masu haɗari sosai, suna zuwa haɗari sosai idan suna yin ayyukan da ke haifar da aerosols ko ɗaukar ko sarrafa samfurori daga mutanen da ake zargi ko aka sani da cutar COVID-19.
Kulawar haɗarin da ya dace ga waɗannan ma'aikata ya haɗa da kulawar fasaha kamar ɗakunan iska mai matsin lamba da kayan kariya na mutum wanda ya dace da aikin.
Cutar COVID-19 na iya haifar da sakamako da yawa a wuraren aiki.
Ma'aikata za su iya yin hakan domin sun yi rashin lafiya, suna kula da wasu ko kuma suna tsoron kamuwa da cutar.
Hanyoyin kasuwanci na iya canzawa, duka game da kayan da aka nema da kuma hanyoyin da za a samu (misali cin kasuwa a waje da lokacin aiki ko amfani da sabis na bayarwa ko tuki).
A ƙarshe, ana iya dakatar da jigilar kayayyaki daga yankunan da COVID-19 ta shafa sosai. Za a iya amfani da shiri da kuma shirin magance cututtuka masu yaduwa a matsayin jagora don matakan kariya.
Shirye-shiryen suna la'akari da matakan haɗari da ke tattare da wurare daban-daban na aiki da ayyuka, gami da tushen haɗari, abubuwan haɗari da suka danganci iyali da al'umma da kuma abubuwan haɗari na mutum na ma'aikata kamar tsufa ko cututtuka na yau da kullun.
Sun kuma tsara yadda za a iya magance wannan haɗarin da kuma yadda za a yi shirin gaggawa don yanayin da zai iya tasowa sakamakon annobar.
Shirye-shiryen shirye-shirye da kuma amsawa ga cututtuka masu yaduwa na iya zama batun shawarwari na ƙasa ko na yanki.
Manufofin magance annobar sun haɗa da rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke da haɗarin kamuwa da cututtukan cututtuka, ci gaba da ayyukan kasuwanci da rage tasirin da ba a so ga sauran ƙungiyoyi a cikin sarƙoƙin samar da su.
Ƙungiyar da ke kula da aikin ta ce, "Muna bukatar mu yi amfani da wannan zarafin don mu magance matsalar".
Tsarin kula da haɗari yana samar da tsarin da ake amfani da shi gaba ɗaya a cikin lafiya da lafiya don haɗa haɗarin haɗari ta hanyar tasiri.
Idan ba za a iya kawar da haɗarin COVID-19 ba, hanyoyin da suka fi dacewa su ne na fasaha, sannan na gwamnati, da kuma kayan kariya na mutum.
Ana iya yin amfani da fasaha wajen hana haɗarin aiki a wurin aiki, ba tare da dogara ga halayyar ma'aikata ba.
Ana amfani da kalmar nan administrative controls wajen kwatanta canje-canje a manufofi ko kuma hanyoyin aiki da ke bukatar ma'aikaci ko kuma ma'aikaci ya yi wani abu.
Kayan kariya na mutum (PPE) ana ganin ba shi da tasiri kamar na fasaha da na gudanarwa, amma zai iya taimakawa wajen hana wasu kamuwa.
Dukkanin nau'ikan PPE dole ne a zaɓa bisa ga haɗarin da ke tattare da ma'aikaci, a daidaita su yadda ya kamata (misali abin rufe fuska), a sa su yadda ya kamata kuma a yi amfani da su a kai a kai, a duba su a kai, a kula da su kuma a sauya su yadda ya kamata, kuma a cire su, a tsabtace su kuma a adana su ko kuma a zubar da su yadda ya kamata don hana gurɓata su.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Aiki (OSHA) a Amirka, ayyuka da ke da haɗarin ƙarancin ƙwayoyin cuta suna da ƙarancin hulɗa da jama'a da kuma ma'aikata.
Matakan farko na rigakafin kamuwa da cuta da aka ba da shawarar ga duk wuraren aiki sun haɗa da wanke hannu da yawa da kyau, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, ƙa'idodin numfashi, gami da rufe baki da hanci don tari da hancin, samar da kayan shafawa da shara, shirya don aiki ta waya ko kuma a cikin sa'o'i masu yawa idan ya cancanta, hana ma'aikata amfani da kayan aiki da kayan aiki na wasu, da kiyaye tsaftacewa da tsabtace yanayin aiki.
Gano da kuma ware mutanen da za su iya kamuwa da cutar da wuri muhimmin mataki ne na kare ma'aikata, abokan ciniki, baƙi da sauransu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Rigakafin Cutar (CDC) a Amurka sun ba da shawarar cewa ma'aikata da ke nuna alamun ciwon numfashi mai tsanani su zauna a gida har sai sun daina zazzabi, alamun zazzabi, ko wasu alamun aƙalla awanni 24 ba tare da amfani da maganin zazzabi ko wasu magunguna da ke magance alamun ba. Sun kuma ba da shawarar cewa a yi amfani da manufofin hutu na rashin lafiya, a ba ma'aikata damar zama a gida don kula da wani dangin da ke rashin lafiya, da kuma sanar da ma'aikata waɗannan manufofin.
A cewar OSHA, ayyukan da ke da haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar hulɗa sau da yawa ko kusa, a cikin ƙafa shida (1.8 m), tare da mutanen da ba a yi zaton ko san su da COVID-19 ba, amma waɗanda za su iya kamuwa da SARS-CoV-2 saboda yaduwar al'umma a kusa da hedkwatar kamfanin ko kuma saboda mutumin ya yi balaguron ƙasa da ƙasa kwanan nan zuwa yankin da yaduwar COVID-19 ke yaduwa.
Wannan ya haɗa da ma'aikata da ke hulɗa da jama'a musamman a makarantu, wuraren aiki masu yawan jama'a da wasu wuraren sayar da kayayyaki masu yawa. Kulawa na fasaha ga wannan rukuni da waɗanda ke da haɗari sun haɗa da sanya matattarar iska mai inganci, ƙara yawan iska, sanya shinge na zahiri kamar gilashin tsabtace filastik mai haske da shigar da taga mai motsawa don sabis na abokin ciniki. Kulawa na gudanarwa ga wannan rukuni da waɗanda ke da haɗari sun haɗa da ƙarfafa ma'aikata marasa lafiya su zauna a gida, maye gurbin tarurrukan mutum da sadarwar kama-da-wane, samar da kayan aiki masu haɗari, hana tafiya zuwa manyan wuraren da ba su da haɗari ga cutar COVID-19, da samar da kayan aiki masu amfani da kayan aiki masu haɗari da haɗari, da samar da kayan aiki na yau da kullun don kare ma'aikata daga cutar COVID-19, ko samar da kayan aiki na yau da kullun, ko samar da kayan aikin karewa, musamman masu aiki da ke da haɗari, ko samar da kayan aikin karewa, ko samar da kayan aiki na yau da kullun, ko samar da kayan aikin karewa, ko samar da kayan aiki na musamman ga masu aiki da ke da haɗari, ko samar da kayan aiki na yau da kullun, ko samar da kayan aiki na musamman don kare masu aiki da masu haɗari daga COVID-19.
Ma'aikata a cikin wannan rukunin haɗarin ba sa bukatar yin amfani da abin rufe fuska.
Idan wani ya kamu da rashin lafiya a cikin jirgin sama, matakan da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da: ware mai ciwon daga wasu a tazarar ƙafa 6, sanya wani ma'aikacin jirgin don kula da mai ciwon, da ba mai ciwon abin rufe fuska ko kuma tambayarsa ya rufe bakinsa da hancinsa da zane lokacin da yake tari ko hancinsa.
Ma'aikatan jirgin za su sa safar hannu da za a zubar da su idan sun kula da fasinja mai ciwo ko kuma sun taɓa ruwa mai narkewa ko kuma wuraren da za su iya zama da cutar, kuma idan zai yiwu, su sa ƙarin kayan kariya idan fasinja mai ciwo yana da zazzabi, tari ko kuma yana fama da numfashi.
Ya kamata a zubar da safar hannu da sauran abubuwa da za a iya zubar da su a cikin jaka don ɓarnatar da ƙwayoyin cuta masu haɗari kuma a tsabtace da kuma kashe ƙwayoyin cuta daga baya. Don jirgin ruwa na kasuwanci, gami da jiragen ruwa na jirgin ruwa da sauran jiragen fasinja, sarrafa haɗari ya haɗa da jinkirta tafiya idan akwai rashin lafiya da keɓe kai da sanar da cibiyar likitancin jirgin nan da nan idan mutum ya kamu da zazzabi ko wasu alamomi a cikin jirgin.
A mafi kyau, dole ne a kula da lafiyar a cikin ɗakin da aka ware. Ga makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa da kashe ƙwayoyin cuta idan mutum mai cutar ya shiga ginin makaranta, ba tare da la'akari da yaduwar al'umma ba.
A cikin yanayin watsawa na al'umma mai sauƙi zuwa matsakaici, ana iya aiwatar da dabarun nisantar zamantakewa, kamar soke tafiye-tafiye na ilimi, taro da sauran manyan tarurruka kamar darussan motsa jiki ko rukuni ko abinci a kantin, ƙara sarari tsakanin ofisoshi, sauye-sauyen lokacin isowa da fita, rage baƙi marasa mahimmanci da amfani da sashin kulawa na musamman don yara masu alamun mura.
Idan akwai yaduwar cutar a cikin al'umma, ban da dabarun nisantar jama'a, ana iya yin la'akari da tsawaita hutun makaranta. Ga jami'an tsaro da ke yin ayyukan yau da kullun, CDC ta ɗauki haɗarin lafiyar nan da nan a matsayin ƙarami.
Jami'an tsaro da ke da alaƙa da mutanen da ake zargi ko kuma aka tabbatar da cutar COVID-19 dole ne su bi ƙa'idodin da masu aikin jinya suke bi, gami da saka kayan kariya na mutum.
Idan ma'aikata sun yi tuntuɓe a lokacin da aka dakatar da su, dole ne su tsabtace da kuma kashe ƙwayoyin cuta na kayan aiki da bel kafin sake amfani da su ta hanyar wankin wanki ko kuma fesa kayan wanki na gida kuma su bi ƙa'idodin tsarewa da zubar da PPE da aka yi amfani da su da kuma tsarewa da wanke tufafi.
Hukumar LOSHA ta ce wasu ma'aikatan kiwon lafiya da na jana'iza suna cikin manyan ko manyan haɗarin kamuwa da cutar.
Ayyukan da ke da haɗarin kamuwa da cutar sun haɗa da ma'aikatan kiwon lafiya, masu tallafawa, masu bincike da masu jigilar magani waɗanda ke fuskantar haɗarin kamuwa da marasa lafiya da ake zargi ko sanannun COVID-19.
Suna zama ma'aikata masu haɗarin kamuwa da cutar idan suna yin ayyukan da ke haifar da iska ko ɗaukar ko sarrafa samfurori daga marasa lafiya da ake zargi ko sanannun COVID-19.
Hanyoyin da ke samar da aerosols sun hada da intubation, hanyoyin hana tari, bronchoscopy, wasu gwaje-gwaje da hanyoyin hakori ko kuma daukar samfurori.
Ayyukan jana'izar da ke da haɗarin kamuwa da cutar sun haɗa da ma'aikatan da ke shirya gawawwakin mutanen da ake zargi ko aka san suna da COVID-19 a lokacin mutuwarsu; suna cikin haɗarin kamuwa da cutar sosai idan sun yi ta yin ta. Ƙarin ƙwarewar fasaha don waɗannan rukunin haɗarin sun haɗa da ɗakunan keɓewa don marasa lafiya da ake zargi ko aka sani da COVID-19, gami da yin ayyukan da ke haifar da iska.
Ana iya yin amfani da iska mai ƙarancin iska a wasu wuraren da ake kula da lafiya da kuma jana'iza.
Dole ne a sarrafa samfurori ta amfani da matakan kariya na matakin 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar ware marasa lafiya da ke shiga ɗakunan jira daban-daban dangane da zargin COVID-19. Baya ga sauran PPE, OSHA ta ba da shawarar rufe fuska ga mutanen da ke aiki a cikin ƙafa 6 daga marasa lafiya da ake zargi ko sanannun kamuwa da cutar SARS-CoV-2 da kuma waɗanda ke yin hanyoyin da ke haifar da aerosols.
A Amurka, dole ne a yi amfani da masks na numfashi na N95 da NIOSH ta amince da su ko mafi girma a cikin cikakken shirin kariya na numfashi wanda ya haɗa da daidaitawa, horo da gwajin likita.
Sauran nau'ikan abin rufe fuska na numfashi na iya ba da kariya da kwanciyar hankali ga ma'aikaci. WHO ba ta ba da shawarar sutura ba saboda COVID-19 cuta ce ta numfashi maimakon ta ruwa.
WHO ta ba da shawarar cewa ma'aikatan gwajin ne kawai za su sa abin rufe fuska a wurin da aka yi musu tiyata.
Ga waɗanda ke ɗaukar samfurori na numfashi, kula da ko jigilar marasa lafiya na COVID-19 ba tare da hanyoyin da ke samar da iska ba, WHO ta ba da shawarar rufe fuska, tabarau na kariya ko murfin fuska, rigar riga da safar hannu.
Idan ana yin aikin da ke haifar da iska, ana maye gurbin abin rufe fuska da abin rufe fuska na N95 ko FFP2.
Saboda wadatar PPE a duniya ba ta isa ba, WHO ta ba da shawarar rage buƙatar PPE ta hanyar telemedicine, shinge na zahiri kamar windows mai haske, ƙuntata damar zuwa ɗakin da mai haƙuri na COVID-19 ke zaune ga waɗanda ke da hannu kai tsaye cikin kula da shi, amfani da PPE da ake buƙata don takamaiman aiki kawai, ci gaba da amfani da abin rufe fuska guda ɗaya ba tare da cire shi ba don kula da marasa lafiya da yawa tare da ganewar asali ɗaya ba, saka idanu da daidaita sarkar samar da PPE da hana amfani da abin rufe fuska ga mutane marasa alamomi.
DE: Katherine Maher, Shugabar Gidauniyar Wikimedia
Ga: Duk ma'aikatan Gidauniyar Wikimedia
ABUBUWAN: [Covid-19] Sauƙaƙa Nauyin da ke tattare da Shirye-shiryen Nan Gaba
Ranar da aka aiko shi: 14 ga Maris, 2020, 00:24 UTC
LAISASAN: CC0: Babu wani haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin haƙƙin mal
A wannan watan muna cikin yanayi na musamman.
Cutar COVID-19 ta nuna yadda mutane suke da alaƙa da juna da kuma yadda muke da hakki ga juna.
Matsalolinta ba su da iyaka, amma mun san cewa amsarmu mafi kyau ta dogara ne da irin tausayi, hadin kai da kuma gina al'umma a duniya wanda ke zuciyar wannan kungiya.
Abokantaka da kuma alheri da muka gani tsakanin abokan aikinmu a cikin imel, kira da kuma tattaunawa ta kai tsaye shaida ce mai ban mamaki game da mutane masu ban mamaki da muke da damar aiki tare.
Ina godiya sosai kuma ina alfahari da ku don ku abokan aikina ne.
A makon da ya shige, wani ya nuna mini godiyarsa don aikin da muke yi.
Wannan mutumin ya tunatar da ni muhimmancin samun damar shiga Wikipedia a yau, da kuma muhimmancin kasancewa da wannan muhimmin kayan aiki a kan layi da kuma samun dama ga kowa.
Wannan yana yiwuwa ne saboda aikinku, ko kuna kula da ayyukanmu, kuna biyan abokan aikinmu, ko kuma kuna kiyaye al'ummominmu.
Duniya tana bukatar bayanan da Wikipedia ke bayarwa yanzu fiye da kowane lokaci.
Wannan lokaci ne da ba kawai abin da muke yi ba, amma yadda muke yi, zai yi tasiri sosai a duniya.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa, za mu yi wasu canje-canje a yadda muke aiki tare daga mako mai zuwa.
Canje-canjen da Muka Yi a Ayyukanmu da Kuma Tsarin Lokaci
Kamar yadda Robyn ta ambata a baya, ƙungiyar ta haɗu a daren jiya don tattauna yadda za mu bi da kuma tsarinmu na kwanaki da watanni masu zuwa.
A lokacin tattaunawar, mun tattauna yadda za mu iya magance matsalar da muke fuskanta da kuma yadda za mu ci gaba da kasancewa da ƙungiyar a wannan lokacin.
Abin da ya fi muhimmanci a gare mu shi ne mu kawar da matsi kuma mu ci gaba da hidimarmu.
Idan kana bukatar ka daina yin hakan, kada ka damu.
Ga dukkan ma'aikata, masu aiki da kwangila:
Aƙalla, za mu yi aiki na sa'o'i huɗu a rana, ko kuma sa'o'i 20 a mako har sai an ba da ƙarin bayani.
Ba za mu yi hutu ba: idan za ka iya yin aiki a kan lokaci, za ka iya taimaka wa aikin.
Amma, duniya ba ta da tabbas a yau, kuma idan kana bukatar kula da waɗanda kake ƙauna, sayayya, ko kuma likita, lafiyarka ita ce abin da ya fi muhimmanci a gare mu.
Ba ma saka idanu a kan lokacin da kuke aiki.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata mu riƙa faɗin hakan, amma muna faɗin hakan.
Ba a bukatar hutu na rashin lafiya ko hutu da ake biya: ka gaya wa shugabanninka kawai kuma ka taimaka wa ƙungiyarka ta sake duba jadawalin aiki da kuma jadawalin aiki don tabbatar da cewa an rufe manyan wuraren aiki.
(Idan an gano cewa kana da cutar COVID-19, ka gaya wa Bryan na Sashen Kula da Ayyukan T&amp;C don T&amp;C su taimaka maka kuma su tabbatar da cewa an kula da yanayinka yadda ya kamata daga manajan).
Za a biya ma'aikatan da suke aiki a kai a kai.
Mun riga mun sanar da hakan, kuma muna sake tabbatar da cewa za mu cika alkawuranmu ga abokan aikinmu da kuma abokan aikinmu.
Za a biya kowa bisa ga yawan sa'o'in da ya yi a aiki a ƙarƙashin yanayi na yau da kullum.
Wannan ya shafi idan kana rashin lafiya kuma ba za ka iya yin aiki ba.
Idan kana son ka yi aiki, muna goyon bayanka.
Mutane da yawa suna amfani da aikinsu don su guji damuwa da ke tattare da duniyar da ke kewaye da su.
Abin da muke yi zai iya sa mu farin ciki sosai, musamman a irin wannan lokacin.
Amma, abin da ya fi muhimmanci shi ne kāre ku.
Abin da kawai za mu ce shi ne ka tuntuɓi shugabanka don mu san abin da za ka yi tsammani kuma mu yi shiri.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da muke bukatar mu ci gaba da yi.
Ƙungiyoyin SRE, HR Ops, Trust &amp; Security da kuma Fundraising (da sauransu) suna yin aiki mai muhimmanci da zai bukaci ƙarin taimako.
Za mu fara aiki tare da dukkan sassanmu don tantance manufofinmu na yanzu da kuma mai da hankali kan tallafawa ayyukan da suka dace da aikinmu.
Akwai aiki da yawa da za mu yi, amma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan ka rage gudu yanzu, hakan ba zai ɓata maka rai ba.
Ba mu da niyyar  aiki sau biyu don dawo da lokacin da muka rasa  lokacin da annobar ta wuce.
Ba za mu ce ku yi aiki na tsawon lokaci don ku cika jadawalin da ba za ku iya cim ma ba.
Mun san cewa yanayi ya canja, kuma za mu yi ƙoƙari mu kafa sababbin maƙasudai da kuma lokacin da ya dace.
Mene ne za mu iya faɗa game da shirin shekara-shekara?
Don daidaitawa da sabon yanayinmu da kuma burin lokacin aiki na yau da kullun, muna shirin daidaita lokacin isar da Shirinmu na Shekarar 2020-2021.
Muna da niyyar ba da shawarar tsawaita shirinmu na 2019-2020 wanda ke ba da ƙarin lokaci don tsara kasafin kuɗi don bawa ma'aikata damar mai da hankali kan aiki mai mahimmanci, kula da kansu da ƙaunatattun su yayin daidaitawa da waɗanda ke buƙatar ko son rage jadawalin aikin su a cikin makonni masu zuwa.
Wannan tsawaita lokaci yana rage yawan aiki da matsin lamba na tsarawa a cikin ƙungiyar gaba ɗaya.
Za mu gabatar da shawararmu ga Majalisar mako mai zuwa kuma za mu sanar da wakilai da ƙungiyoyi game da matakai na gaba da zarar an tabbatar da hakan.
Na gode wa APP don jagorancinku a wannan batun.
Yanayin, Bayyanawa da kuma Tsabtace Ofishin
A makon da ya gabata, mun sami labarin cewa wani abokin aikinmu da ke San Francisco na iya kamuwa da cutar COVID-19.
Amma, don mu mai da hankali sosai, mun tura wasu masu tsabtace wuraren da ke San Francisco su yi aikin kashe ƙwayoyin cuta.
Sun yi amfani da maganin rigakafin ƙwayoyin cuta na asibiti don kashe ƙwayoyin cuta a dukan wurare, har da harabar gidan da kuma ɗakunan hawa da ke kaiwa bene.
Ginin yana da tsarin kula da lafiyarsa wanda ke amfani da kayayyakin da ke sa masu zama a cikinsa su kasance da aminci.
Mun tabbata cewa za a shirya ofishin sosai sa'ad da muka koma wurin.
Ofishinmu na Washington DC yana cikin wani ofishin WeWork, wanda ya raba mana da kuma ma'aikatansa na Washington DC, tsarin COVID-19.
Tun makon da ya gabata, ofishinmu a Washington DC ya karɓi tsari na nesa kamar yadda San Francisco ta ba da shawara.
Wasu abokan aikinmu a New York sun san cewa mun tattauna batun yin hayar wani ɗaki a Brooklyn.
Ana ci gaba da tattaunawar amma ana iya jinkirta ta.
Wasu abokan aikinmu suna aiki daga nesa a karon farko.
Abokan aikinmu da suka saba da aiki daga nesa sun san cewa sauyawa zai iya zama da wuya kuma suna so su ba ku wasu shawarwari:
Ka rage tsawon taron zuwa sa'o'i ɗaya ko biyu.
Idan ana bukatar a yi nazari na tsawon lokaci, ka yi tunanin raba shi a kwanaki da yawa.
Ka bayyana abin da za ka yi a taron, ka tsara abin da za ka yi a taron kuma ka aika da takardun a gaba.
Ka sa bidiyo ya zama al'ada, ta amfani da kayan aiki kamar Google Docs da Zoom don ƙarfafa haɗin kai da musayar kai tsaye.
Ka kasance da mai kula don gudanar da kowane taro, da wanda zai kula da tattaunawar nan take da kuma jerin masu jawabi, da kuma wanda zai taimaka wajen yin rubutu (ko kuma yin rubutu tare).
Idan kana bukatar lasifika mai kyau, ka aika wa masu ba da taimako ta imel.
Ku yi amfani da kuɗin da kuka samu don ku ci abinci.
Shiga cikin Slack #remoties channel don tattaunawa da abokan aikinka game da rarraba aiki
Ƙungiyar Ayyukan HR tana nazarin jagororin ergonomics bisa ga yanar gizo don tallafawa haɓaka rarraba aiki a cikin Gidauniyar.
A makon da ya gabata, mun nemi duk masu karɓar tallafin al'umma su soke abubuwan da Wikimedia ke tallafawa jama'a, kamar su shirya-a-thons, har sai WHO ta sanar da ƙarshen annobar.
Mun bayyana musu cewa mun fahimci cewa buƙatunmu na sokewa da sauran ƙuntatawa na iya sa ba za su iya aiwatar da ayyukan tallafin da aka amince da su ba kuma ba za a hukunta kowa ba idan aka jinkirta ko canza waɗannan manufofin.
A mako mai zuwa, za mu fitar da ƙarin jagororin kan Wikimania da sauran taron al'umma na yanki da na yanki.
Babban abin da al'ummar duniya ke ji a yanzu shi ne bakin ciki da wannan tashin hankali da kuma jin dadi da samun haske da kuma damar mayar da hankali ga al'ummomin su, Wikimedia da sauransu.
A nan gaba, CRT tana aiki kan kafa shafi a Meta-Wiki don samar da sarari ga al'umma don lura da tasirin da kuma ci gaba da sadarwa da su.
Kasancewa a kan hanya duk da matsalolin COVID-19
Za mu aika da gayyata zuwa kalandarku don taron ma'aikata na musamman a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don raba wasu sabbin bayanai, amsa tambayoyinku da kuma yin wasu abubuwa tare.
Wannan yanayin ya shafe mu duka kuma muna shirye mu taimaka muku a kowane hanya.
Har sai lokacin, za ka iya samun bayanan da ke cikin wannan imel ɗin, da kuma duk wasu muhimman bayanai game da COVID-19, a kan Office Wiki.
Cibiyar TSA za ta ci gaba da ɗaukaka waɗannan shafuka kuma ta tattara dukan bayanan a wuri ɗaya.
Muna kuma ƙoƙari mu riƙa tattaunawa da ma'aikatanmu a ƙasashen da bala'in ya fi tsanani.
Idan kana da tambayoyi game da tafiya, abubuwan da suka faru, aiki mai yawa ko matsalolin ɗaukar hoto, ko kuma kana buƙatar taimako game da wani abu, kada ka yi jinkirin sanar da kuma aiki tare da CRT.
Muna nan don mu taimaka muku kuma mu yi magana da ku idan kuna bukatar hakan.
Don duk wata tambaya ta sirri ko mai daɗi, ku aika da imel zuwa Bryan Judan, Darakta na Ayyukan Ƙasa da Ƙasa na Ƙasa da Ƙasa.
Babu wani cikin waɗannan canje-canjen da za a ɗauka cewa mun bar aikinmu da kuma hakkokinmu.
Maimakon haka, muna bukatar mu fahimci cewa a yanzu, aikinmu da kuma hakkokinmu za su iya canjawa sosai.
Waɗannan matakai ne da muka ga ya zama dole mu tallafa wa juna don mu ci gaba da aikinmu, mu ba wa ƙungiyarmu taimakon da take bukata, kuma mu ba duniya hidimar da kowa zai iya dogara da ita.
Aikin da aka shirya mana zai kasance a wurin.
Yanzu lokaci ya yi da za mu taimaka wa juna kuma mu shirya kanmu don aikin da za mu yi a makonni masu zuwa ko wata-wata.
Muna bukatar kowannenku ya yi hakan, don haka ku kula da kanku da kuma iyalinku don ku iya ba da mafi kyawun kanku a lokacin.
A ƙarshe, ku wanke hannuwanku kuma kada ku taɓa fuskokinku.
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M da Tony S), da sauran ƙungiyar gudanarwa (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M da Toby N).
L-angiotensin converting enzyme 2 (ACE2) wani enzyme ne wanda ke da alaƙa da gefen waje (ƙwayoyin sel) na ƙwayoyin huhu, jijiyoyi, zuciya, koda, da hanji.
LACE2 yana hana aikin enzyme mai canza angiotensin (ACE) ta hanyar rage adadin dangiotensin II da kuma kara lAng (1-7) wanda ya sa ya zama kyakkyawan makamin magani don magance cututtukan zuciya. LACE2 kuma shine wurin shiga cikin ƙwayoyin wasu coronavirus.
Ana kiran kwayar halitta ta ɗan adam hACE2.
Angiotensin Converting Enzyme 2 wani sinadarin zinc ne wanda yake kan farfajiyar ƙwayoyin endothelial da sauran ƙwayoyin.
Protein ACE2 yana dauke da yankin peptidase M2 mai ƙare N da yankin renal amino acid transporter collectrin mai ƙare C.
LACE2 shine nau'in furotin mai wucewa guda ɗaya na nau'in I, wanda yankin aikin enzymatic ya bayyana akan farfajiyar ƙwayoyin huhu da sauran kyallen takarda.
Wani sinadarin da ake kira sheddase ne yake raba sashen waje na ACE2 daga sashen da ke cikin ƙwayoyin cuta, kuma sai ya fitar da furotin da ke cikin jini kuma ya fitar da shi cikin fitsari.
LACE2 yana cikin yawancin gabobin jiki: ACE2 yana haɗuwa da ƙwayoyin salula na ƙwayoyin cuta na nau'in II na alveoli, ƙananan ƙwayoyin hanji, ƙwayoyin jini da ƙwayoyin jini da ƙwayoyin jini na ƙwayoyin tsoka a yawancin gabobin jiki.
Ana kuma nuna mRNA na ACE2 a cikin ƙwaƙwalwar ƙwaƙwalwa, striatum, hypothalamus da kuma kwakwalwar kwakwalwa.
Aikin farko na ACE2 shi ne ya daidaita ACE.
Ƙwayoyin cuta suna raba ƙwayar angiotensin I zuwa ƙwayar angiotensin II.
ACE2 kuma yana raba amino acid phenylamine mai ƙare carboxyl na angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana haɓaka shi zuwa angiotensin mai fadada jini (1-7), (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
LACE2 na iya rarraba wasu peptides da yawa ciki har da [des-Arg9]-bradykinin, lapelin, neurotensin, dynorphine A, da ghrelin.
LACE2 kuma yana sarrafa yaduwar membrane na mai jigilar amino acid mai tsaka tsaki SLC6A19 kuma yana da hannu cikin cutar Hartnup.
A matsayin furotin mai wucewa, ACE2 shine babban wurin shiga cikin ƙwayoyin wasu coronavirus, gami da HCoV-NL63; SARS-CoV (kwayar cutar SARS); da SARS-CoV-2 (kwayar cutar COVID-19).
Musamman, ɗaurewar furotin S1 na SARS-CoV da SARS-CoV2 zuwa yankin enzymatic na ACE2 a saman sel yana haifar da endocytosis da kuma sauyawar kwayar cutar da enzyme a cikin endosomes a cikin sel.
Wannan tsarin shiga kuma yana buƙatar kunna furotin S ta hanyar mai karɓar serine protease TMPRSS2, hanawa na TMPRSS2 ana bincika shi a matsayin magani mai yuwuwa. Wannan ya sa wasu suna tunanin cewa rage matakan ACE2 a cikin sel na iya taimakawa wajen yaƙar kamuwa da cuta.
Duk da haka, ƙungiyoyi da yawa na ƙwararru da hukumomin kulawa sun ba da shawarar ci gaba da daidaitaccen magani tare da ACE mai hanawa da ARB.
Binciken da aka yi da kuma nazarin da aka yi a ranar 11 ga Yuli, 2012 ya nuna cewa  amfani da ACE inhibitors yana da alaƙa da raguwar haɗarin ciwon huhu da kashi 34% idan aka kwatanta da na masu kulawa. 
Bugu da ƙari,  haɗarin ciwon huhu ya ragu a cikin marasa lafiya da ke shan ACE inhibitor waɗanda ke da haɗarin ciwon huhu, musamman waɗanda ke fama da bugun jini da rashin ƙarfi.
Amfani da ACE inhibitors kuma yana da alaƙa da rage mutuwar da ke tattare da ciwon huhu, kodayake sakamakon bai da ƙarfi kamar na haɗarin ciwon huhu gaba ɗaya.
Ana tsammanin cewa kwayar halittar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar jujjuyawar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar juwar ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju ju
Rabin rayuwar rhACE2 a cikin ɗan adam kusan awanni 10 ne kuma lokacin aiki minti 30 ne ban da tsawon lokacin aiki (tsawon) awanni 24.
Yawancin binciken sun nuna cewa rhACE2 na iya zama kyakkyawan magani ga mutanen da ba su yarda da masu hana tsarin renin-angiotensin (RA) na yau da kullun ba ko kuma cututtukan da ke da babban yaduwar dangiotensin II. An tantance rhACE2 a cikin jarabawar asibiti don maganin ciwon damuwa na numfashi mai tsanani.
Aikace-aikacen COVID-19 aikace-aikacen wayar hannu ne da aka tsara don sauƙaƙe gano waɗanda suka taɓa saduwa da cutar coronavirus ta 2019-20, wato, gano mutanen da za su iya kasancewa tare da wanda ya kamu da cutar.
An samar da aikace-aikace daban-daban ko kuma an ba da shawarar, tare da goyon bayan gwamnati a wasu yankuna da kuma wasu hukunce-hukuncen.
An samar da wasu kayayyakin more rayuwa don tsara aikace-aikacen gano lamba.
Waɗannan tsarin, musamman waɗanda ke dogara da bin diddigin wurin masu amfani da aikace-aikacen, suna haifar da tambayoyin sirri.
Akwai wasu zaɓuɓɓuka masu sauƙi, kamar amfani da siginar Bluetooth don yin rajistar kusanci da mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da haɗin kai tsaye a cikin tsarin aiki na Android da iOS don haɓaka fasalin don tallafawa waɗannan aikace-aikacen Bluetooth.
Gwamnatin China tare da Alipay sun ƙaddamar da wata manhaja a China da ke ba 'yan ƙasa damar bincika ko sun taɓa saduwa da mutanen da ke dauke da COVID-19.
Ana amfani da wannan manhajar a birane fiye da 200 na ƙasar Sin, kuma Singapore ta yi amfani da wata manhajar da ake kira TraceTogether.
Ƙungiyar masana kimiyyar kwamfuta ta ƙera shi, an samar da shi a matsayin tushen buɗe kuma za a ba da shi ga gwamnati. Arewacin Macedonia ta ƙaddamar da  StopKorona! , aikace-aikacen Bluetooth wanda ke gano haɗarin mutane masu yuwuwar kamuwa da cutar da kuma sadarwa da sauri tare da hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya ne suka samar da manhajar.
Tun daga ranar 14 ga Afrilu, 2020, aikace-aikacen yana jiran amincewa daga Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnati ta ce aikace-aikacen gano lamba yana cikin ci gaba kuma ana iya tura shi a cikin makonni masu zuwa. Ana shirin yin irin wannan aikace-aikacen a Ireland da Faransa ( StopCovid).
Australia da New Zealand suna shirin kafa manhajoji kamar TraceTogether a Singapore da kuma bisa tsarin BlueTrace. Rasha na son gabatar da manhajar gano wuri ga marasa lafiya da ke da cutar COVID-19 da ke zaune a Moscow don tabbatar da cewa ba sa barin gidajensu.
Ross Anderson, farfesa a fannin aikin injiniya a jami'ar Cambridge, ya tattauna wasu matsaloli masu amfani da amfani da tsarin da ke amfani da aikace-aikace, ciki har da kuskuren karya da kuma rashin inganci idan ƙananan mutane ne kawai ke amfani da aikace-aikacen.
Dangane da damuwa game da yaduwar aikace-aikacen  coronavirus  na ƙarya ko cutarwa, Apple yana ba da izinin ƙungiyoyi  na hukuma  ko kuma waɗanda aka amince da su gaba ɗaya don ƙara aikace-aikacen da suka shafi coronavirus zuwa App Store.
Google da Amazon sun kafa irin wannan dokar.
Masu fafutukar kare sirrin mutane sun nuna damuwa game da tasirin aikace-aikacen coronavirus a kan sa ido kan mutane da yawa, musamman yadda za a iya rushe tsarin sa ido da aka gina don magance annobar coronavirus da zarar an kawar da barazanar.
Ƙungiyar Amnesty International da kuma wasu ƙungiyoyi fiye da 100 sun ba da sanarwar cewa ya kamata a rage irin wannan sa ido.
Waɗannan kungiyoyin sun kafa dokoki guda takwas da za a bi a ayyukan gwamnati:
Dole ne kulawa ta kasance  doka, dole kuma mai dacewa ;
Ƙarin kulawa da kulawa ya kamata ya ƙunshi ɓoyewa;
Ya kamata a iyakance amfani da bayanai ga manufofin COVID-19;
yakamata a tabbatar da tsaro da rashin sani;
Ya kamata a kula da sa ido kan dijital don kauce wa ƙara nuna bambanci da ɓoyewa;
Duk wani musayar bayanai da wasu kamfanoni ya kamata a tsara shi a cikin doka;
Ya kamata a samar da kariya daga cin zarafi da kuma hanyoyin da 'yan kasa za su bi idan aka yi musu cin zarafi;
 muhimmiyar shiga  daga dukkan  masu ruwa da tsaki  da abin ya shafa  za a tilasta, musamman ma daga masana kiwon lafiya da kungiyoyin da ba a kula da su.
Shirin da Google/Apple suka gabatar ya yi nufin magance matsalar ci gaba da sa ido ta hanyar cire tsarin bin diddigin na'urorin su idan ba a bukatar hakan.
Wasu ƙasashe sun yi amfani da tsarin gano wuri na cibiyar sadarwa maimakon aikace-aikace, wanda ke kawar da buƙatar sauke aikace-aikacen da kuma ikon kauce wa bin sawu.
An amince da bin hanyar sadarwa a Isra'ila.
Hanyoyin sadarwa masu amfani da bayanai na GIS suna da manyan matsalolin sirri.
Duk da haka, ba duk tsarin da ke dogara da uwar garke na tsakiya ba ne ke buƙatar samun damar bayanan wurin mutum; an tsara wasu tsarin don amfani da uwar garke na tsakiya don sadarwa kawai, wanda ke ba da damar mutunta sirrin (duba sashe na gaba).
A Koriya ta Kudu, an yi amfani da tsarin da ba ya amfani da manhajar kwamfuta don gano waɗanda suka tuntube su.
Maimakon amfani da wata manhaja ta musamman, tsarin ya tattara bayanan ganowa daga wurare daban-daban, ciki har da bayanan gano na'urar hannu da bayanan ma'amala ta katin, sannan suka haɗa su don aika saƙonnin SMS na gargadi ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da waɗanda za su iya tuntuɓar su, gwamnati ta kuma ba da bayanin wurin da jama'a za su iya samunsa, wanda aka ba da izinin bayan canje-canje masu yawa a dokokin tsare sirri bayan barkewar cutar MERS a ƙasar.
Ana iya samun wannan bayanin ta hanyar manhajoji da shafukan yanar gizo da yawa.Ƙasashen kamar Jamus sun yi la'akari da amfani da tsarin tsare sirri na tsakiya.
Har zuwa ranar 6 ga Afrilu, 2020 ba a ba da cikakken bayani ba.
Binciken tuntuɓar sirri ya zama sananne, wanda aka tallafawa da yawan bayanan bincike tun daga 2013. A ranar 7 ga Afrilu, 2020, sama da ƙungiyoyin masana goma sha biyu suna aiki kan hanyoyin magance sirrin sirri, gami da amfani da fasahar Bluetooth Low Energy (BLE) don yin rajistar kusanci da mai amfani da wasu wayoyin hannu.
Duk da haka, aikin PEPP-PT aiki ne na daidaitawa wanda ya haɗu da hanyoyin tsakiya da na rarraba kuma ba yarjejeniya ɗaya ba.
Waɗannan ladabi suna tabbatar da cewa bayanan sirri ba sa fita daga na'urar kuma duk abin da aka yi daidai yana faruwa ne a kan na'urar.
Rukunin Sirri na MIT Media Lab a halin yanzu yana haɓaka SafePaths, dandamali don amfani da fasahohin tsare sirri yayin tattarawa da amfani da bayanan wuri ko tuntuɓar don bin diddigin yaduwar COVID-19.
Wannan fasaha ta dogara ne akan sakamakon takardar farin  Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic  da aka buga a watan Maris na 2020.
SafeTrace yana amfani da fasaha mai ƙarfi don bawa masu amfani damar raba wuri mai mahimmanci da bayanan kiwon lafiya tare da sauran masu amfani da hukumomi, ba tare da lalata sirrin su ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyin da suka haɗu a kan hanyar da ta dace da kuma ƙa'idodin da suka dace sun kafa Ƙungiyar TCN ta Duniya don rage rarrabuwa da tabbatar da haɗin gwiwar duniya na aikace-aikacen sa ido da faɗakarwa, babban mahimmin abu don karɓar su ta hanyar jama'a.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da sakin lambar tushe ta yarjejeniyar BlueTrace da aikace-aikacen hukuma ke amfani da ita.
A ranar 10 ga Afrilu, 2020, Google da Apple, waɗanda ke sarrafa dandamali na wayar hannu na Android da iOS, sun sanar da shirin bin sawun lamba, suna cewa zai ba da damar kiyaye sirrin mutane kuma zai haɗa fasahar Bluetooth Low Energy da ɓoye ɓoye.
Sun kuma wallafa takamaiman fasahohin da za a yi amfani da su a cikin tsarin.
A cewar Apple da Google, tsarin zai gudana a matakai uku:
tura kayan aiki don gwamnatoci su kirkiro aikace-aikacen gano cutar korona na hukuma da ke mutunta sirrin mutane
Google da Apple suna shirin magance matsalolin tallafi da kuma ci gaba da saka idanu ta hanyar fara rarraba tsarin ta hanyar sabunta tsarin aiki sannan kuma cire shi ta wannan hanyar bayan an kawar da barazanar.
Sake sanya magani (wanda ake kira sake juyawa, sake fasalin, sake amfani da shi ko kuma sauya yanayin magani) yana nufin sake amfani da magani da aka amince da shi don wata cuta ko yanayin likita daban da wanda aka fara haɓaka shi.
Wannan wani yanki ne na binciken kimiyya da ake yi yanzu don samar da lafiya da kuma ingantaccen magani don COVID-19.
Sauran fannonin bincike sun haɗa da samar da allurar rigakafin COVID-19 da kuma ƙarin jini daga masu warkewa. SARS-CoV-2 yana da kusan furotin 66 da ake amfani da su don magani, kowannensu yana da wurare da yawa na ɗaure ligand.
Binciken waɗannan wuraren haɗin yana ba da kyakkyawan tsari don haɓaka ingantaccen maganin rigakafin ƙwayar cuta akan sunadarai na COVID-19.
Wasu daga cikin manyan sunadarai da SARS-CoV-2 ke kaiwa hari sun haɗa da protease mai kama da papain, RNA polymerase mai dogara da RNA, helixase, S protein da ADP ribose phosphatase.
Hussein A A, et al. sun yi nazarin wasu mahaɗan da suka yi niyyar amfani da su sannan suka inganta su kuma suka bincika su don ƙayyade kamaninsu da magungunan da aka amince da su don hanzarta haɓaka magani mai ƙarfi na SARS-CoV-2 a cikin binciken su na farko don ba da shawarar a cikin ƙirar gwajin asibiti.
Chloroquine magani ne na zazzabin cizon sauro da ake amfani da shi wajen magance wasu cututtuka na jikin mutum.
A ranar 18 ga Maris, WHO ta sanar da cewa chloroquine da hydroxychloroquine masu alaƙa za su kasance cikin magunguna huɗu da ake nazari a gwajin asibiti na Solidarity.
Gwamnan New York, Andrew Cuomo ya sanar da cewa gwajin da jihar New York ke yi na chloroquine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da hydroxychloroquine sulfate da chloroquine phosphate a ƙarƙashin izinin amfani da gaggawa (Amurka).
Ba a amince da maganin ta hanyar gwajin asibiti na FDA ba kuma an ba da izinin shi a ƙarƙashin Amurka kawai azaman magani na gwaji don amfani da gaggawa a cikin marasa lafiya da ke asibiti amma ba za su iya karɓar magani a gwajin asibiti ba.
CDC ta ce har yanzu ba a tabbatar da amfani da kashi ko tsawon lokacin da za a yi amfani da hydroxychloroquine don hana ko magance kamuwa da cutar SARS-COV-2 ba.
Likitoci sun ce a yi amfani da wannan magani idan babu wani zaɓi.
Wata ƙungiyar bincike a Turkiyya a Istanbul tana gudanar da wani ƙaramin bincike game da amfani da chloroquine tare da zinc, bitamin A, bitamin C da bitamin D.
Ana gudanar da bincike mai zurfi a jami'ar Duke da Oxford.
Makarantar Likita ta NYU Langone tana gudanar da gwaji kan lafiya da ingancin amfani da hydroxychloroquine don hana cutar.
Gwaje-gwajen asibiti na kasar Sin da aka gudanar a Wuhan da Shenzhen sun tabbatar da favipiravir  a fili yana da tasiri .
An gwada marasa lafiya 35 a Shenzhen marasa lafiya a cikin kwanaki 4 yayin da tsawon lokacin cutar ya kasance kwanaki 11 a cikin marasa lafiya 45 da ba su karɓi magani ba.
A wani bincike da aka yi a Wuhan da ya shafi marasa lafiya 240 da ke fama da ciwon huhu, rabin sun karɓi favipiravir da sauran rabin kuma lumifenovir.
Hukumar kula da magunguna ta Italiya ta tunatar da jama'a cewa shaidar da ke akwai don maganin ba ta da ƙarfi kuma na farko.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi maganin daga Japan don ajiyarta kuma za ta yi amfani da sojoji don isar da maganin zuwa asibitocin jami'a inda za a yi amfani da maganin don kula da marasa lafiya da ke da COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya buɗe wa gwamnatin Trump hanyar sayen maganin, wanda zai iya zama da ƙarancin tasiri a cikin masu fama da cutar inda cutar ta riga ta ƙaru.
Zai iya zama da haɗari ga mata masu ciki ko kuma waɗanda suke ƙoƙarin haifan yara.
Wani bincike da aka yi akan lopinavir/ritonavir (Kaletra), wani magani ne na maganin rigakafin cutar lopinavir da ritonavir, ya kammala  cewa babu wata fa'ida .
An tsara waɗannan magungunan don su hana ƙwayar HIV ta sake haifuwa ta wajen ɗaure ta da ƙwayar protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado suna ƙoƙarin canza waɗannan magungunan don nemo wani fili wanda zai ɗaure da protease na SARS-CoV-2. Akwai ƙin yarda a cikin ƙungiyar kimiyya game da amfani da albarkatu don sake sanya magunguna musamman don HIV/AIDS.
WHO ta haɗa lopinavir/ritonavir cikin gwajin Solidarity na duniya.
Gilead Sciences ne suka kirkiro da kuma samar da maganin Remdesivir don maganin cutar Ebola da cututtukan Marburg. Daga baya Gilead Sciences ta gano cewa remdesivir yana da maganin rigakafin cutar a cikin kwayoyin cutar da ke da yawa kamar filovirus, pneumovirus, paramyxovirus da coronavirus.
Wata matsala da maganin rigakafin cutar ita ce ci gaban juriya ta hanyar maye gurbi wanda zai iya haifar da ciwo mai tsanani da kuma yaduwa.
Wasu binciken da aka yi kafin gwaji sun nuna cewa remdesivir na iya samun babban shinge na kwayoyin don juriya. Ana gudanar da gwaji da yawa na asibiti, ciki har da biyu da asibitocin jami'a na Cleveland ke gudanarwa; ɗaya a kan mutanen da ke da matsakaiciyar cuta da ɗayan a kan waɗanda ke da mafi tsanani.
Akwai gwaji uku na asibiti da ke gudana kan bitamin C a cikin jijiya ga mutanen da ke asibiti da ke fama da cutar COVID-19; biyu da aka sarrafa da placebo (China da Kanada) da ɗaya ba tare da sarrafawa ba (Italiya).
Jihar New York ta fara gwajin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kiwon Lafiya ta Kasa da Magunguna ta Duniya ta Japan (NCGM) tana shirin gwajin asibiti akan Teijin alvesco (cyclesonide), corticosteroid na numfashi da ake amfani da shi don asma, don kula da marasa lafiya da ke da alamun cutar coronavirus.
Wani nau'in enzyme mai canza angiotensin 2, ana gudanar da gwajin kashi na biyu tare da marasa lafiya 200 da za a ɗauka daga cikin masu fama da cutar a Denmark, Jamus da Austria don sanin ingancin maganin.
Masu bincike a Cibiyar Zuciya ta Montreal a Kanada a halin yanzu suna nazarin rawar colchicine wajen rage kumburi da matsalolin huhu a cikin marasa lafiya da ke fama da alamun COVID-19 masu sauƙi.
Binciken da ake kira COLCORONA ya haɗa da manya 6,000 masu shekaru 40 zuwa sama waɗanda aka gano suna da COVID-19 kuma suna da alamun rashin lafiya da ba sa bukatar zuwa asibiti.
Mata masu ciki ko masu shayarwa ko kuma waɗanda ba su da maganin hana ɗaukar ciki mai inganci ba su cancanci shiga makarantar ba.
Ana gwada wasu magunguna da ke hana jini gudu a ƙasar Italiya.
Ana amfani da ƙananan ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
An sanar da wani bincike mai yawa da ya shafi marasa lafiya 300 da ke nazarin amfani da linoxaparin sodium a cikin allurai na rigakafi da magani a Italiya a ranar 14 ga Afrilu.
Tun da yake SARS-CoV-2 kwayar cuta ce, yawancin masu bincike sun mai da hankali kan sake sanya magungunan rigakafin ƙwayoyin cuta da aka amince da su waɗanda aka haɓaka don barkewar cutar da ta gabata kamar MERS, SARS da West Nile Virus.
Ribavirin: an ba da shawarar ribavirin don maganin COVID-19 bisa ga jagororin China na 7
Umifenovir: an ba da shawarar lumifenovir don maganin COVID-19 bisa ga jagororin China na 7
An gano wasu magungunan rigakafi da za a iya sake saka su a matsayin magungunan COVID-19:
Tocilizumab (mai hana IL-6 karɓar IL-6): da China ta amince.
Ana kuma yin gwaji a Italiya da China. Ka duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19 allurar rigakafi ce da ake tsammani da za ta iya hana cutar coronavirus ta 2019 (COVID-19).
Ko da yake babu wani allurar da ta wuce gwajin asibiti, ana ƙoƙarin yin wasu gwaje-gwaje.
A ƙarshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba a sa ran samun allurar rigakafin cutar SARS-CoV-2 ba, cutar da ke haifar da cutar, har zuwa aƙalla watanni 18.
A watan Afrilu, an yi gwajin lafiya na farko kan alluran rigakafi biyar.
An gano COVID-19 a watan Disamba na 2019.
Wani babban annobar cuta ya ɓarke a duniya a shekarar 2020, wanda ya haifar da saka hannun jari da bincike mai yawa don samar da allurar rigakafi.
Ƙungiyoyi da yawa suna amfani da ƙwayoyin halittar da aka buga don haɓaka alluran rigakafin SARS-CoV-2.
An bayyana a watan Afrilu, abubuwan da ke buƙatar CEPI don samar da allurar rigakafi sune sauri, iya samarwa, turawa da samun dama a duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa kamfanonin fasaha daban-daban 10 suna gudanar da bincike da ayyukan ci gaba a farkon 2020 da nufin samar da allurar rigakafin COVID-19.
Manufofin babban dandamali wanda aka ƙaddamar da shi a cikin binciken I na Tsaro sun haɗa da:
nucleic acid (DNA da RNA) (lokaci na farko mai haɓaka da mai neman allurar rigakafi: Moderna, mRNA-1273)
mai ɗaukar hoto (lokaci na farko mai haɓaka da mai neman rigakafi: CanSino Biologics, mai ɗaukar hoto na adenoviral na 5)
Kamar yadda masana kimiyya na CEPI suka bayyana a watan Afrilu, jimillar alluran rigakafi 115 suna cikin matakan farko na ci gaba, 78 (79 bisa ga Cibiyar Milken) an tabbatar da aiki da kuma wasu 37 da aka sanar, amma tare da ɗan bayani na jama'a (wanda ake tsammanin a cikin shiri ko zane).
Gwajin Mataki na I-II yana gudanar da gwajin farko na aminci da rigakafi, yawanci ana sarrafa shi ta hanyar bazuwar, ana sarrafa shi da wuribo kuma ana gudanar dashi a wurare da yawa, yana ƙayyade ƙarin ƙayyadaddun allurai masu tasiri.
Gwaje-gwaje na Mataki na III yawanci sun haɗa da mahalarta da yawa, gami da ƙungiyar sarrafawa, kuma suna gwada ingancin allurar rigakafin don hana cutar, yayin lura da tasirin sakamako mara kyau a mafi kyawun sashi.
Daga cikin alluran rigakafi 79 da ake ci gaba da su (wanda aka tabbatar a farkon Afrilu 2020), 74 ba su riga sun fara gwaji a kan mutane ba (har yanzu a cikin bincike  kafin asibiti ).
A ranar 24 ga Janairu, 2020, Jami'ar Queensland ta Australia ta sanar cewa tana nazarin yiwuwar yin allurar rigakafin kwayar halitta da za ta iya canza kwayoyin halittar ƙwayoyin cuta don haɓaka maganin rigakafi.
A kusan ranar 24 ga Janairu, 2020, Cibiyar allurar rigakafin ƙasa da ƙasa (VIDO-InterVac) a Jami'ar Saskatchewan ta Kanada ta sanar da cewa ta fara aiki kan allurar rigakafi, wanda ake sa ran za a fara gwajin ɗan adam a 2021.
An sanar da shirye-shiryen samar da allurar rigakafi a Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta China a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceutical Companies, wanda Hanneke Schuitemaker ke jagoranta, ya sanar da cewa sun fara aiki kan samar da allurar rigakafi.
Janssen tana yin allurar rigakafi da za a iya amfani da ita ta baki tare da abokin aikinta a fannin fasahar halittu, Vaxart.
A ranar 18 ga Maris, 2020, kamfanin Emergent BioSolutions ya sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar.
A ranar 8 ga Fabrairu, 2020, OncoGen Lab a Romania ta buga takarda game da ƙirar allurar rigakafi tare da fasaha mai kama da allurar rigakafin neonantigen da ake amfani da ita don maganin cutar kansa.
A ranar 25 ga Maris, darektan cibiyar bincike ya sanar cewa sun kammala samar da allurar rigakafin kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani reshen kamfanin Generex, NuGenerex Immuno-Oncology ya sanar da cewa ya fara aikin allurar rigakafi don samar da allurar rigakafi da ke da maganin II-Key peptides don COVID-19.
Sun so su samar da allurar rigakafin da za a iya gwadawa a kan mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da shirin samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Hukumar Kula da Kula da Kula da Kiwon Lafiya da Kayan Aiki ta Sojojin Amurka a Fort Detrick da Cibiyar Nazarin Sojojin Walter Reed a Silver Spring, duka biyu a yammacin Maryland, sun sanar da cewa suna aiki kan allurar rigakafi.
A kusan ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da haɗin gwiwa tare da Novavax Inc.
A cikin ci gaba da kuma samar da allurar rigakafi.
Abokan hulɗar sun kuma sanar da shirye-shiryen gwajin rigakafi da gwajin gwaji na farko a watan Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar cewa suna aiki a kan mutane 11 kuma ko da a cikin hanzarta aiki, zai ɗauki kimanin shekara ɗaya da rabi zuwa shekaru biyu don samar da allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin fasahar halittu da ke birnin Quebec, Quebec, ya ba da rahoton cewa yana samar da wani abu mai kama da cutar korona ta hanyar samun tallafin kuɗi daga Cibiyoyin Bincike na Kiwon Lafiya na Kanada.
Ana gudanar da bincike a dakin gwaje-gwaje kan allurar rigakafin, kuma an shirya gwajin mutum a watan Yuli ko Agusta na 2020.
A farkon wannan makon, jaridar Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac  kuɗi masu yawa don samun damar yin allurar rigakafin COVID-19 , wanda hakan ya jawo ƙin amincewar gwamnatin Jamus.
A ranar 17 ga Maris, 2020, kamfanin harhada magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
A halin yanzu, ana gwajin rigakafin da ke da tushen BNT162 mRNA a matakin gwaji tare da fara gwajin asibiti a watan Afrilu na 2020.
A ranar 17 ga Maris, 2020, a Italiya, Takis Biotech, wani kamfanin fasahar halittu na Italiya, ya sanar da cewa zai sami sakamakon gwajin farko a watan Afrilu na 2020 kuma gwajin ɗan adam na allurar rigakafinsa ta ƙarshe na iya farawa a kaka.
A Faransa, a ranar 19 ga Maris, 2020, Ƙungiyar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙirƙirar Ƙir
Sauran abokan haɗin gwiwar saka hannun jari na CEPI don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, hukumomin kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na alluran rigakafi daban-daban guda shida.
Masu bincike a Kwalejin Imperial ta Landan sun sanar a ranar 20 ga Maris, 2020 cewa suna kan aikin samar da allurar rigakafin RNA mai kara kuzari don COVID-19.
An samar da allurar rigakafin a cikin kwanaki 14 bayan China ta aika da jerin.
A ƙarshen watan Maris, gwamnatin Kanada ta sanar da bayar da tallafin C$275 miliyan don ayyukan bincike 96 kan maganin COVID-19, ciki har da wasu alluran rigakafi a kamfanonin Kanada da jami'o'i kamar Medicago da Jami'ar Saskatchewan.
A kusan lokaci guda, gwamnatin Kanada ta sanar da ware dala miliyan 192 na C don samar da allurar rigakafin COVID-19 tare da shirye-shiryen ƙirƙirar  bankin allurar rigakafin  na ƙasa wanda ke ɗauke da sabbin alluran rigakafi da yawa waɗanda za a iya amfani da su idan ƙarin barkewar cutar coronavirus ta faru.
A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar rigakafin COVID-19 a cikin beraye, suna cewa ƙananan alluran allurar rigakafin SARS-CoV-2 S1 da aka yi amfani da su ta hanyar allurar microaids sun haifar da babban amsawar ƙwayoyin cuta na musamman ga antigen [a cikin beraye] da aka gani makonni 2 bayan allurar rigakafi.
A Kanada, a ranar 16 ga Afrilu, 2020, Makarantar Magunguna ta Jami'ar Waterloo ta sanar da ƙirar takarar allurar rigakafin DNA a cikin nau'in fesa hanci.
Ta amfani da kwayoyin cuta, za a tsara DNA don yin kwafi a cikin ƙwayoyin cuta na mutum don samar da ƙwayoyin cuta marasa lahani kamar ƙwayoyin cuta waɗanda za su iya ƙarfafa samar da ƙwayoyin cuta ga ƙwayar SARS-CoV-2 ta tsarin garkuwar jiki.
A watan Maris na 2020, gwamnatin Amurka, masana'antu da jami'o'i uku sun haɗa kan albarkatun su don samun damar kwamfutocin IBM, haɗe da albarkatun kwamfuta da ke cikin girgije na Hewlett Packard Enterprise, Amazon, Microsoft da Google.
Wasu alluran rigakafi suna da sakamako dabam dabam, wanda ake kira sakamako marar iyaka.
Hakan yana nufin cewa za su iya kawo amfani fiye da hana cututtuka.
Wani gwaji da aka yi a Australia ya haɗa da ma'aikatan kiwon lafiya 4,170.
Ana iya samun alluran rigakafin da ba su da lafiya ko tasiri.
Binciken farko don kimanta ingancin allurar rigakafi ta amfani da samfurin dabba na musamman don COVID-19, kamar ƙwayoyin ACE-2 da aka canza, wasu dabbobin gwaji, da manyan dabbobi ba mutane ba, ya nuna buƙatar aiwatar da matakan tsare-tsare na matakin 3 don sarrafa ƙwayoyin cuta masu rai, da haɗin gwiwar ƙasa da ƙasa don tabbatar da daidaitaccen hanyoyin aminci.
An gwada alluran rigakafin SARS da MERS a kan dabbobi da ba mutane ba.
A shekarar 2020, babu wani maganin riga-kafi da zai iya warkarwa ko kare SARS da ya nuna cewa yana da lafiya da kuma tasiri a cikin mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da haɓaka sabbin alluran rigakafi da magunguna don magance SARS sun kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya a duniya. Babu wani allurar rigakafin MERS da aka tabbatar.
Lokacin da MERS ya bazu, an yi tunanin cewa binciken da ake yi a kan SARS zai iya zama abin koyi don samar da alluran rigakafi da magunguna don kamuwa da MERS-CoV.
A watan Maris na 2020, riga-kafi guda ɗaya na MERS (wanda ya dogara da DNA) ya kammala gwajin gwaji na farko a cikin ɗan adam kuma wasu uku suna gudana; duk alluran sun kasance masu ɗaukar hoto na kwayar cuta, biyu masu ɗaukar hoto na adenoviral (ChAdOx1-MERS, BVRS-GamVac) da ɗaya mai ɗaukar hoto na MVA (MVA-MERS-S).
Wasu shafukan sada zumunta sun yada ra'ayin makirci cewa an san kwayar cutar da ke haifar da COVID-19 kuma an riga an samu allurar rigakafi.
Takardun haƙƙin mallaka da aka ambata a shafukan sada zumunta daban-daban suna nufin takardun haƙƙin mallaka na asali da ke tattare da jerin kwayoyin halitta da alluran rigakafi don wasu nau'ikan coronavirus kamar SARS coronavirus.
Cutar coronavirus ta 2019 (COVID-19) cuta ce mai saurin yaduwa ta hanyar coronavirus 2 da ke da alaƙa da mummunan cututtukan numfashi (SARS-CoV-2).
Alamun cututtuka na yau da kullum sun haɗa da zazzabi, tari da kuma numfashi.
Sauran alamun cututtuka sun haɗa da gajiya, ciwon tsoka, zawo, ciwon makogwaro, rashin ɗanɗano, da ciwon ciki.
Yawancin lokaci lokaci tsakanin kamuwa da cutar da bayyanar cututtuka kusan kwanaki biyar ne, amma zai iya zama tsakanin kwanaki biyu zuwa 14.
Ko da yake yawancin mutane ba su da alamun cutar, wasu suna ci gaba zuwa ciwon huhu da kuma rashin aiki na gabobin jiki.
A ranar 17 ga Afrilu, 2020, an samu sama da mutane miliyan 2.24 a duniya a ƙasashe 210 da yankuna, kuma mutane fiye da 153,000 sun mutu.
Fiye da mutane 568,000 sun warke. Ana yada kwayar cutar ne ta hanyar kusanci, sau da yawa ta hanyar ɗigon ruwa da ake samu ta tari, hancinsa ko magana.
Tun da yake ana fitar da waɗannan ɗigon ruwa a numfashi, yawanci suna faɗuwa ne a ƙasa ko kuma a kan abubuwa maimakon su zama haɗarin kamuwa da cuta a nesa.
Mutane za su iya kamuwa da cutar ta wurin taɓa wani abu da ya kamu da cutar, da kuma idanunsu da hanci da kuma bakinsu.
Kwayar cutar na iya rayuwa a kan abubuwa har tsawon sa'o'i 72.
Ana iya kamuwa da cutar a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake ana iya kamuwa da cutar kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda suke zaton suna da cutar da kuma masu kula da su.
Shawarwarin da aka bayar game da sanya abin rufe fuska ga jama'a gabaɗaya sun bambanta, tare da wasu hukumomi da ke hana amfani da shi, wasu da ke ba da shawarar amfani da shi, wasu kuma da ke tilasta amfani da shi.
A halin yanzu babu wani rigakafi ko magani na musamman na cutar COVID-19.
An samu yaduwar cutar a cikin yawancin ƙasashe a cikin yankuna shida na WHO.
Mutane da ke dauke da kwayar cutar ba za su iya nuna alamun cutar ba ko kuma su nuna alamun mura kamar zazzabi, tari, gajiya, da kuma numfashi a hankali.
Alamomin gaggawa sun hada da wahalar numfashi, ciwon kirji ko matsin lamba, rikicewa, wahalar tafiya da fuska ko lebe mai launin shuɗi.
A wasu lokatai, ana iya samun alamun numfashi kamar yin fitsari, ɓoyewa daga hanci ko kuma ciwon makogwaro.
An lura da alamun cututtuka na ciki da na ciki kamar su tashin zuciya, amai da gudawa a wurare dabam dabam.
Wasu mutane a China sun fara nuna matsa lamba a kirji da bugun zuciya.
A wasu mutane, cutar tana iya sa su kamu da ciwon huhu, su rasa gabobin jikinsu, kuma su mutu.
Wannan lokaci ne da ake kira lokacin ƙwanƙwasawa.
Lokacin kamuwa da COVID-19 yawanci kwanaki biyar zuwa shida ne, amma zai iya kaiwa kwanaki 14.
Kashi 97.5 cikin ɗari na mutanen da suka kamu da cutar za su kamu da cutar a cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba dukan mutanen da ke kamuwa da cutar ba ne za su kamu da cutar.
Har yanzu ba a san cikakken rawar da waɗannan masu ɗauke da cutar ba a cikin yaduwar cutar ba, duk da haka, bayanan farko sun nuna cewa suna iya taimakawa wajen yaduwar cutar.
Ba a san adadin mutanen da ke da cutar ba tare da alamun cutar ba kuma ana nazarin su. Cibiyoyin Kula da Cututtuka na Koriya (KCDC) sun ba da rahoton cewa kashi 20 cikin ɗari na duk waɗanda aka tabbatar da cutar ba su da alamun cutar yayin kwantar da su a asibiti.
Hukumar Lafiya ta Kasa ta kasar Sin ta fara haɗa marasa alamun cutar a cikin adadin masu cutar a ranar 1 ga Afrilu; daga cikin mutane 166 da suka kamu da cutar a ranar, 130 (78%) ba su da alamun cutar a lokacin gwajin.
Ƙura da kuma leɓen ruwa suna ɗauke da ƙwayoyin cuta masu yawa.
Yin magana da babbar murya tana sa ruwa ya zubo fiye da yin magana da ƙarfi.
Wani bincike da aka yi a ƙasar Sigapur ya nuna cewa idan mutum ya yi tari ba tare da ya yi amfani da abin da zai kāre shi ba, zai iya jefa ruwa daga nesa har tsawon mita 4.5.
Kodayake ba a yawan daukar kwayar cutar ta iska, Cibiyar Kimiyya ta Kasa ta ba da shawarar cewa watsawa ta hanyar bioaerosol na iya yiwuwa kuma masu karɓar iska a cikin zauren da ke wajen ɗakunan marasa lafiya sun samar da samfuran tabbataccen RNA na kwayar cutar.
Wasu hanyoyin likita kamar intubation da CPR na iya watsa ɓoyayyen numfashi kuma don haka ya haifar da yaduwar iska.
Ko da yake akwai damuwa game da yaduwar ta hanyar bargo, ana ganin cewa wannan haɗarin ba shi da yawa. Kwayar cutar tana da saurin yaduwa lokacin da mutane ke nuna alamomi; kodayake yaduwa na iya yiwuwa kafin bayyanar alamomi, haɗarin ba shi da yawa.
Cibiyar Kula da Cututtuka ta Turai (ECDC) ta ce ko da yake ba a san yadda cutar take yaduwa ba, mutum ɗaya yakan kamu da mutane biyu zuwa uku. Kwayar cutar tana rayuwa na sa'o'i ko ma kwanaki a kan abubuwa.
Ainihin, an gano kwayar cutar bayan kwana ɗaya a kan kwali, kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304) da kuma bayan sa'o'i huɗu a kan jan ƙarfe 99%.
Amma hakan ya dangana ga yanayin zafi da kuma zafi.
Sabulu da kayan wanki ma suna da amfani idan aka yi amfani da su yadda ya kamata; sabulu yana lalata fatar da ke kare kwayar cutar, yana kashe ta kuma kawar da ita daga fata da sauran wurare.
Wasu magunguna kamar su benzalkonium chloride da chlorhexidine gluconate (wani maganin kashe ƙwayoyin cuta na tiyata) ba su da tasiri sosai.
A cikin marasa lafiya biyar cikin shida, samfurin farko ya nuna yawan kwayar cutar mafi girma, yayin da a cikin mai haƙuri na shida, yawan kwayar cutar mafi girma ya kasance a rana ta biyu da aka gwada.
Cutar coronavirus 2 da ke da alaƙa da mummunan cututtukan numfashi (SARS-CoV-2) wata sabuwar kwayar cuta ce da ke haifar da mummunan cututtukan numfashi, da farko an ware ta daga mutane uku da ke fama da cutar huhu da ke da alaƙa da cutar numfashi mai tsanani a Wuhan.
Dukkanin halaye na sabon kwayar SARS-CoV-2 suna cikin coronaviruses masu alaƙa a cikin yanayi.
A waje da jikin mutum, sabulu na gida yana lalata kwayar cutar, wanda ke karya murfinta na kariya. SARS-CoV-2 dangi ne na kusa da SARS-CoV na asali.
Cutar COVID-19 ta fi shafar huhu domin kwayar cutar tana shiga cikin ƙwayoyin halitta ta hanyar ƙwayar halittar mai canza angiotensin 2 (ACE2) wanda ya fi yawa a cikin ƙwayoyin alveolar nau'in II na huhu.
Kwayar cutar tana amfani da takamaiman glycoprotein mai ƙarancin ƙwayoyin cuta da ake kira  spicular  (peplomer) don ɗaure kansa da ACE 2 kuma ya shiga cikin ƙwayoyin halitta.
An samu mummunan rauni a cikin kashi 12 cikin ɗari na waɗanda aka kwantar a asibiti a Wuhan, China, kuma yawanci yakan faru ne idan cutar ta yi tsanani.
Yawan alamun cututtukan zuciya suna da yawa, saboda amsawar kumburi da kuma lalacewar tsarin garkuwar jiki yayin ci gaban cutar, amma lalacewar jijiyoyin zuciya na iya kasancewa da alaƙa da masu karɓar ACE-2 a cikin zuciya.
Masu karɓar ACE2 suna da ƙarfi a cikin zuciya da ayyukan zuciya da ke ciki.
An lura da yawan kamuwa da cutar thrombosis (31%) da cututtukan thromboembolic veinary (25%) a cikin marasa lafiya a sashen kulawa mai tsanani da ke fama da kamuwa da COVID-19 kuma ana iya alakanta su da mummunan yanayin. Binciken gawa na mutanen da suka mutu daga COVID-19 ya nuna lalacewar alveolar (DAD) da kuma ƙwayoyin ƙwayoyin ƙwayoyin cuta a cikin huhu.
Ko da yake SARS-COV-2 yana nuna ƙwayoyin ƙwayoyin cuta na iska waɗanda ke bayyana ACE-2, marasa lafiya da ke fama da COVID-19 mai tsanani suna nuna alamun ƙonewa.
Musamman ƙwayoyin T masu ɓoye GM-CSF sun kasance masu alaƙa da ɗaukar ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙ
An kuma samu wasu ƙwayoyin lymphocyte a lokacin da aka yi wa mutum autopsy.
WHO ta wallafa wasu hanyoyin gwaji don cutar.
Hanyar gwajin da aka saba amfani da ita ita ce ta amfani da kwafin kwayar halittar polymerase a ainihin lokacin (rRT-PCR).
Ana yawan yin gwajin ne akan samfurori na numfashi da aka samu ta hanyar shan hanci da hanci; duk da haka, ana iya amfani da samfurin hanci ko kuma zubar da jini.
Ana samun sakamako a cikin sa'o'i kaɗan ko kuma cikin kwana biyu.
Ana iya yin amfani da gwaje-gwajen jini, amma suna bukatar a ɗauki jini sau biyu a mako biyu kuma sakamakon ba shi da amfani nan da nan.
Masana kimiyya na kasar Sin sun iya ware wani kwayar cutar korona kuma sun wallafa tsarin kwayoyin halitta don haka dakunan gwaje-gwaje a duk faɗin duniya sun iya samar da gwajin PCR don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin ƙwayoyin cuta (wanda zai iya gano cututtukan da ke aiki da kuma cutar da mutum ya taɓa kamuwa da ita) amma ba a yi amfani da su sosai ba.
A cikin gwajin da aka yi a ƙasar Sin, an sami daidaito tsakanin kashi 60 da 70 cikin ɗari kawai.
Hukumar FDA a Amurka ta amince da gwajin farko na kusa da mai haƙuri a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Jagororin bincike da Asibitin Zhongnan na Jami'ar Wuhan ya buga sun ba da shawarar hanyoyin gano kamuwa da cuta bisa ga halayen asibiti da haɗarin annoba.
Rashin haske na gilashin filastik mai yawa tare da rarrabawa na waje, rashin daidaituwa da baya sune alamun bayyanar cututtuka na farko.
Dominance na pleural, crazy paving (tsananin ƙwayar cuta tare da cikewar alveolar mai canzawa) da ƙarfafawa na iya bayyana yayin ci gaban cutar.
Akwai karancin bayanai game da lalacewar ƙananan abubuwa da kuma ilimin cututtukan COVID-19.
Abubuwan da aka gano a lokacin da aka yi bincike a kan gawa sune:
Maganin gani da ido: pleurisy, pericarditis, ƙwayar huhu da kuma ƙonewa
Akwai nau'i huɗu na ciwon huhu na kwayar cuta:
Ciwon huhu mai tsanani: ƙonewar huhu, ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
Ciwon huhu mai tsanani: lalacewar alveolar (DAD) tare da ɓarna na alveolar.
DAD yana jawo ciwon sanyin jiki mai tsanani da kuma ciwon jini mai tsanani.
Ciwon huhu mai warkewa: tsarin ƙwayoyin cuta a cikin ƙwayoyin cuta da kuma ƙwayar cuta na huhu
Jini: yaduwar jini (CIVD); amsawar leuko-erythroblastic
Matakan kariya don rage haɗarin kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren da mutane suke da yawa, wanke hannuwanku da sabulu da ruwa a kai a kai na aƙalla dakika 20, kiyaye tsabtace numfashi da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba.
CDC ta bada shawarar rufe baki da hanci da zane yayin tari ko hancin kuma amfani da cikin gwiwar hannu idan babu zane.
Ana ba da shawarar tsabtace hannu bayan tari ko hancin.
Cibiyar Kula da Cututtuka ta CDC ta ba da shawarar rufe fuska da masana'anta a wuraren jama'a don rage yaduwar cutar idan akwai mutane marasa alamomi. Dabarun nisantar jama'a suna nufin rage hulɗar masu kamuwa da cutar da manyan ƙungiyoyi ta rufe makarantu da wuraren aiki, rage tafiya da kuma soke manyan tarurruka.
Ka'idojin nisantawa sun hada da kiyaye nesa ta ƙafa 6 (1.8 m) tsakanin mutane.
Babu wani magani da aka sani da zai yi tasiri wajen hana COVID-19. Tun da ba a sa ran samun allurar rigakafi ba kafin 2021 a farkon lokaci, babban sashi na kula da COVID-19 shine ƙoƙarin rage ƙaruwa, wanda kuma ake kira  daidaitawa .
CDC ta kuma ba da shawarar cewa mutane su riƙa wanke hannayensu da sabulu da ruwa aƙalla na dakika 20, musamman bayan sun je bayan gida ko kuma idan hannayensu sun ƙazantu sosai; kafin su ci abinci; da kuma bayan sun yi tari, tari, ko hancin.
Ya kuma ba da shawarar yin amfani da maganin kashe ƙwayoyin cuta na hannu na giya wanda ya ƙunshi aƙalla kashi 60% na barasa, amma kawai idan ba a samun sabulu da ruwa.
A cikin waɗannan ƙwayoyin, maganin ƙwayoyin cuta yana zuwa ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide don kawar da ƙwayoyin cuta a cikin barasa, ba maganin kashe hannu ba ne.
Ana ƙara glycerol a matsayin mai sa ruwa.
Ana kula da mutane ta hanyar kula da taimako wanda zai iya haɗa da maganin ruwa, maganin oxygen da kuma tallafawa sauran gabobin da ke da muhimmanci.
Hukumar CDC ta ba da shawarar cewa mutanen da ake zargi da dauke da cutar su sanya abin rufe fuska.
An yi amfani da ECMO don magance rashin numfashi, amma har yanzu ana nazarin amfaninta.
An ba da shawarar tsabtace jiki, rayuwa mai kyau da kuma cin abinci mai gina jiki don ƙarfafa rigakafi.
Magungunan tallafi na iya taimakawa ga waɗanda ke da alamun rashin lafiya a farkon kamuwa da cutar. Hukumar Lafiya ta Duniya da Hukumar Lafiya ta Kasa ta China sun ba da shawarwari game da kula da mutanen da ke asibiti don COVID-19.
Likitocin jinya da likitocin huhu a Amurka sun tattara shawarwarin magani daga hukumomi da yawa zuwa cikin wata hanya ta kyauta, IBCC.
A watan Afrilu na 2020, babu takamaiman magani ga COVID-19.
Wasu likitoci suna ba da shawarar yin amfani da maganin paracetamol (acetaminophen) maimakon ibuprofen a matsayin magani na farko don magance cututtuka.
Ya kamata a ɗauki matakan kariya don rage haɗarin watsa kwayar cutar, musamman a yanayin kulawa inda aiwatar da hanyoyin zai iya haifar da aerosols, kamar intubation ko numfashi na hannu.
Ga ma'aikatan kiwon lafiya da ke kula da mutanen da ke fama da COVID-19, CDC ta ba da shawarar sanya mutum a cikin ɗakin keɓewa don kamuwa da cutar ta iska (AIIR) ban da amfani da matakan kariya na yau da kullun, kariya na tuntuɓar mutane da kariya game da watsawa ta iska. CDC ta jaddada jagororin don amfani da kayan kariya na mutum (PPE) yayin annobar.
Ana ba da shawarar kayan aiki kamar su: rigar PPE, abin rufe fuska ko na numfashi, abin kare ido da safar hannu. Idan akwai, ana ba da fifiko ga abin rufe fuska.
An amince da abin rufe fuska na N95 a ƙarƙashin yanayin masana'antu, amma FDA ta ba da izinin amfani da waɗannan abin rufe fuska a ƙarƙashin izinin Amfani da Gaggawa (USA).
An tsara su don kare ƙwayoyin iska kamar ƙura, amma ba a tabbatar da ingancinsu kan takamaiman ƙwayoyin halitta ba don amfani da ba a nuna ba.
Idan ba a samu abin rufe fuska ba, CDC ta ba da shawarar amfani da abin rufe fuska, ko kuma a ƙarshe, abin rufe fuska na gida.
Yawancin masu kamuwa da COVID-19 ba su da tsanani sosai da za su bukaci yin amfani da iska ko wasu hanyoyin, amma akwai wasu kashi na masu kamuwa da cutar.
Ana nazarin irin taimakon numfashi ga mutanen da ke fama da rashin numfashi saboda COVID-19 don waɗanda ke asibiti. Wasu shaidu sun nuna cewa ana iya hana intubation ta amfani da bututun hanci mai saurin gudu ko matsin lamba mai kyau na hanyoyi biyu.
Ba a san ko ɗaya ko biyun suna da amfani iri ɗaya ga waɗanda suke cikin mawuyacin hali ba.
Wasu likitoci sun fi son yin amfani da iska mai guba idan akwai ta domin wannan fasaha tana rage yaduwar ƙwayoyin aerosol idan aka kwatanta da na hanci mai gudu.
Kasashe masu tasowa da yawa ba su da isassun gadajen asibiti ga kowane mutum, wanda ke iyakance ikon tsarin kula da lafiya don magance ƙaruwar kwatsam na adadin masu cutar COVID-19 waɗanda ke da tsanani sosai don buƙatar asibiti.
Wani bincike a China ya nuna cewa kashi 5 cikin ɗari na waɗanda suka kamu da cutar sun shiga sashen kula da marasa lafiya, kashi 2.3 cikin ɗari sun bukaci taimakon numfashi, kuma kashi 1.4 cikin ɗari sun mutu.
A China, kusan kashi 30 cikin ɗari na mutanen da ke cikin asibiti da COVID-19 a ƙarshe suna cikin sashen kulawa mai tsanani.
Yin iska ta hanyar inji ya zama da wahala yayin da cutar COVID-19 ta haifar da ciwon numfashi mai tsanani (ADRS) kuma samun iskar oxygen ya zama da wahala.
Ana buƙatar na'urorin numfashi tare da hanyoyin sarrafa matsin lamba da PEEP mai girma don inganta isar da iskar oxygen da rage haɗarin lalacewar huhu da ke tattare da numfashi da kuma pneumothorax.
Ana iya samun PEEP mai yawa a kan tsofaffin kayan iska.
Binciken yiwuwar magani ya fara a watan Janairun 2020 kuma ana gwada magungunan rigakafin ƙwayoyin cuta da yawa.
Da alama cewa maganin remdesivir ne zai taimaka.
Ko da yake ba za a iya samar da sababbin magunguna ba kafin shekara ta 2021, an riga an amince da wasu magunguna da ake gwadawa a wasu alamomi kuma an riga an ci gaba da gwaji.
Za a iya gwada maganin rigakafin ƙwayoyin cuta a kan mutanen da suke da ciwo mai tsanani.
WHO ta ba da shawarar masu sa kai su shiga gwajin inganci da amincin magunguna masu yuwuwa. FDA ta ba da izinin ɗan lokaci don plasma na mutanen da ke murmurewa a matsayin magani na gwaji a lokuta da rayuwar mutum ke cikin haɗari ko kuma nan da nan.
Ba a yi gwajin asibiti da ya dace don tabbatar da amincinsa da ingancinsa ga cutar ba.
A watan Fabrairun 2020, kasar Sin ta kaddamar da wata manhajar wayar hannu don magance annobar.
Ana tambayar masu amfani su shigar da sunayensu da kuma lambar shaida.
Aikace-aikacen na iya gano  kusanci  ta amfani da bayanan sa ido kuma don haka gano yiwuwar kamuwa da cuta.
Kowane mai amfani zai iya sarrafa matsayin wasu masu amfani uku.
Idan an gano wata haɗari, ba wai kawai ana ba da shawarar keɓe kai ba ne, amma ana kuma faɗakar da hukumomin kiwon lafiya na gida. Ana amfani da nazarin bayanai masu yawa na wayar hannu, fasahar gane fuska, gano wurin wayar hannu da kuma ilimin kere kere don gano mutanen da ke da cutar da kuma waɗanda suka taɓa saduwa da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na 2020, gwamnatin Isra'ila ta ba hukumomin tsaro izinin gano bayanan wayar hannu na mutanen da ake zargi da cutar coronavirus.
An yi wannan ne don tabbatar da keɓewa da kuma kare mutanen da wataƙila sun taɓa saduwa da wasu da suka kamu da cutar.
A watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanan wurin wayar tarho tare da cibiyar gwamnatin tarayya ta Jamus, cibiyar Robert Koch, don nazarin da kuma hana yaduwar cutar.
Rasha ta yi amfani da fasahar gane fuska don gano mutanen da ba su bi dokar killacewa ba.
A Italiya, Ministan Lafiya na Yanki Giulio Gallera ya ce masu amfani da wayoyin salula sun gaya masa cewa  kashi 40 cikin ɗari na mutane suna ci gaba da tafiya .
Gwamnatin Jamus ta gudanar da taron fasahar kwamfuta na tsawon sa'o'i 48 a ƙarshen mako tare da masu halarta fiye da 42,000.
Shugabar Estonia, Kersti Kaljulaid, ta yi kira ga duniya da ta nemi hanyoyin samar da hanyoyin magance yaduwar cutar korona.
Mutane suna iya shan wahala daga keɓewa, ƙuntatawa na tafiya, sakamako na magani ko tsoron kamuwa da cutar kanta.
BBC ta nakalto Rory O'Connor yana cewa,  kara kebewar kai, kadaici, damuwa game da lafiya, damuwa da koma bayan tattalin arziki sune cikakkiyar hadin gwiwa don cutar da lafiyar kwakwalwa da jin daɗin mutane .
Cutar na iya zama mai tsaka-tsakin ci gaba tare da alamomi kaɗan ko babu alamomi, kamar sauran cututtukan numfashi na yau da kullun kamar sanyi.
Masu fama da cutar mai tsanani sukan warke cikin makonni biyu, amma masu fama da cutar mai tsanani sukan yi mako uku zuwa shida.
Mata masu ciki na iya zama cikin haɗarin kamuwa da cutar COVID-19 mai tsanani bisa ga bayanan da aka samu daga ƙwayoyin cuta masu kama da SARS da MERS, duk da haka babu bayanai game da COVID-19. A wasu lokuta, COVID-19 na iya shafar huhu da haifar da ciwon huhu.
A cikin mutane da cutar ta fi shafawa, COVID-19 na iya saurin ci gaba zuwa ciwon numfashi mai tsanani (ADRS) wanda ke haifar da rashin numfashi, damuwa ko rashin aiki.
Matsalolin da ke tattare da COVID-19 sun haɗa da cutar sankarar jini, cututtukan jini da kuma ciwon zuciya, koda da hanta.
An bayyana rashin jinin jini, musamman ƙara lokacin prothrombin, a cikin kashi 6 cikin ɗari na masu cutar COVID-19 da aka kwantar a asibiti, tare da rashin aikin koda a cikin kashi 4 cikin ɗari na mutanen da ke cikin wannan rukunin.
Kimanin kashi 20 zuwa 30 cikin ɗari na mutanen da ke da COVID-19 suna da ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo
Rahoton ya ce, matsakaicin lokacin da ya wuce tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki goma, kuma biyar daga cikinsu an kwantar da su a asibiti.
Amma, marasa lafiya da aka kai asibiti suna da matsakaicin kwanaki bakwai kafin su mutu.
A cikin binciken da aka yi kan marasa lafiya na farko, matsakaicin lokacin da ke tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki 14, tare da jimlar kwanaki shida zuwa 41.
A wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta yi, maza sun mutu da kashi 2.8 cikin dari yayin da mata suka mutu da kashi 1.7 cikin dari.
Binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututututut
An lura da canjin kwayar cutar ta hanyar kwayar cuta a cikin ƙwayoyin huhu.
Hoton na huhu yana kama da na ciwon numfashi mai tsanani (ARDS).
A cikin kashi 11.8 cikin dari na mutuwar da Hukumar Kiwon Lafiyar Kasa ta kasar Sin ta ruwaito, an samu lalacewar zuciya saboda yawan troponin ko kuma ciwon zuciya.
Bayanai daga watan Maris daga Amurka sun nuna cewa kashi 89 cikin ɗari na waɗanda aka kwantar a asibiti suna da cututtuka da suka riga sun kamu da su. Samun albarkatun kiwon lafiya da yanayin tattalin arziki na yanki na iya shafar mutuwar.
Ƙididdigar yawan mutuwar cutar ta bambanta saboda waɗannan bambance-bambance na yanki, amma kuma saboda matsalolin hanyoyin.
Rashin ƙididdigar ƙananan lokuta na iya haifar da ƙididdigar yawan mutuwar.
Koyaya, gaskiyar cewa mutuwar ta kasance sakamakon cututtukan da aka kamu da su a baya na iya nuna cewa an rage yawan mutuwar yanzu.
Masu shan taba sun fi sau 1.4 fuskantar kamuwa da mummunan alamun COVID-19 kuma suna da sau 2.4 na haɗarin zuwa asibiti ko mutuwa idan aka kwatanta da waɗanda ba masu shan taba ba. An kuma nuna damuwa game da tasirin cutar na dogon lokaci.
Gwamnatin asibitin Hong Kong ta lura da raguwar numfashi da kashi 20 zuwa 30 cikin ɗari a cikin wasu mutanen da suka warke daga cutar, kuma binciken huhu ya nuna lalacewar jiki.
Hakan zai iya sa mutum ya soma ciwo bayan ya warke daga ciwon.
Har zuwa watan Maris na 2020, ba a san ko kamuwa da cutar da ta gabata tana samar da kariya mai inganci na dogon lokaci a cikin mutanen da suka warke daga cutar ba.
Ana ganin cewa zai yiwu a samu rigakafi, bisa ga yadda wasu cututtukan korona suke nunawa, amma an samu rahotanni na mutanen da suka warke daga COVID-19 da kuma waɗanda suka kamu da cutar a wani lokaci.
Ana ganin waɗannan lamuran a matsayin mummunan kamuwa da cuta maimakon sake kamuwa da cuta.
Ana ganin cewa kwayar cutar ta samo asali ne daga dabbobi, ta hanyar yaduwar kamuwa da cuta.
Ba a san ainihin asalin cutar ba, amma a watan Disamba na 2019, kusan ana yada cutar ne ta hanyar watsawa daga mutum zuwa mutum.
Binciken da aka yi a kan mutane 41 da suka kamu da cutar COVID-19 da aka buga a cikin jaridar The Lancet a watan Janairun 2020 ya nuna cewa farkon lokacin da alamun cutar suka fara bayyana shi ne ranar 1 ga Disamba, 2019.
Littattafan WHO na hukuma sun nuna farkon bayyanar cututtuka a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni dabam dabam wajen sanin yawan mutuwa.
Waɗannan ƙididdigar sun bambanta tsakanin yankuna da lokaci, kuma suna da tasiri ta yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta fara, da kuma yanayin alƙaluma kamar shekaru, jinsi da yanayin lafiya.
A ƙarshen 2019, WHO ta sanya lambobin gaggawa na CIM-10 U07.1 don mutuwar da aka tabbatar a cikin dakin gwaje-gwaje na kamuwa da cutar SARS-CoV-2 da U07.2 don mutuwar COVID-19 da aka gano a cikin asibiti ko cututtukan cututtuka ba tare da kamuwa da cutar SARS-CoV-2 da aka tabbatar a cikin dakin gwaje-gwaje ba. Matsakaicin mutuwar zuwa yanayin yana nuna yawan mutuwar da aka raba da yawan masu kamuwa da cutar a cikin wani lokaci.
A cewar kididdigar Jami'ar Johns Hopkins, adadin mutuwar da cutar a duniya ya kai kashi 6.9 (153,822/2 240 191) a ranar 17 ga Afrilu, 2020.
Wannan adadi ya bambanta da yanki. Sauran ma'auni sun haɗa da yawan mutuwar (CFR) wanda ke nuna yawan mutanen da aka gano sun mutu daga cutar da kuma yawan mutuwar kamuwa da cuta (IRF) wanda ke nuna yawan mutanen da ke da cutar (wanda aka gano ko ba a gano ba) waɗanda suka mutu daga cutar.
Waɗannan ƙididdigar ba su da iyaka a lokaci kuma suna bin takamaiman yawan mutane daga kamuwa da cutar zuwa ƙarshen cutar.
Ko da yake ba dukan mutanen da ke da cutar ba ne suke samun ƙwayoyin rigakafi, amma idan akwai ƙwayoyin rigakafi, hakan zai nuna yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, a Castiglione d'Adda, wani ƙaramin ƙauye mai yawan mutane 4,600, 80 daga cikinsu (1.7%) sun riga sun mutu.
A Gangelt, cutar ta yadu ta hanyar bukukuwa, da kuma ga matasa, wanda ya haifar da ƙananan mutuwar, kuma ba duk mutuwar da ke da alaƙa da COVID-19 ba ne aka yi la'akari da su a matsayin irin wannan.
Ƙari ga haka, ba a cika tsarin kiwon lafiya na Jamus da abinci ba.
A Netherlands, kashi uku cikin ɗari na mutane suna da ƙwayoyin rigakafi, in ji wani bincike da aka yi a kan masu ba da jini.
An tabbatar da mutuwar mutane 69 (kashi 0.004 cikin ɗari na yawan jama'a) da ke da nasaba da COVID-19.
Tasirin annobar da kuma yawan mace-mace sun bambanta tsakanin maza da mata.
Matattu sun fi yawa a cikin maza a binciken da aka yi a China da Italiya.
Maza da suka kai shekara hamsin ne suke da haɗarin yin hakan, kuma a shekara ta 90 ne kaɗai za a iya ganin bambancin tsakanin maza da mata.
A ƙasar Sin, mace-macen da ke mutuwa a lokacin cutar sun kai kashi 2.8 cikin ɗari a tsakanin maza da kuma kashi 1.7 cikin ɗari a tsakanin mata.
Ba a san ainihin dalilin da ya sa maza da mata ba sa yin aure ba, amma wataƙila wasu abubuwa da ke tattare da hali ne suke jawo hakan.
Bambancin tsarin rigakafi tsakanin maza da mata, ƙarancin shan taba a cikin mata, da kuma ci gaban cututtuka a cikin maza kamar hawan jini a cikin shekaru masu zuwa fiye da mata na iya taimakawa wajen mutuwar maza.
A Turai, kashi 57 cikin ɗari na mutanen da suka kamu da cutar maza ne, kuma kashi 72 cikin ɗari na mutanen da suka mutu daga COVID-19 maza ne.
A watan Afrilun 2020, gwamnatin Amurka ba ta tattara bayanan da suka shafi jinsi na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtuka kamar su Ebola, HIV, mura, da kuma SARS suna shafan maza da mata dabam dabam.
Yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne kuma suna cikin haɗarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar shine  COVID-19 .
Darakta Janar na WHO Tedros Adhanom Ghebreyesus ya bayyana cewa CO na nufin corona, VI na nufin kwayar cuta, kuma D na nufin cuta, 19 shine farkon gano cutar: 31 ga Disamba, 2019.
An zaɓi wannan sunan ne don kauce wa yin magana game da wani wuri na musamman (misali China), dabba ko rukuni na mutane, bisa ga shawarwarin ƙididdigar ƙasa da ƙasa don hana ƙyama. Ana kiran kwayar cutar da ke haifar da COVID-19 coronavirus 2 mai alaƙa da mummunan cututtukan numfashi (SARS-CoV-2).
WHO ta kuma yi amfani da  kwayar cutar COVID-19  da  kwayar cutar da ke haifar da COVID-19  a cikin sadarwar jama'a.
Ana kiran cutar da kwayar cutar  coronavirus .
A lokacin barkewar cutar a Wuhan, China, ana kiran kwayar cutar da cutar  coronavirus  da  Wuhan coronavirus .
A watan Janairun 2020, WHO ta ba da shawarar yin amfani da sunayen cutar na wucin gadi 2019-nCov da kuma cutar numfashi mai tsanani 2019-nCoV don kwayar cutar da cutar, daidai da umarnin 2015 game da amfani da wurare a cikin sunayen cututtuka da ƙwayoyin cuta.
An buga sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar samar da kayayyaki, wasu masana'antun dijital suna buga kayan aikin kulawa kamar su swabs da sassan numfashi.
Alal misali, sa'ad da asibiti a ƙasar Italiya yake bukatar bawul na numfashi da gaggawa kuma mai sayar da shi bai iya ba da shi a kan lokaci ba, wata 'yar kasuwa ta ƙasar ta sake tsara bawul ɗin da ake bukata kuma ta buga su a cikin dare ɗaya.
Bayan barkewar cutar COVID-19, ra'ayoyin makirci, labaran karya da kuma rashin gaskiya game da asalin cutar, yaduwarta, rigakafi, magani da sauran fannoni sun bayyana kuma sun bazu cikin sauri a kan layi.
Da alama cewa mutane suna iya yaɗa cutar ga wasu dabbobi.
Binciken bai sami wata hujja ba game da kwayar cutar a aladu, ducks da kaji.
Babu magani ko allurar riga-kafi da aka amince da ita don magance cutar.
A halin yanzu ƙungiyoyin gwamnati, ƙungiyoyin ilimi da masu bincike na masana'antu suna gudanar da bincike na duniya kan alluran rigakafi da magunguna don COVID-19.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da gwajin SOLIDARITY don tantance tasirin maganin maganin ƙwayoyin cuta huɗu da ke da alamar tasiri.
Babu riga-kafi da ake da shi, amma hukumomi da yawa suna aiki sosai wajen samar da riga-kafin da za a yi.
Ana amfani da binciken da aka yi a baya akan SARS-CoV saboda duka SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam.
Ana bincika dabarun yin rigakafi guda uku.
Na farko, masu bincike suna ƙoƙarin yin allurar rigakafi da ke ɗauke da ƙwayar cuta.
Amfani da irin wannan kwayar cutar, ko ba ta aiki ko ta mutu, yana nufin sa jikin mutum ya amsa da sauri idan aka sake kamuwa da COVID-19.
Dabara ta biyu, allurar rigakafin da ke da ƙananan raka'a, tana nufin samar da allurar rigakafin da ke sa tsarin garkuwar jiki ya san wasu ƙananan ƙwayoyin cutar.
A game da SARS-CoV-2, wannan bincike ya mai da hankali ne kan furotin S mai ƙwanƙwasawa wanda ke taimaka wa kwayar cutar ta shiga cikin mai karɓar ACE 2.
Hanya ta uku ita ce rigakafin nucleic acid (DNA ko RNA rigakafi, sabuwar hanyar samar da rigakafi).
An yi tsammanin za a gwada alluran rigakafin gwaji daga duk waɗannan dabarun don aminci da inganci. A ranar 16 ga Maris, 2020, gwajin asibiti na farko na allurar rigakafi ya fara tare da masu sa kai huɗu a Seattle.
Allurar rigakafin ta ƙunshi kwafin kwayar halitta mara lahani daga kwayar cutar da ke haifar da cutar. An nuna cewa kunnawar ƙwayoyin cuta da ke dogara da ƙwayoyin cuta wata matsala ce a cikin haɓaka allurar rigakafin SARS-CoV-2, amma ana jayayya.
A watan Afrilun 2020, an yi gwaji sama da 300 a asibiti.
Gwaje-gwaje bakwai sun kimanta maganin zazzabin cizon sauro da aka riga aka amince da su, ciki har da bincike huɗu da suka shafi hydroxychloroquine ko chloroquine.
Magungunan rigakafin cutar da aka sake sarrafawa sune mafi yawan binciken da ake yi a China, tare da gwaji tara na gwaji na uku na remdesivir a ƙasashe da yawa da ake sa ran rahotanni a ƙarshen Afrilu.
An kuma gudanar da bincike mai zurfi kan ci gaban asibiti na alluran rigakafi da magunguna masu dacewa da COVID-19 a watan Afrilu na 2020. Ana nazarin magungunan rigakafin cutar da ke akwai don maganin COVID-19, gami da remdesivir, chloroquine da lhydroxychloroquine, lopinavir/ritonavir, da lopinavir/ritonavir tare da interferon beta.
Bayanai na farko sun nuna tasirin remdesivir a watan Maris na 2020.
An lura da ci gaba a cikin marasa lafiya da ke shan remdesivir don jinƙai.
Ana gudanar da gwaji na asibiti na kashi na uku a Amurka, China da Italiya. An yi nazarin chloroquine, wanda aka yi amfani da shi a baya don magance zazzabin cizon sauro, a China a watan Fabrairun 2020, tare da sakamakon farko.
Amma, wasu suna son a bincika binciken da kansu.
Hukumomin kiwon lafiya na kasar Sin da Koriya sun ba da shawarar yin amfani da chloroquine.
Koyaya, Cibiyar Kwayoyin Cutar Wuhan, duk da cewa tana ba da shawarar kashi ɗaya na gram a kowace rana, ta ce ninki biyu na wannan adadin yana da haɗari sosai kuma yana iya zama mai kisa.
A ranar 28 ga Maris, 2020, Hukumar Kula da Abinci da Magunguna ta amince da amfani da hydroxychloroquine da chloroquine a ƙarƙashin izinin amfani da gaggawa a kan shawarar likitocin da ke kula da marasa lafiya na COVID-19.
Bayanai na farko sun nuna cewa ana buƙatar ribavirin mai yawa don hana SARS-CoV-2 a cikin vitro.
An ba da shawarar nitazoxanide don ƙarin binciken in vivo bayan ya nuna ƙarancin hanawa na SARS-CoV-2. Nazarin ya nuna cewa furotin na farko na farko wanda ke haifar da serine transmembrane protease 2 (TMPRSS2) yana da mahimmanci don shigar SARS-CoV-2 ta hanyar hulɗa tare da mai karɓar ACE 2.
Nazarin chloroquine da lhydroxychloroquine tare da azithromycin ko ba tare da azithromycin ba yana da manyan iyakoki waɗanda suka hana ƙungiyar likitoci karɓar waɗannan magungunan ba tare da ƙarin bincike ba. Loseltamivir baya hana SARS-CoV-2 a cikin vitro kuma ba shi da wani sanannen aiki a cikin maganin COVID-19.
Cytokine shock na iya zama matsala a matakan COVID-19 mai tsanani.
Akwai shaidar cewa hydroxychloroquine na iya samun kayan aikin tsayayya da harin cytokine. Hukumar Lafiya ta Kasa ta kasar Sin ta sanya tocilizumab a cikin jagororin magani bayan an gudanar da karamin bincike.
Ana gudanar da gwajin kashi na 2 a Italiya bayan ya nuna sakamako mai kyau a cikin mutanen da ke da mummunan cutar.
Idan aka haɗa shi da gwajin jini na ferritin na jini don gano harin cytokine, dole ne ya magance irin waɗannan canje-canjen da ake tsammanin sun haifar da mutuwar wasu mutanen da ke fama da cutar.
FDA ta amince da maganin mai karɓar mai karɓar interleukin-6 bisa ga nazarin shari'ar baya don maganin cutar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan CART.
Har zuwa yau, babu wata hujja da aka sarrafa ta hanyar bazuwar da ke nuna cewa tocilizumab magani ne mai tasiri don CFS.
Ana nazarin canja wurin ƙwayoyin cuta masu ƙoshin lafiya da aka tsarkake waɗanda tsarin garkuwar jiki na mutanen da suka warke daga COVID-19 zuwa ga waɗanda suke buƙatar su azaman hanyar rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigakafin rigaka
An gwada wannan dabarar don SARS ba tare da sakamako mai kyau ba.
Rashin cutar kwayar cuta shine hanyar da ake tsammani ta hanyar maganin ƙwayoyin cuta na ƙwayoyin cuta na iya haifar da kariya daga SARS-CoV-2.
Koyaya, wasu hanyoyin kamar ƙwayoyin cuta na ƙwayoyin cuta da ke dogara da ƙwayoyin cuta da/ko phagocytosis na iya yiwuwa.
Ana kuma yin wasu hanyoyin maganin rigakafi, kamar amfani da ƙwayoyin rigakafi na monoclonal.
Za a iya ƙara samar da maganin warkewa, wanda ya ƙunshi ruwa daga jinin marasa lafiya da aka warkar da shi kuma yana ɗauke da ƙwayoyin cuta na musamman da cutar don saurin yaduwa.
Cutar coronavirus, wata ƙungiya ce ta cututtuka masu alaƙa da juna
Li Wenliang, likita a babban asibitin Wuhan, wanda daga baya ya kamu da COVID-19 kuma ya mutu bayan ya jawo hankali ga yaduwar cutar.
